page	event	quadrant	sample_name	position	oscillating_cn_2&3_states	cn_segments	event_region	full_text
1	1	Upper_Left	BTCA_donor_A153	1:218376406−246159643	5, 8	8	{'min_x': 58.789798736572266, 'min_y': 296.9750061035156, 'max_x': 226.21180725097656, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB BTCA_donor_A153 Biliary−AdenoCA Cancer type 1:218376406−246159643 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 116 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9599662 FDR fragment joints
1	2	Upper_Right	096b4f32-10c1-4737-a0dd-cae04c54ee33	13:42975600−107442606	10, 10	10	{'min_x': 329.07000732421875, 'min_y': 296.9750061035156, 'max_x': 537.65966796875, 'max_y': 406.2539978027344}	60 MB 80 MB 100 MB 096b4f32−10c1−4737−a0dd−cae04c54ee33 Bladder−TCC Cancer type 13:42975600−107442606 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 136 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.05741733 FDR fragment joints
1	3	Lower_Left	24f21425-b001-4986-aedf-5b4dd851c6ad	X:6615453−133296546	7, 9	30	{'min_x': 39.73979949951172, 'min_y': 731.9749755859375, 'max_x': 247.99203491210938, 'max_y': 831.8338012695312}	50 MB 100 MB 24f21425−b001−4986−aedf−5b4dd851c6ad Bladder−TCC Cancer type X:6615453−133296546 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 8; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 2 271 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 30 CN segments
1	4	Lower_Right	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	13:20578507−113387449	12, 12	12	{'min_x': 306.0400085449219, 'min_y': 731.9749755859375, 'max_x': 537.6519775390625, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB 100 MB 419deaac−ea45−4bdd−9fa0−b5cd8429b44f Bladder−TCC Cancer type 13:20578507−113387449 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 62 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
2	1	Upper_Left	556fcbc8-172a-4af1-8822-ae036e8d68e8	11:43215596−134760626	5, 7	13	{'min_x': 40.36989974975586, 'min_y': 296.9750061035156, 'max_x': 247.36195373535156, 'max_y': 406.2539978027344}	60 MB 80 MB 100 MB 120 MB 556fcbc8−172a−4af1−8822−ae036e8d68e8 Bladder−TCC Cancer type 11:43215596−134760626 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 207 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints
2	2	Upper_Right	904a8757-e0c5-41ef-b583-c8f170caaac1	3:1555799−137115914	7, 7	13	{'min_x': 330.0400085449219, 'min_y': 296.9750061035156, 'max_x': 536.69189453125, 'max_y': 406.2539978027344}	50 MB 100 MB 904a8757−e0c5−41ef−b583−c8f170caaac1 Bladder−TCC Cancer type 3:1555799−137115914 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 3 274 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.0726553 FDR fragment joints
2	3	Lower_Left	cb664eef-be6f-44ef-aa90-6f6da0e6440a	8:47026265−51150625	4, 4	12	{'min_x': 41.539798736572266, 'min_y': 731.9749755859375, 'max_x': 268.9220886230469, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB cb664eef−be6f−44ef−aa90−6f6da0e6440a Bladder−TCC Cancer type 8:47026265−51150625 Position 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 1 180 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 12 CN segments
2	4	Lower_Right	CGP_donor_1437403	9:3641509−137589235	8, 10	28	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 100 MB CGP_donor_1437403 Bone−Osteosarc Cancer type 9:3641509−137589235 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 9; h2hINV: 0; SV types t2tINV: 1; TRA: 5 445 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 28 CN segments
3	1	Upper_Left	CGP_donor_1475256	7:43498754−52862136	4, 4	6	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 250.41006469726562, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB CGP_donor_1475256 Bone−Osteosarc Cancer type 7:43498754−52862136 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 0 217 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 6 CN segments 0.615458 FDR fragment joints
3	2	Upper_Right	CGP_donor_1691147	3:78199279−90320009	8, 8	8	{'min_x': 309.3399963378906, 'min_y': 296.9750061035156, 'max_x': 528.0322875976562, 'max_y': 406.2539978027344}	75 MB 100 MB 125 MB 150 MB 175 MB CGP_donor_1691147 Bone−Osteosarc Cancer type 3:78199279−90320009 Position 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 4 279 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9723381 FDR fragment joints
3	3	Lower_Left	CGP_donor_1691212	9:14638768−26392657	7, 7	14	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 230.8000030517578, 'max_y': 831.8338012695312}	16 MB 20 MB 24 MB CGP_donor_1691212 Bone−Osteosarc Cancer type 9:14638768−26392657 Position 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 6 135 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 14 CN segments
3	4	Lower_Right	CGP_donor_1691217	2:59017074−241406602	14, 40	40	{'min_x': 326.5299987792969, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 836.9337768554688}	100 MB 150 MB 200 MB CGP_donor_1691217 Bone−Osteosarc Cancer type 2:59017074−241406602 Position 9 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 8 380 SVs in sample 14, 40 Oscillating CN (2 and 3 states) 40 CN segments 0.615458 FDR fragment joints
4	1	Upper_Left	CGP_donor_1691217	5:82186991−145068339	6, 17	17	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 257.0020751953125, 'max_y': 406.2539978027344}	80 MB 120 MB 160 MB CGP_donor_1691217 Bone−Osteosarc Cancer type 5:82186991−145068339 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 380 SVs in sample 6, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.8653243 FDR fragment joints
4	2	Upper_Right	CGP_donor_1691217	11:819052−86320878	14, 25	25	{'min_x': 307.2200012207031, 'min_y': 296.9750061035156, 'max_x': 541.400146484375, 'max_y': 406.2539978027344}	0 MB 20 MB 40 MB 60 MB 80 MB CGP_donor_1691217 Bone−Osteosarc Cancer type 11:819052−86320878 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 2 380 SVs in sample 14, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.01147689 FDR fragment joints
4	3	Lower_Left	CGP_donor_1691217	19:43092652−56632954	7, 7	10	{'min_x': 46.16019821166992, 'min_y': 731.9749755859375, 'max_x': 234.59010314941406, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_1691217 Bone−Osteosarc Cancer type 19:43092652−56632954 Position 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 5 380 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 10 CN segments
4	4	Lower_Right	CGP_donor_1232859	8:91550520−101047671	7, 12	12	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB CGP_donor_1232859 Breast−AdenoCA Cancer type 8:91550520−101047671 Position 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 3 316 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
5	1	Upper_Left	CGP_donor_1333048	4:22856554−121362620	11, 14	14	{'min_x': 59.41019821166992, 'min_y': 296.9750061035156, 'max_x': 234.19200134277344, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CGP_donor_1333048 Breast−AdenoCA Cancer type 4:22856554−121362620 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 178 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.04139017 FDR fragment joints
5	2	Upper_Right	CGP_donor_1347742	3:25050231−162503837	9, 11	11	{'min_x': 332.5799865722656, 'min_y': 296.9750061035156, 'max_x': 556.2020874023438, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB CGP_donor_1347742 Breast−AdenoCA Cancer type 3:25050231−162503837 Position 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 6 230 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
5	3	Lower_Left	CGP_donor_1347751	1:1174539−247054567	38, 50	50	{'min_x': 61.849998474121094, 'min_y': 731.9749755859375, 'max_x': 226.75213623046875, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 1:1174539−247054567 Position 1 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 2; DUP: 33; h2hINV: 0; SV types t2tINV: 0; TRA: 2 828 SVs in sample 38, 50 Oscillating CN (2 and 3 states) 50 CN segments
5	4	Lower_Right	CGP_donor_1347751	2:11684173−217099835	30, 56	56	{'min_x': 352.9700012207031, 'min_y': 731.9749755859375, 'max_x': 519.7420043945312, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 2:11684173−217099835 Position 2 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 828 SVs in sample 30, 56 Oscillating CN (2 and 3 states) 56 CN segments
6	1	Upper_Left	CGP_donor_1347751	3:2964392−195733210	9, 25	27	{'min_x': 61.849998474121094, 'min_y': 296.9750061035156, 'max_x': 225.87779235839844, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 3:2964392−195733210 Position 1 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 15; h2hINV: 1; SV types t2tINV: 2; TRA: 2 828 SVs in sample 9, 25 Oscillating CN (2 and 3 states) 27 CN segments 0.0009494935 FDR fragment joints
6	2	Upper_Right	CGP_donor_1347751	7:63018209−154939154	16, 20	20	{'min_x': 346.1199951171875, 'min_y': 296.9750061035156, 'max_x': 515.3778686523438, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 7:63018209−154939154 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 13; h2hINV: 0; SV types t2tINV: 1; TRA: 2 828 SVs in sample 16, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.0002315962 FDR fragment joints
6	3	Lower_Left	CGP_donor_1347751	15:34326314−93601501	13, 19	19	{'min_x': 40.06990051269531, 'min_y': 731.9749755859375, 'max_x': 254.9401397705078, 'max_y': 831.8338012695312}	40 MB 50 MB 60 MB 70 MB 80 MB 90 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 15:34326314−93601501 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 14; h2hINV: 0; SV types t2tINV: 0; TRA: 0 828 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 19 CN segments
6	4	Lower_Right	CGP_donor_1347751	16:1073804−87928916	10, 19	19	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 537.39990234375, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 16:1073804−87928916 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 1; SV types t2tINV: 0; TRA: 0 828 SVs in sample 10, 19 Oscillating CN (2 and 3 states) 19 CN segments
7	1	Upper_Left	CGP_donor_1347751	20:11282201−60847010	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 259.7601013183594, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 20:11282201−60847010 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 828 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1013295 FDR fragment joints
7	2	Upper_Right	CGP_donor_1353427	6:100548524−101591934	7, 7	11	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 557.2719116210938, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB CGP_donor_1353427 Breast−AdenoCA Cancer type 6:100548524−101591934 Position 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 3 267 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
7	3	Lower_Left	CGP_donor_1353434	6:104620681−144195202	5, 5	5	{'min_x': 60.23979949951172, 'min_y': 731.9749755859375, 'max_x': 238.01177978515625, 'max_y': 831.8338012695312}	75 MB 100 MB 125 MB 150 MB CGP_donor_1353434 Breast−AdenoCA Cancer type 6:104620681−144195202 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 0; SV types t2tINV: 2; TRA: 0 291 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
7	4	Lower_Right	CGP_donor_1364033	2:2226914−240877127	7, 12	12	{'min_x': 307.2699890136719, 'min_y': 731.9749755859375, 'max_x': 520.8821411132812, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 2:2226914−240877127 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 529 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
8	1	Upper_Left	CGP_donor_1397278	2:22430768−219287015	9, 21	23	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 244.2220001220703, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_1397278 Breast−AdenoCA Cancer type 2:22430768−219287015 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 3 340 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 23 CN segments 0.001274711 FDR fragment joints
8	2	Upper_Right	CGP_donor_1397278	7:5041125−108355553	16, 16	16	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB CGP_donor_1397278 Breast−AdenoCA Cancer type 7:5041125−108355553 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 340 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.1790694 FDR fragment joints
8	3	Lower_Left	CGP_donor_1397278	15:33060156−81482186	8, 13	13	{'min_x': 51.04999923706055, 'min_y': 731.9749755859375, 'max_x': 261.8998718261719, 'max_y': 831.8338012695312}	40 MB 50 MB 60 MB 70 MB 80 MB CGP_donor_1397278 Breast−AdenoCA Cancer type 15:33060156−81482186 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 3 340 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 13 CN segments
8	4	Lower_Right	CGP_donor_1397278	X:12671854−155005826	7, 9	9	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB CGP_donor_1397278 Breast−AdenoCA Cancer type X:12671854−155005826 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 6 340 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments
9	1	Upper_Left	CGP_donor_1475200	2:81350895−234457223	7, 12	14	{'min_x': 56.53010177612305, 'min_y': 296.9750061035156, 'max_x': 232.7118377685547, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_1475200 Breast−AdenoCA Cancer type 2:81350895−234457223 Position 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 6 331 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints
9	2	Upper_Right	CGP_donor_1069291	2:30546371−228922869	9, 9	22	{'min_x': 330.1099853515625, 'min_y': 296.9750061035156, 'max_x': 526.7620849609375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_1069291 Breast−AdenoCA Cancer type 2:30546371−228922869 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 0 277 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.003601907 FDR fragment joints
9	3	Lower_Left	CGP_donor_1069291	14:23497943−75621029	10, 14	14	{'min_x': 55.36989974975586, 'min_y': 731.9749755859375, 'max_x': 245.14016723632812, 'max_y': 831.8338012695312}	30 MB 40 MB 50 MB 60 MB 70 MB CGP_donor_1069291 Breast−AdenoCA Cancer type 14:23497943−75621029 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 277 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 14 CN segments
9	4	Lower_Right	CGP_donor_1167079	6:6984465−157517645	10, 13	13	{'min_x': 351.3500061035156, 'min_y': 731.9749755859375, 'max_x': 515.3778686523438, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB CGP_donor_1167079 Breast−AdenoCA Cancer type 6:6984465−157517645 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 5 258 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 13 CN segments
10	1	Upper_Left	CGP_donor_1199138	6:146079326−157043927	8, 11	11	{'min_x': 55.139801025390625, 'min_y': 296.9750061035156, 'max_x': 236.9117889404297, 'max_y': 406.2539978027344}	60 MB 80 MB 100 MB 120 MB 140 MB CGP_donor_1199138 Breast−AdenoCA Cancer type 6:146079326−157043927 Position 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 5 426 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.8653243 FDR fragment joints
10	2	Upper_Right	CGP_donor_1230785	1:10186027−116894133	11, 15	32	{'min_x': 308.32000732421875, 'min_y': 296.9750061035156, 'max_x': 561.1619262695312, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB CGP_donor_1230785 Breast−AdenoCA Cancer type 1:10186027−116894133 Position 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 5 502 SVs in sample 11, 15 Oscillating CN (2 and 3 states) 32 CN segments 0.9804396 FDR fragment joints
10	3	Lower_Left	CGP_donor_1347745	6:22611379−97921915	7, 8	30	{'min_x': 37.03010177612305, 'min_y': 731.9749755859375, 'max_x': 265.05206298828125, 'max_y': 836.9337768554688}	40 MB 80 MB 120 MB 160 MB CGP_donor_1347745 Breast−AdenoCA Cancer type 6:22611379−97921915 Position 3 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 3; SV types t2tINV: 0; TRA: 24 551 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 30 CN segments 0.8393975 FDR fragment joints
10	4	Lower_Right	CGP_donor_1353432	18:20297595−48213819	5, 7	12	{'min_x': 305.92999267578125, 'min_y': 731.9749755859375, 'max_x': 534.6401977539062, 'max_y': 831.8338012695312}	20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1353432 Breast−AdenoCA Cancer type 18:20297595−48213819 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 0 185 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 12 CN segments
11	1	Upper_Left	CGP_donor_1353432	20:34182540−35338513	4, 5	13	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.92996215820312, 'max_y': 406.2539978027344}	35 MB 37 MB 39 MB CGP_donor_1353432 Breast−AdenoCA Cancer type 20:34182540−35338513 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 0 185 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 13 CN segments 0.5435077 FDR fragment joints
11	2	Upper_Right	CGP_donor_1363969	1:20593050−248597403	8, 9	59	{'min_x': 321.5199890136719, 'min_y': 296.0599670410156, 'max_x': 561.7822265625, 'max_y': 407.0240173339844}	CGP_donor_1363969 50 MB 100 MB 150 MB 200 MB 250 MB Breast−AdenoCA Cancer type 1:20593050−248597403 Position 1 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 2; DUP: 12; h2hINV: 2; SV types t2tINV: 1; TRA: 22 680 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 59 CN segments 0.01578149 FDR fragment joints 0.02 FDR chr. breakp. enrich.
11	3	Lower_Left	CGP_donor_1374619	6:12789227−162322086	13, 15	18	{'min_x': 57.960201263427734, 'min_y': 731.9749755859375, 'max_x': 256.4219970703125, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB CGP_donor_1374619 Breast−AdenoCA Cancer type 6:12789227−162322086 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 3 273 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 18 CN segments
11	4	Lower_Right	CGP_donor_1410205	3:7876202−196628059	8, 9	20	{'min_x': 351.3500061035156, 'min_y': 731.9749755859375, 'max_x': 515.3778686523438, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB CGP_donor_1410205 Breast−AdenoCA Cancer type 3:7876202−196628059 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 1 341 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 20 CN segments
12	1	Upper_Left	CGP_donor_1410205	7:6389159−157049440	7, 15	15	{'min_x': 61.849998474121094, 'min_y': 296.9750061035156, 'max_x': 225.87779235839844, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB CGP_donor_1410205 Breast−AdenoCA Cancer type 7:6389159−157049440 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 1; TRA: 5 341 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.002298705 FDR fragment joints
12	2	Upper_Right	CGP_donor_1410210	11:2846968−112273249	9, 21	37	{'min_x': 323.19000244140625, 'min_y': 296.9750061035156, 'max_x': 552.5322265625, 'max_y': 411.343994140625}	25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_1410210 Breast−AdenoCA Cancer type 11:2846968−112273249 Position 1 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 4; DUP: 15; h2hINV: 0; SV types t2tINV: 1; TRA: 8 543 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 37 CN segments 0.06904132 FDR fragment joints 0 FDR chr. breakp. enrich.
12	3	Lower_Left	CGP_donor_1410210	12:972252−79594700	7, 7	11	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 259.01190185546875, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB CGP_donor_1410210 Breast−AdenoCA Cancer type 12:972252−79594700 Position 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 2 543 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 11 CN segments
12	4	Lower_Right	CGP_donor_1472394	4:19561889−181450628	7, 23	23	{'min_x': 321.5199890136719, 'min_y': 731.9749755859375, 'max_x': 515.5822143554688, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB CGP_donor_1472394 Breast−AdenoCA Cancer type 4:19561889−181450628 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 10; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 9 366 SVs in sample 7, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.04139017 FDR fragment joints
13	1	Upper_Left	CGP_donor_1472394	5:31416901−59923452	10, 10	10	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 233.56182861328125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CGP_donor_1472394 Breast−AdenoCA Cancer type 5:31416901−59923452 Position 4 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 4 366 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.615458 FDR fragment joints
13	2	Upper_Right	CGP_donor_1472394	6:4012667−165902670	11, 11	11	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 551.991943359375, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB CGP_donor_1472394 Breast−AdenoCA Cancer type 6:4012667−165902670 Position 4 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 3 366 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.7735152 FDR fragment joints
13	3	Lower_Left	CGP_donor_1472395	5:161143076−169493045	10, 14	15	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	160 MB 170 MB CGP_donor_1472395 Breast−AdenoCA Cancer type 5:161143076−169493045 Position 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 132 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 15 CN segments
13	4	Lower_Right	05506f4c-e701-4a9d-ae06-97f066aade43	11:8956771−130101571	15, 15	24	{'min_x': 321.5199890136719, 'min_y': 731.0599975585938, 'max_x': 550.6921997070312, 'max_y': 832.6138916015625}	05506f4c−e701−4a9d−ae06−97f066aade43 25 MB 50 MB 75 MB 100 MB 125 MB Breast−AdenoCA Cancer type 11:8956771−130101571 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 13 742 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 24 CN segments 0.07914058 FDR fragment joints
14	1	Upper_Left	05506f4c-e701-4a9d-ae06-97f066aade43	12:8551694−125253036	13, 31	31	{'min_x': 40.36989974975586, 'min_y': 296.9750061035156, 'max_x': 268.37200927734375, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 05506f4c−e701−4a9d−ae06−97f066aade43 Breast−AdenoCA Cancer type 12:8551694−125253036 Position 1 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 13; h2hINV: 1; SV types t2tINV: 1; TRA: 6 742 SVs in sample 13, 31 Oscillating CN (2 and 3 states) 31 CN segments 0.02295299 FDR fragment joints
14	2	Upper_Right	05506f4c-e701-4a9d-ae06-97f066aade43	17:7564505−56539923	9, 14	23	{'min_x': 329.8699951171875, 'min_y': 296.9750061035156, 'max_x': 557.8404541015625, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB 05506f4c−e701−4a9d−ae06−97f066aade43 Breast−AdenoCA Cancer type 17:7564505−56539923 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 742 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 23 CN segments 0.1178349 FDR fragment joints
14	3	Lower_Left	05506f4c-e701-4a9d-ae06-97f066aade43	21:18301501−38211721	12, 12	12	{'min_x': 40.36989974975586, 'min_y': 731.9749755859375, 'max_x': 247.36195373535156, 'max_y': 831.8338012695312}	30 MB 40 MB 05506f4c−e701−4a9d−ae06−97f066aade43 Breast−AdenoCA Cancer type 21:18301501−38211721 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 742 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
14	4	Lower_Right	0dca98b0-f43e-45b6-9a02-00092c78678c	3:4014626−181407638	8, 8	43	{'min_x': 321.5199890136719, 'min_y': 731.9749755859375, 'max_x': 537.6898803710938, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 0dca98b0−f43e−45b6−9a02−00092c78678c Breast−AdenoCA Cancer type 3:4014626−181407638 Position 1 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 2; DUP: 14; h2hINV: 1; SV types t2tINV: 0; TRA: 21 552 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 43 CN segments 0.02438658 FDR fragment joints
15	1	Upper_Left	0dca98b0-f43e-45b6-9a02-00092c78678c	22:30225731−42768139	7, 12	12	{'min_x': 39.539798736572266, 'min_y': 296.9750061035156, 'max_x': 248.18995666503906, 'max_y': 406.2539978027344}	25 MB 30 MB 35 MB 40 MB 0dca98b0−f43e−45b6−9a02−00092c78678c Breast−AdenoCA Cancer type 22:30225731−42768139 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 1 552 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.1278363 FDR fragment joints
15	2	Upper_Right	1557183c-aedd-4df6-b98a-3654667f7b69	14:23971383−48794055	10, 13	17	{'min_x': 329.4100036621094, 'min_y': 296.9750061035156, 'max_x': 537.3218383789062, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 1557183c−aedd−4df6−b98a−3654667f7b69 Breast−AdenoCA Cancer type 14:23971383−48794055 Position 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 2 435 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 17 CN segments 0.9000538 FDR fragment joints
15	3	Lower_Left	174850b4-5ec2-462b-a890-89bd1716b3c2	1:2158692−242947867	8, 11	29	{'min_x': 35.360198974609375, 'min_y': 731.9749755859375, 'max_x': 249.18795776367188, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 200 MB 174850b4−5ec2−462b−a890−89bd1716b3c2 Breast−AdenoCA Cancer type 1:2158692−242947867 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 9; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 7 456 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 29 CN segments 0.002665934 FDR fragment joints
15	4	Lower_Right	174850b4-5ec2-462b-a890-89bd1716b3c2	2:25587490−225396473	11, 11	46	{'min_x': 307.1400146484375, 'min_y': 731.9749755859375, 'max_x': 538.6879272460938, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB 174850b4−5ec2−462b−a890−89bd1716b3c2 Breast−AdenoCA Cancer type 2:25587490−225396473 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 15; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 2 456 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 46 CN segments
16	1	Upper_Left	18eb4dfc-556f-4bf3-a411-4780209ed1e0	6:1006535−165186446	7, 10	23	{'min_x': 40.710201263427734, 'min_y': 296.9750061035156, 'max_x': 263.6220703125, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 18eb4dfc−556f−4bf3−a411−4780209ed1e0 Breast−AdenoCA Cancer type 6:1006535−165186446 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 2 280 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 23 CN segments 0.1278363 FDR fragment joints
16	2	Upper_Right	2a84997d-ccee-4f46-bea2-752534f26416	3:4487143−195190136	11, 15	89	{'min_x': 329.8699951171875, 'min_y': 296.9750061035156, 'max_x': 536.8618774414062, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 3:4487143−195190136 Position 1 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 28; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 1 596 SVs in sample 11, 15 Oscillating CN (2 and 3 states) 89 CN segments 4.073413e−09 FDR fragment joints
16	3	Lower_Left	2a84997d-ccee-4f46-bea2-752534f26416	4:1211134−170990779	7, 21	37	{'min_x': 40.36989974975586, 'min_y': 731.9749755859375, 'max_x': 255.97203063964844, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 4:1211134−170990779 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 10; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 3 596 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 37 CN segments
16	4	Lower_Right	2a84997d-ccee-4f46-bea2-752534f26416	8:17394507−100542792	10, 16	16	{'min_x': 323.8699951171875, 'min_y': 731.9749755859375, 'max_x': 561.55224609375, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 8:17394507−100542792 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 596 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 16 CN segments
17	1	Upper_Left	2a84997d-ccee-4f46-bea2-752534f26416	11:16375267−126235971	7, 29	29	{'min_x': 40.36989974975586, 'min_y': 296.9750061035156, 'max_x': 268.31182861328125, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 125 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 11:16375267−126235971 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 10; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 0 596 SVs in sample 7, 29 Oscillating CN (2 and 3 states) 29 CN segments 0.02132783 FDR fragment joints
17	2	Upper_Right	2a84997d-ccee-4f46-bea2-752534f26416	13:23906490−101146717	14, 20	20	{'min_x': 329.8699951171875, 'min_y': 296.9750061035156, 'max_x': 556.982177734375, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 13:23906490−101146717 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 9; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 596 SVs in sample 14, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.01020027 FDR fragment joints
17	3	Lower_Left	2a84997d-ccee-4f46-bea2-752534f26416	16:148109−89946753	7, 28	39	{'min_x': 40.36989974975586, 'min_y': 731.9749755859375, 'max_x': 247.36195373535156, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 16:148109−89946753 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 12; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 3 596 SVs in sample 7, 28 Oscillating CN (2 and 3 states) 39 CN segments
17	4	Lower_Right	2a84997d-ccee-4f46-bea2-752534f26416	X:2221350−153108115	23, 23	28	{'min_x': 329.8699951171875, 'min_y': 731.9749755859375, 'max_x': 555.6521606445312, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type X:2221350−153108115 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 9; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 596 SVs in sample 23, 23 Oscillating CN (2 and 3 states) 28 CN segments
18	1	Upper_Left	441919eb-8c9f-478c-bda3-8de4f8295e8a	3:3385898−154169466	7, 9	31	{'min_x': 40.039798736572266, 'min_y': 296.9750061035156, 'max_x': 247.69195556640625, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 441919eb−8c9f−478c−bda3−8de4f8295e8a Breast−AdenoCA Cancer type 3:3385898−154169466 Position 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 7 744 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 31 CN segments 0.615458 FDR fragment joints 1 FDR chr. breakp. enrich.
18	2	Upper_Right	441919eb-8c9f-478c-bda3-8de4f8295e8a	6:6025768−153367099	7, 19	26	{'min_x': 307.6199951171875, 'min_y': 296.9750061035156, 'max_x': 547.63232421875, 'max_y': 411.343994140625}	0 MB 40 MB 80 MB 120 MB 160 MB 441919eb−8c9f−478c−bda3−8de4f8295e8a Breast−AdenoCA Cancer type 6:6025768−153367099 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 12; h2hINV: 1; SV types t2tINV: 0; TRA: 3 744 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 26 CN segments 0.03488837 FDR fragment joints 0.04 FDR chr. breakp. enrich.
18	3	Lower_Left	441919eb-8c9f-478c-bda3-8de4f8295e8a	8:1680713−143764779	7, 8	56	{'min_x': 40.039798736572266, 'min_y': 731.9749755859375, 'max_x': 247.69195556640625, 'max_y': 831.8338012695312}	50 MB 100 MB 441919eb−8c9f−478c−bda3−8de4f8295e8a Breast−AdenoCA Cancer type 8:1680713−143764779 Position 9 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 13 744 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 56 CN segments
18	4	Lower_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	2:2340260−239159179	14, 24	47	{'min_x': 307.1499938964844, 'min_y': 731.9749755859375, 'max_x': 538.35791015625, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 2:2340260−239159179 Position 1 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 0; DUP: 26; h2hINV: 0; SV types t2tINV: 0; TRA: 1 475 SVs in sample 14, 24 Oscillating CN (2 and 3 states) 47 CN segments
19	1	Upper_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	5:3827801−176614919	28, 39	39	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 248.8579559326172, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 5:3827801−176614919 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 17; h2hINV: 0; SV types t2tINV: 0; TRA: 2 475 SVs in sample 28, 39 Oscillating CN (2 and 3 states) 39 CN segments 1.804575e−06 FDR fragment joints
19	2	Upper_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	9:66454886−110368911	8, 8	14	{'min_x': 308.70001220703125, 'min_y': 296.9750061035156, 'max_x': 538.35791015625, 'max_y': 406.2539978027344}	0 MB 30 MB 60 MB 90 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 9:66454886−110368911 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 1 475 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 14 CN segments 0.7735152 FDR fragment joints
19	3	Lower_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	11:34123374−49526843	4, 5	23	{'min_x': 38.86989974975586, 'min_y': 731.9749755859375, 'max_x': 259.6020812988281, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 11:34123374−49526843 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 1 475 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 23 CN segments
19	4	Lower_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	12:1602975−124219176	11, 21	21	{'min_x': 328.3699951171875, 'min_y': 731.9749755859375, 'max_x': 559.522216796875, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 12:1602975−124219176 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 12; h2hINV: 1; SV types t2tINV: 0; TRA: 0 475 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 21 CN segments
20	1	Upper_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	14:32732923−74134194	8, 8	8	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 270.6419372558594, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 14:32732923−74134194 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 475 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1013295 FDR fragment joints
20	2	Upper_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	15:43723632−62360621	5, 5	12	{'min_x': 328.3699951171875, 'min_y': 296.9750061035156, 'max_x': 554.982421875, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 15:43723632−62360621 Position 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 0; SV types t2tINV: 2; TRA: 0 475 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.4101979 FDR fragment joints
20	3	Lower_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	16:421761−85786009	17, 17	17	{'min_x': 38.86989974975586, 'min_y': 731.9749755859375, 'max_x': 253.31976318359375, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 16:421761−85786009 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 14; h2hINV: 0; SV types t2tINV: 0; TRA: 1 475 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
20	4	Lower_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	17:26864514−75974296	7, 11	20	{'min_x': 322.2099914550781, 'min_y': 731.9749755859375, 'max_x': 538.35791015625, 'max_y': 831.8338012695312}	30 MB 40 MB 50 MB 60 MB 70 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 17:26864514−75974296 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 1; TRA: 2 475 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 20 CN segments
21	1	Upper_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	19:998026−47861482	8, 15	21	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 248.8579559326172, 'max_y': 406.2539978027344}	10 MB 20 MB 30 MB 40 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 19:998026−47861482 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 1; SV types t2tINV: 0; TRA: 5 475 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 21 CN segments 0.0366383 FDR fragment joints
21	2	Upper_Right	5ed024e8-d05e-4c65-9441-eda9930ccc82	20:25612239−58105683	7, 11	11	{'min_x': 328.3699951171875, 'min_y': 296.9750061035156, 'max_x': 538.35791015625, 'max_y': 406.2539978027344}	30 MB 40 MB 50 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 20:25612239−58105683 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 475 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.1278363 FDR fragment joints
21	3	Lower_Left	65cac997-4d39-4501-85ec-4fcb328a8eb5	1:149881190−243814704	7, 12	36	{'min_x': 32.019901275634766, 'min_y': 731.0599975585938, 'max_x': 248.18995666503906, 'max_y': 832.6138916015625}	65cac997−4d39−4501−85ec−4fcb328a8eb5 50 MB 100 MB 150 MB 200 MB Breast−AdenoCA Cancer type 1:149881190−243814704 Position 3 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 2; TRA: 23 909 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints
21	4	Lower_Right	65cac997-4d39-4501-85ec-4fcb328a8eb5	6:1730813−139089485	13, 19	21	{'min_x': 321.5199890136719, 'min_y': 731.9749755859375, 'max_x': 537.68994140625, 'max_y': 836.9337768554688}	40 MB 80 MB 120 MB 65cac997−4d39−4501−85ec−4fcb328a8eb5 Breast−AdenoCA Cancer type 6:1730813−139089485 Position 5 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 22 909 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 21 CN segments 0.9284301 FDR fragment joints
22	1	Upper_Left	65cac997-4d39-4501-85ec-4fcb328a8eb5	7:95697844−156942103	7, 10	18	{'min_x': 32.019901275634766, 'min_y': 296.9750061035156, 'max_x': 248.18995666503906, 'max_y': 411.343994140625}	40 MB 80 MB 120 MB 65cac997−4d39−4501−85ec−4fcb328a8eb5 Breast−AdenoCA Cancer type 7:95697844−156942103 Position 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 7 909 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0.01 FDR chr. breakp. enrich.
22	2	Upper_Right	6956473b-92e5-4069-a26b-b48e280e76f2	8:127655333−142568575	4, 6	6	{'min_x': 329.0400085449219, 'min_y': 296.9750061035156, 'max_x': 537.6898803710938, 'max_y': 406.2539978027344}	50 MB 100 MB 6956473b−92e5−4069−a26b−b48e280e76f2 Breast−AdenoCA Cancer type 8:127655333−142568575 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 227 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints
22	3	Lower_Left	7861a5f2-8910-4bcb-9c34-f79c5acd6e21	8:107480527−115223161	4, 7	32	{'min_x': 40.210201263427734, 'min_y': 731.9749755859375, 'max_x': 247.52195739746094, 'max_y': 831.8338012695312}	60 MB 80 MB 100 MB 7861a5f2−8910−4bcb−9c34−f79c5acd6e21 Breast−AdenoCA Cancer type 8:107480527−115223161 Position 13 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 5 172 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 32 CN segments
22	4	Lower_Right	786e8dbe-442e-4551-87b3-b4c333b04dd4	3:5449076−156876693	4, 6	44	{'min_x': 327.739990234375, 'min_y': 731.9749755859375, 'max_x': 538.988037109375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 786e8dbe−442e−4551−87b3−b4c333b04dd4 Breast−AdenoCA Cancer type 3:5449076−156876693 Position 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 6 222 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 44 CN segments
23	1	Upper_Left	8785012f-f73e-4d68-87cf-1d804af32782	6:1759680−160510927	10, 18	30	{'min_x': 41.710201263427734, 'min_y': 296.9750061035156, 'max_x': 270.1618347167969, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 8785012f−f73e−4d68−87cf−1d804af32782 Breast−AdenoCA Cancer type 6:1759680−160510927 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 11; h2hINV: 0; SV types t2tINV: 2; TRA: 2 530 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 30 CN segments 0.05741733 FDR fragment joints
23	2	Upper_Right	8785012f-f73e-4d68-87cf-1d804af32782	10:949660−110004864	8, 15	31	{'min_x': 307.44000244140625, 'min_y': 296.9750061035156, 'max_x': 535.515869140625, 'max_y': 406.2539978027344}	0 MB 30 MB 60 MB 90 MB 8785012f−f73e−4d68−87cf−1d804af32782 Breast−AdenoCA Cancer type 10:949660−110004864 Position 1 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 14; h2hINV: 0; SV types t2tINV: 0; TRA: 8 530 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 31 CN segments 0.005291502 FDR fragment joints
23	3	Lower_Left	88db1340-e4bf-451a-87c0-6e9168296f5e	19:2788499−51420171	11, 20	20	{'min_x': 40.210201263427734, 'min_y': 731.9749755859375, 'max_x': 262.21978759765625, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB 50 MB 88db1340−e4bf−451a−87c0−6e9168296f5e Breast−AdenoCA Cancer type 19:2788499−51420171 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 1; TRA: 3 415 SVs in sample 11, 20 Oscillating CN (2 and 3 states) 20 CN segments
23	4	Lower_Right	8bd68696-5eeb-46d7-9dc6-c39c849029a4	2:4653440−175863031	9, 15	24	{'min_x': 328.0400085449219, 'min_y': 731.9749755859375, 'max_x': 538.6878662109375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 8bd68696−5eeb−46d7−9dc6−c39c849029a4 Breast−AdenoCA Cancer type 2:4653440−175863031 Position 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 6 343 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 24 CN segments
24	1	Upper_Left	993103b1-e5a1-4c33-8629-be53ebc41d64	10:110197032−121335390	7, 7	7	{'min_x': 38.70000076293945, 'min_y': 296.9750061035156, 'max_x': 249.0279541015625, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type 10:110197032−121335390 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 1 202 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.6776251 FDR fragment joints
24	2	Upper_Right	9f6be944-83de-42ab-8738-f0022f475e61	3:9745722−194626444	12, 14	60	{'min_x': 323.19000244140625, 'min_y': 296.0599670410156, 'max_x': 536.3538818359375, 'max_y': 407.0240173339844}	9f6be944−83de−42ab−8738−f0022f475e61 50 MB 100 MB 150 MB Breast−AdenoCA Cancer type 3:9745722−194626444 Position 1 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 6; DUP: 16; h2hINV: 2; SV types t2tINV: 0; TRA: 22 864 SVs in sample 12, 14 Oscillating CN (2 and 3 states) 60 CN segments 0.04139017 FDR fragment joints 0.19 FDR chr. breakp. enrich.
24	3	Lower_Left	9f6be944-83de-42ab-8738-f0022f475e61	5:10244050−179437055	11, 11	28	{'min_x': 37.03010177612305, 'min_y': 731.9749755859375, 'max_x': 246.8539581298828, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 9f6be944−83de−42ab−8738−f0022f475e61 Breast−AdenoCA Cancer type 5:10244050−179437055 Position 1 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 1; DUP: 14; h2hINV: 0; SV types t2tINV: 1; TRA: 11 864 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 28 CN segments 0.01686763 FDR fragment joints
24	4	Lower_Right	9f6be944-83de-42ab-8738-f0022f475e61	7:27995787−139646245	15, 16	31	{'min_x': 322.8599853515625, 'min_y': 731.9749755859375, 'max_x': 536.3538818359375, 'max_y': 836.9337768554688}	50 MB 100 MB 9f6be944−83de−42ab−8738−f0022f475e61 Breast−AdenoCA Cancer type 7:27995787−139646245 Position 3 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 11 864 SVs in sample 15, 16 Oscillating CN (2 and 3 states) 31 CN segments 0.9794281 FDR fragment joints
25	1	Upper_Left	9f6be944-83de-42ab-8738-f0022f475e61	1:2210884−224017647	7, 10	61	{'min_x': 33.360198974609375, 'min_y': 291.7399597167969, 'max_x': 250.69595336914062, 'max_y': 412.114013671875}	9f6be944−83de−42ab−8738−f0022f475e61 50 MB 100 MB Breast−AdenoCA Cancer type 8:6488297−144963441 Position 1 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 1; DUP: 15; h2hINV: 0; SV types t2tINV: 0; TRA: 23 864 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 61 CN segments 0.1241446 FDR fragment joints 0 FDR chr. breakp. enrich. 1:2210884−224017647;12:672188−132675127
25	2	Upper_Right	9f6be944-83de-42ab-8738-f0022f475e61	X:64211866−154270745	14, 23	28	{'min_x': 330.3699951171875, 'min_y': 296.9750061035156, 'max_x': 536.3538818359375, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 9f6be944−83de−42ab−8738−f0022f475e61 Breast−AdenoCA Cancer type X:64211866−154270745 Position 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 10 864 SVs in sample 14, 23 Oscillating CN (2 and 3 states) 28 CN segments 0.7257048 FDR fragment joints
25	3	Lower_Left	9fefbe7c-f66a-4940-843e-285cb7b392c1	5:74688832−80707030	6, 11	25	{'min_x': 40.900001525878906, 'min_y': 731.9749755859375, 'max_x': 262.4521179199219, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 5:74688832−80707030 Position 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 0 740 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 25 CN segments
25	4	Lower_Right	9fefbe7c-f66a-4940-843e-285cb7b392c1	9:21844042−112515969	5, 10	16	{'min_x': 330.3999938964844, 'min_y': 731.9749755859375, 'max_x': 536.3237915039062, 'max_y': 831.8338012695312}	30 MB 60 MB 90 MB 9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 9:21844042−112515969 Position 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 1 740 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 16 CN segments
26	1	Upper_Left	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	2:26459899−233537709	11, 14	14	{'min_x': 40.539798736572266, 'min_y': 296.9750061035156, 'max_x': 247.1839599609375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 2:26459899−233537709 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 2 463 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.05370273 FDR fragment joints
26	2	Upper_Right	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	3:29682227−151361518	7, 13	31	{'min_x': 330.0400085449219, 'min_y': 296.9750061035156, 'max_x': 536.683837890625, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 3:29682227−151361518 Position 10 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 1; SV types t2tINV: 0; TRA: 7 463 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 31 CN segments 0.5435077 FDR fragment joints
26	3	Lower_Left	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	6:134899220−141764105	7, 17	17	{'min_x': 40.539798736572266, 'min_y': 731.9749755859375, 'max_x': 268.2320556640625, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB 150 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 6:134899220−141764105 Position 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 6; TRA: 1 463 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 17 CN segments
26	4	Lower_Right	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	7:123121252−157394758	5, 9	9	{'min_x': 330.0400085449219, 'min_y': 731.9749755859375, 'max_x': 536.683837890625, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 7:123121252−157394758 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 463 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments
27	1	Upper_Left	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	19:13207846−29674953	7, 7	12	{'min_x': 40.539798736572266, 'min_y': 296.9750061035156, 'max_x': 253.2697296142578, 'max_y': 406.2539978027344}	10 MB 20 MB 30 MB 40 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 19:13207846−29674953 Position 5 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 8 463 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints
27	2	Upper_Right	b094e8b2-8ece-4b36-8025-18073a8b873c	10:84390295−134360314	11, 11	54	{'min_x': 319.8599853515625, 'min_y': 291.7399597167969, 'max_x': 562.55224609375, 'max_y': 412.114013671875}	b094e8b2−8ece−4b36−8025−18073a8b873c 50 MB 100 MB 150 MB 200 MB 250 MB Breast−AdenoCA Cancer type 1:3498809−247725333 Position 6 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 25 763 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 54 CN segments 0.7622832 FDR fragment joints 0.02 FDR chr. breakp. enrich. 10:84390295−134360314;12:62348764−100607993
27	3	Lower_Left	b094e8b2-8ece-4b36-8025-18073a8b873c	3:4164393−197488086	7, 17	47	{'min_x': 33.68980026245117, 'min_y': 731.0599975585938, 'max_x': 249.0279541015625, 'max_y': 832.6138916015625}	b094e8b2−8ece−4b36−8025−18073a8b873c 50 MB 100 MB 150 MB Breast−AdenoCA Cancer type 3:4164393−197488086 Position 1 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 2; DUP: 24; h2hINV: 0; SV types t2tINV: 0; TRA: 19 763 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 47 CN segments 0.0009227593 FDR fragment joints
27	4	Lower_Right	b094e8b2-8ece-4b36-8025-18073a8b873c	6:107054725−113512450	4, 4	32	{'min_x': 328.20001220703125, 'min_y': 731.9749755859375, 'max_x': 548.2421264648438, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB b094e8b2−8ece−4b36−8025−18073a8b873c Breast−AdenoCA Cancer type 6:107054725−113512450 Position 22 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 3; SV types t2tINV: 8; TRA: 2 763 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 32 CN segments
28	1	Upper_Left	b094e8b2-8ece-4b36-8025-18073a8b873c	7:31636190−151854819	7, 11	28	{'min_x': 30.360200881958008, 'min_y': 296.9750061035156, 'max_x': 249.0279541015625, 'max_y': 411.343994140625}	40 MB 80 MB 120 MB b094e8b2−8ece−4b36−8025−18073a8b873c Breast−AdenoCA Cancer type 7:31636190−151854819 Position 5 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 13 763 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 28 CN segments 0.4989394 FDR fragment joints 0 FDR chr. breakp. enrich.
28	2	Upper_Right	b094e8b2-8ece-4b36-8025-18073a8b873c	9:71374858−72890109	4, 5	6	{'min_x': 328.20001220703125, 'min_y': 296.9750061035156, 'max_x': 538.5279541015625, 'max_y': 406.2539978027344}	50 MB 100 MB b094e8b2−8ece−4b36−8025−18073a8b873c Breast−AdenoCA Cancer type 9:71374858−72890109 Position 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 5 763 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints
28	3	Lower_Left	b58ad350-5140-4fa8-bc2c-24bca8395f3a	18:20248444−50278950	7, 8	8	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 247.69195556640625, 'max_y': 836.9337768554688}	20 MB 40 MB 60 MB b58ad350−5140−4fa8−bc2c−24bca8395f3a Breast−AdenoCA Cancer type 18:20248444−50278950 Position 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 518 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.7735152 FDR fragment joints
28	4	Lower_Right	c0892598-1f7b-4f23-9cd8-731f797753d5	14:32936197−105369365	10, 11	13	{'min_x': 330.3699951171875, 'min_y': 731.9749755859375, 'max_x': 536.3538818359375, 'max_y': 831.8338012695312}	50 MB 70 MB 90 MB c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 14:32936197−105369365 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 1 358 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 13 CN segments
29	1	Upper_Left	ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21	2:30492069−242512963	8, 11	86	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 249.3579559326172, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB ccd4a24b−d8cc−4686−9dee−c98b0c5a8d21 Breast−AdenoCA Cancer type 2:30492069−242512963 Position 1 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 2; DUP: 14; h2hINV: 0; SV types t2tINV: 0; TRA: 10 936 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 86 CN segments 0.002298705 FDR fragment joints 0.69 FDR chr. breakp. enrich.
29	2	Upper_Right	d2f2560c-ec80-4fea-9474-c47a2e85ea95	1:10197061−240751611	10, 10	48	{'min_x': 324.8599853515625, 'min_y': 296.9750061035156, 'max_x': 536.6617431640625, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB d2f2560c−ec80−4fea−9474−c47a2e85ea95 Breast−AdenoCA Cancer type 1:10197061−240751611 Position 1 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 6; DUP: 14; h2hINV: 0; SV types t2tINV: 1; TRA: 15 546 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 48 CN segments 0.03325273 FDR fragment joints 0.06 FDR chr. breakp. enrich.
29	3	Lower_Left	d2f2560c-ec80-4fea-9474-c47a2e85ea95	2:6059598−203121904	6, 9	35	{'min_x': 40.56990051269531, 'min_y': 731.9749755859375, 'max_x': 247.1618194580078, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB d2f2560c−ec80−4fea−9474−c47a2e85ea95 Breast−AdenoCA Cancer type 2:6059598−203121904 Position 6 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 11 546 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 35 CN segments
29	4	Lower_Right	d2f2560c-ec80-4fea-9474-c47a2e85ea95	12:329064−133417882	10, 10	29	{'min_x': 308.8599853515625, 'min_y': 731.9749755859375, 'max_x': 536.6617431640625, 'max_y': 836.9337768554688}	0 MB 50 MB 100 MB d2f2560c−ec80−4fea−9474−c47a2e85ea95 Breast−AdenoCA Cancer type 12:329064−133417882 Position 1 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 1; SV types t2tINV: 0; TRA: 10 546 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 29 CN segments 0.1278363 FDR fragment joints
30	1	Upper_Left	d3d545b3-457f-4389-821f-704cb24aff7f	6:1587687−158509485	7, 10	40	{'min_x': 42.04999923706055, 'min_y': 296.9750061035156, 'max_x': 273.10205078125, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB d3d545b3−457f−4389−821f−704cb24aff7f Breast−AdenoCA Cancer type 6:1587687−158509485 Position 1 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 12 709 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 40 CN segments 0.1635872 FDR fragment joints
30	2	Upper_Right	d3d545b3-457f-4389-821f-704cb24aff7f	X:30768634−150086913	5, 6	11	{'min_x': 331.54998779296875, 'min_y': 296.9750061035156, 'max_x': 560.2622680664062, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB d3d545b3−457f−4389−821f−704cb24aff7f Breast−AdenoCA Cancer type X:30768634−150086913 Position 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 2 709 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.8653243 FDR fragment joints
30	3	Lower_Left	d6f7afc0-1558-43ad-acb1-2b5311ed2264	8:37191389−43639589	4, 6	17	{'min_x': 39.88010025024414, 'min_y': 731.9749755859375, 'max_x': 269.8323059082031, 'max_y': 831.8338012695312}	60 MB 80 MB 100 MB 120 MB d6f7afc0−1558−43ad−acb1−2b5311ed2264 Breast−AdenoCA Cancer type 8:37191389−43639589 Position 11 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 3 304 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 17 CN segments
30	4	Lower_Right	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	1:1898876−77522550	5, 12	28	{'min_x': 307.6300048828125, 'min_y': 731.9749755859375, 'max_x': 538.1898803710938, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 1:1898876−77522550 Position 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 3 1222 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 28 CN segments
31	1	Upper_Left	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	3:83571470−194744514	7, 11	34	{'min_x': 32.019901275634766, 'min_y': 296.9750061035156, 'max_x': 248.68995666503906, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 3:83571470−194744514 Position 11 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 5; TRA: 8 1222 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 34 CN segments 0.6776251 FDR fragment joints 0.83 FDR chr. breakp. enrich.
31	2	Upper_Right	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	9:100142774−123611055	12, 12	12	{'min_x': 328.5400085449219, 'min_y': 296.9750061035156, 'max_x': 538.1898803710938, 'max_y': 406.2539978027344}	50 MB 100 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 9:100142774−123611055 Position 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 3 1222 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints
31	3	Lower_Left	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	14:25445910−99447397	9, 15	36	{'min_x': 39.039798736572266, 'min_y': 731.9749755859375, 'max_x': 255.94183349609375, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 14:25445910−99447397 Position 9 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 5 1222 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 36 CN segments
31	4	Lower_Right	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	17:2481365−78698346	7, 16	20	{'min_x': 328.5400085449219, 'min_y': 731.9749755859375, 'max_x': 538.1898803710938, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 17:2481365−78698346 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 0; DUP: 16; h2hINV: 0; SV types t2tINV: 0; TRA: 4 1222 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 20 CN segments
32	1	Upper_Left	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	X:7323507−150791833	8, 14	14	{'min_x': 39.039798736572266, 'min_y': 296.9750061035156, 'max_x': 269.661865234375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type X:7323507−150791833 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 5 1222 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.01147689 FDR fragment joints
32	2	Upper_Right	e4fc0909-f284-4471-866d-d8967b6adcbc	5:3262330−164768438	9, 11	26	{'min_x': 329.3800048828125, 'min_y': 296.9750061035156, 'max_x': 553.5921630859375, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 5:3262330−164768438 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 3 630 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 26 CN segments 0.01333161 FDR fragment joints
32	3	Lower_Left	e4fc0909-f284-4471-866d-d8967b6adcbc	6:93474674−108070113	7, 14	27	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 255.57191467285156, 'max_y': 836.9337768554688}	40 MB 80 MB 120 MB 160 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 6:93474674−108070113 Position 6 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 17 630 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 27 CN segments 0.7861024 FDR fragment joints
32	4	Lower_Right	e4fc0909-f284-4471-866d-d8967b6adcbc	8:138302264−144043894	4, 10	10	{'min_x': 329.3800048828125, 'min_y': 731.9749755859375, 'max_x': 537.3519287109375, 'max_y': 831.8338012695312}	50 MB 100 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 8:138302264−144043894 Position 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 2 630 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 10 CN segments
33	1	Upper_Left	e4fc0909-f284-4471-866d-d8967b6adcbc	10:8113663−12635794	4, 6	12	{'min_x': 39.88010025024414, 'min_y': 296.9750061035156, 'max_x': 258.4520263671875, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 10:8113663−12635794 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 1 630 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 12 CN segments 0.8653243 FDR fragment joints
33	2	Upper_Right	e4fc0909-f284-4471-866d-d8967b6adcbc	12:6511073−132672448	15, 19	27	{'min_x': 329.3800048828125, 'min_y': 296.9750061035156, 'max_x': 546.3720703125, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 12:6511073−132672448 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 4 630 SVs in sample 15, 19 Oscillating CN (2 and 3 states) 27 CN segments 0.0366383 FDR fragment joints
33	3	Lower_Left	e4fc0909-f284-4471-866d-d8967b6adcbc	X:4881574−145429683	8, 14	38	{'min_x': 39.88010025024414, 'min_y': 731.9749755859375, 'max_x': 247.85195922851562, 'max_y': 831.8338012695312}	50 MB 100 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type X:4881574−145429683 Position 1 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 0; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 12 630 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 38 CN segments
33	4	Lower_Right	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	5:50309848−62318656	9, 10	20	{'min_x': 329.3800048828125, 'min_y': 731.9749755859375, 'max_x': 537.3518676757812, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 5:50309848−62318656 Position 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 1; SV types t2tINV: 0; TRA: 5 662 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 20 CN segments
34	1	Upper_Left	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	7:49989231−144882103	7, 18	36	{'min_x': 32.019901275634766, 'min_y': 296.9750061035156, 'max_x': 259.5321350097656, 'max_y': 411.343994140625}	60 MB 90 MB 120 MB 150 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 7:49989231−144882103 Position 3 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 8 662 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 36 CN segments 0.8066159 FDR fragment joints 0.91 FDR chr. breakp. enrich.
34	2	Upper_Right	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	11:55709941−81062381	8, 15	28	{'min_x': 329.3800048828125, 'min_y': 296.9750061035156, 'max_x': 555.512451171875, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 11:55709941−81062381 Position 13 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 9 662 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 28 CN segments 0.6776251 FDR fragment joints
34	3	Lower_Left	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	14:20532445−36857210	5, 11	15	{'min_x': 39.88010025024414, 'min_y': 731.9749755859375, 'max_x': 247.85195922851562, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 14:20532445−36857210 Position 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 3 662 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 15 CN segments
34	4	Lower_Right	c13215d9-26a8-4c8b-b4fe-5da6aa3222af	11:133072701−134636862	12, 12	14	{'min_x': 310.0899963378906, 'min_y': 731.9749755859375, 'max_x': 540.352294921875, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB c13215d9−26a8−4c8b−b4fe−5da6aa3222af Cervix−SCC Cancer type 11:133072701−134636862 Position 9 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 8 178 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 14 CN segments
35	1	Upper_Left	0798dbe2-1914-427c-a2fe-2a865d0d6eda	3:183615477−183945373	12, 12	12	{'min_x': 39.23979949951172, 'min_y': 296.9750061035156, 'max_x': 248.48977661132812, 'max_y': 406.2539978027344}	100 MB 150 MB 0798dbe2−1914−427c−a2fe−2a865d0d6eda CNS−GBM Cancer type 3:183615477−183945373 Position 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 0 209 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.9284301 FDR fragment joints
35	2	Upper_Right	8da3103e-3e6c-4176-a583-d5fe5e60601e	3:2515461−3160126	7, 7	7	{'min_x': 329.2300109863281, 'min_y': 296.9750061035156, 'max_x': 537.499755859375, 'max_y': 406.2539978027344}	50 MB 100 MB 8da3103e−3e6c−4176−a583−d5fe5e60601e CNS−GBM Cancer type 3:2515461−3160126 Position 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 131 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.9284301 FDR fragment joints
35	3	Lower_Left	b1c4579c-72fa-4974-830c-b6a81ace45f4	2:66469477−174340940	5, 9	9	{'min_x': 40.36989974975586, 'min_y': 731.9749755859375, 'max_x': 247.36195373535156, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB b1c4579c−72fa−4974−830c−b6a81ace45f4 CNS−GBM Cancer type 2:66469477−174340940 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 0 87 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments
35	4	Lower_Right	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	16:11082483−11804564	5, 5	5	{'min_x': 329.3800048828125, 'min_y': 731.9749755859375, 'max_x': 558.39013671875, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB c184c3ca−7ad3−4202−b108−cb9fd5f5d947 CNS−GBM Cancer type 16:11082483−11804564 Position 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 263 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
36	1	Upper_Left	de7b7cac-f094-4d59-8651-e991e34ea093	8:68506883−72724157	7, 7	7	{'min_x': 39.539798736572266, 'min_y': 296.9750061035156, 'max_x': 251.61180114746094, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB de7b7cac−f094−4d59−8651−e991e34ea093 CNS−GBM Cancer type 8:68506883−72724157 Position 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 0 105 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.615458 FDR fragment joints
36	2	Upper_Right	5116e3b4-2bac-40f5-8046-b9c1783faaa5	7:862136−133957567	7, 8	18	{'min_x': 308.04998779296875, 'min_y': 296.9750061035156, 'max_x': 537.0219116210938, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 5116e3b4−2bac−40f5−8046−b9c1783faaa5 ColoRect−AdenoCA Cancer type 7:862136−133957567 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 8; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 322 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.02438658 FDR fragment joints
36	3	Lower_Left	7d8eab0a-e6c8-4449-9ebf-50c41db94a06	2:43615678−64237004	5, 5	5	{'min_x': 39.210201263427734, 'min_y': 731.9749755859375, 'max_x': 248.51995849609375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 7d8eab0a−e6c8−4449−9ebf−50c41db94a06 ColoRect−AdenoCA Cancer type 2:43615678−64237004 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 170 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
36	4	Lower_Right	a512701f-88bb-4b05-8c94-fd285b9dd13e	7:39647779−158482174	7, 7	7	{'min_x': 329.0799865722656, 'min_y': 731.9749755859375, 'max_x': 562.7023315429688, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB a512701f−88bb−4b05−8c94−fd285b9dd13e ColoRect−AdenoCA Cancer type 7:39647779−158482174 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 134 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
37	1	Upper_Left	bfb07784-693b-4c25-874e-4ad6e04a5d46	5:58280145−129435613	7, 10	10	{'min_x': 39.210201263427734, 'min_y': 296.9750061035156, 'max_x': 258.7020568847656, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 125 MB bfb07784−693b−4c25−874e−4ad6e04a5d46 ColoRect−AdenoCA Cancer type 5:58280145−129435613 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 3 154 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.01743054 FDR fragment joints
37	2	Upper_Right	fafd4576-0709-49e1-926f-ad1ee09907ec	3:20473702−196392506	10, 22	22	{'min_x': 330.5400085449219, 'min_y': 296.9750061035156, 'max_x': 536.1838989257812, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB fafd4576−0709−49e1−926f−ad1ee09907ec ColoRect−AdenoCA Cancer type 3:20473702−196392506 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 9; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 146 SVs in sample 10, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.02438658 FDR fragment joints
37	3	Lower_Left	8feb0e8f-d09b-437d-8651-0cdecfe776bf	6:1750031−162731368	8, 8	10	{'min_x': 41.110198974609375, 'min_y': 731.9749755859375, 'max_x': 266.7618408203125, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 8feb0e8f−d09b−437d−8651−0cdecfe776bf ColoRect−AdenoCA Cancer type 6:1750031−162731368 Position 1 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 20; h2hINV: 1; SV types t2tINV: 0; TRA: 0 603 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 10 CN segments
37	4	Lower_Right	e2d395f8-bf13-4fe4-8031-683b0eedd875	2:18369748−224149589	10, 10	16	{'min_x': 330.1000061035156, 'min_y': 731.9749755859375, 'max_x': 536.6240844726562, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB e2d395f8−bf13−4fe4−8031−683b0eedd875 ColoRect−AdenoCA Cancer type 2:18369748−224149589 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 7; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 160 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 16 CN segments
38	1	Upper_Left	e2d395f8-bf13-4fe4-8031-683b0eedd875	5:52372824−60181728	4, 4	6	{'min_x': 40.599998474121094, 'min_y': 296.9750061035156, 'max_x': 269.9720458984375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB e2d395f8−bf13−4fe4−8031−683b0eedd875 ColoRect−AdenoCA Cancer type 5:52372824−60181728 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 160 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 6 CN segments 0.8653243 FDR fragment joints
38	2	Upper_Right	e2d395f8-bf13-4fe4-8031-683b0eedd875	13:19176863−91407141	7, 9	11	{'min_x': 310.1099853515625, 'min_y': 296.9750061035156, 'max_x': 536.6240844726562, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB e2d395f8−bf13−4fe4−8031−683b0eedd875 ColoRect−AdenoCA Cancer type 13:19176863−91407141 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 8; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 1 160 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 11 CN segments 0.03230998 FDR fragment joints
38	3	Lower_Left	OCCAMS-AH-014	10:84597156−108564886	4, 5	7	{'min_x': 45.210201263427734, 'min_y': 731.9749755859375, 'max_x': 235.01182556152344, 'max_y': 831.8338012695312}	60 MB 70 MB 80 MB 90 MB 100 MB OCCAMS−AH−014 Eso−AdenoCA Cancer type 10:84597156−108564886 Position 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 2 299 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 7 CN segments
38	4	Lower_Right	OCCAMS-AH-039	2:47547253−227912729	10, 14	14	{'min_x': 310.6199951171875, 'min_y': 731.9749755859375, 'max_x': 524.7022094726562, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB OCCAMS−AH−039 Eso−AdenoCA Cancer type 2:47547253−227912729 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 146 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 14 CN segments
39	1	Upper_Left	OCCAMS-AH-039	3:60184941−60611121	7, 8	8	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	100 MB 150 MB OCCAMS−AH−039 Eso−AdenoCA Cancer type 3:60184941−60611121 Position 5 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 146 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1013295 FDR fragment joints
39	2	Upper_Right	OCCAMS-AH-082	2:20418187−235815453	7, 12	29	{'min_x': 339.1700134277344, 'min_y': 296.9750061035156, 'max_x': 522.0419921875, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB OCCAMS−AH−082 Eso−AdenoCA Cancer type 2:20418187−235815453 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 3 433 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 29 CN segments 0.002321411 FDR fragment joints
39	3	Lower_Left	OCCAMS-AH-086	2:12813030−234404523	7, 34	37	{'min_x': 56.710201263427734, 'min_y': 731.9749755859375, 'max_x': 235.0822296142578, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB OCCAMS−AH−086 Eso−AdenoCA Cancer type 2:12813030−234404523 Position 1 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 4; DUP: 18; h2hINV: 0; SV types t2tINV: 1; TRA: 11 619 SVs in sample 7, 34 Oscillating CN (2 and 3 states) 37 CN segments
39	4	Lower_Right	OCCAMS-AH-086	8:8145650−138110281	7, 14	32	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 100 MB OCCAMS−AH−086 Eso−AdenoCA Cancer type 8:8145650−138110281 Position 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 4 619 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 32 CN segments
40	1	Upper_Left	OCCAMS-AH-086	16:4274640−88167527	10, 14	16	{'min_x': 37.03010177612305, 'min_y': 296.9750061035156, 'max_x': 247.24989318847656, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB 80 MB OCCAMS−AH−086 Eso−AdenoCA Cancer type 16:4274640−88167527 Position 4 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 1; TRA: 17 619 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
40	2	Upper_Right	OCCAMS-AH-135	7:24306872−138562308	8, 9	21	{'min_x': 308.8500061035156, 'min_y': 296.9750061035156, 'max_x': 528.1420288085938, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB OCCAMS−AH−135 Eso−AdenoCA Cancer type 7:24306872−138562308 Position 3 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 10 298 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 21 CN segments 0.9000538 FDR fragment joints
40	3	Lower_Left	OCCAMS-AH-135	11:41887275−103067905	10, 10	19	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 263.9719543457031, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB OCCAMS−AH−135 Eso−AdenoCA Cancer type 11:41887275−103067905 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 1 298 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 19 CN segments
40	4	Lower_Right	OCCAMS-AH-143	9:9270942−115069668	8, 13	23	{'min_x': 351.3500061035156, 'min_y': 731.9749755859375, 'max_x': 515.3778686523438, 'max_y': 831.8338012695312}	50 MB 100 MB OCCAMS−AH−143 Eso−AdenoCA Cancer type 9:9270942−115069668 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 10; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 2 596 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 23 CN segments
41	1	Upper_Left	OCCAMS-AH-160	3:21878297−175600377	7, 12	14	{'min_x': 60.18980026245117, 'min_y': 296.9750061035156, 'max_x': 232.4821319580078, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB OCCAMS−AH−160 Eso−AdenoCA Cancer type 3:21878297−175600377 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 102 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 14 CN segments 0.1178349 FDR fragment joints
41	2	Upper_Right	OCCAMS-AH-173	4:1618263−177859827	12, 12	12	{'min_x': 307.30999755859375, 'min_y': 296.9750061035156, 'max_x': 523.9320068359375, 'max_y': 411.343994140625}	0 MB 50 MB 100 MB 150 MB OCCAMS−AH−173 Eso−AdenoCA Cancer type 4:1618263−177859827 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 4 410 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.03961725 FDR fragment joints 0.03 FDR chr. breakp. enrich.
41	3	Lower_Left	OCCAMS-AH-173	13:26991542−96155452	8, 8	8	{'min_x': 61.38010025024414, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB OCCAMS−AH−173 Eso−AdenoCA Cancer type 13:26991542−96155452 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 410 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
41	4	Lower_Right	OCCAMS-AH-174	12:19271132−109088102	9, 9	16	{'min_x': 320.2200012207031, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB OCCAMS−AH−174 Eso−AdenoCA Cancer type 12:19271132−109088102 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 4 572 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 16 CN segments
42	1	Upper_Left	OCCAMS-AH-197	12:53626633−123151239	6, 8	8	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 261.8619689941406, 'max_y': 406.2539978027344}	60 MB 80 MB 100 MB 120 MB OCCAMS−AH−197 Eso−AdenoCA Cancer type 12:53626633−123151239 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 0 269 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9284301 FDR fragment joints
42	2	Upper_Right	OCCAMS-AH-213	3:13968605−194565147	13, 17	28	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB OCCAMS−AH−213 Eso−AdenoCA Cancer type 3:13968605−194565147 Position 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 283 SVs in sample 13, 17 Oscillating CN (2 and 3 states) 28 CN segments 1 FDR fragment joints
42	3	Lower_Left	OCCAMS-ED-007	6:137614668−144874378	4, 6	16	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 273.0521240234375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB OCCAMS−ED−007 Eso−AdenoCA Cancer type 6:137614668−144874378 Position 24 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 5; SV types t2tINV: 4; TRA: 2 163 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 16 CN segments
42	4	Lower_Right	OCCAMS-PS-012	2:5579139−8930469	7, 11	11	{'min_x': 352.44000244140625, 'min_y': 731.9749755859375, 'max_x': 526.4120483398438, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB OCCAMS−PS−012 Eso−AdenoCA Cancer type 2:5579139−8930469 Position 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 1; SV types t2tINV: 2; TRA: 1 165 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments
43	1	Upper_Left	OCCAMS-QE-095	5:58889907−129722541	11, 12	12	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 256.1519775390625, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB OCCAMS−QE−095 Eso−AdenoCA Cancer type 5:58889907−129722541 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 247 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.1013295 FDR fragment joints
43	2	Upper_Right	OCCAMS-QE-095	7:27948258−157460631	8, 18	18	{'min_x': 311.1400146484375, 'min_y': 296.9750061035156, 'max_x': 547.112060546875, 'max_y': 406.2539978027344}	30 MB 60 MB 90 MB 120 MB 150 MB OCCAMS−QE−095 Eso−AdenoCA Cancer type 7:27948258−157460631 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 8; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 3 247 SVs in sample 8, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.06137436 FDR fragment joints
43	3	Lower_Left	OCCAMS-QE-095	X:6665084−150768368	18, 20	20	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 269.7020263671875, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB OCCAMS−QE−095 Eso−AdenoCA Cancer type X:6665084−150768368 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 9; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 247 SVs in sample 18, 20 Oscillating CN (2 and 3 states) 20 CN segments
43	4	Lower_Right	OCCAMS-RS-032	3:6793668−181259419	7, 17	25	{'min_x': 323.19000244140625, 'min_y': 731.9749755859375, 'max_x': 519.752197265625, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB OCCAMS−RS−032 Eso−AdenoCA Cancer type 3:6793668−181259419 Position 4 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 11 159 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 25 CN segments 0.9348624 FDR fragment joints
44	1	Upper_Left	OCCAMS-RS-032	5:21645067−104326690	14, 14	14	{'min_x': 60.730098724365234, 'min_y': 296.9750061035156, 'max_x': 233.6821746826172, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB OCCAMS−RS−032 Eso−AdenoCA Cancer type 5:21645067−104326690 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 159 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.01743054 FDR fragment joints
44	2	Upper_Right	OCCAMS-RS-047	3:57769950−184424438	7, 23	39	{'min_x': 321.5199890136719, 'min_y': 296.0599670410156, 'max_x': 513.7119140625, 'max_y': 407.0240173339844}	OCCAMS−RS−047 50 MB 100 MB 150 MB Eso−AdenoCA Cancer type 3:57769950−184424438 Position 4 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 11 894 SVs in sample 7, 23 Oscillating CN (2 and 3 states) 39 CN segments 0.925252 FDR fragment joints 0.2 FDR chr. breakp. enrich.
44	3	Lower_Left	OCCAMS-RS-047	14:21444972−103597907	9, 17	35	{'min_x': 32.019901275634766, 'min_y': 731.0599975585938, 'max_x': 260.8019104003906, 'max_y': 832.6138916015625}	OCCAMS−RS−047 40 MB 60 MB 80 MB 100 MB Eso−AdenoCA Cancer type 14:21444972−103597907 Position 3 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 17 894 SVs in sample 9, 17 Oscillating CN (2 and 3 states) 35 CN segments 0.8572806 FDR fragment joints
44	4	Lower_Right	OCCAMS-RS-047	15:40224068−90935523	11, 11	24	{'min_x': 306.4700012207031, 'min_y': 731.9749755859375, 'max_x': 553.3903198242188, 'max_y': 831.8338012695312}	40 MB 50 MB 60 MB 70 MB 80 MB 90 MB OCCAMS−RS−047 Eso−AdenoCA Cancer type 15:40224068−90935523 Position 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 8 894 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 24 CN segments
45	1	Upper_Left	OCCAMS-RS-047	18:19478394−72412983	13, 14	17	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 225.8099822998047, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB OCCAMS−RS−047 Eso−AdenoCA Cancer type 18:19478394−72412983 Position 1 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 11 894 SVs in sample 13, 14 Oscillating CN (2 and 3 states) 17 CN segments 0.02295299 FDR fragment joints 0.55 FDR chr. breakp. enrich.
45	2	Upper_Right	OCCAMS-SH-024	4:1687132−175651479	9, 9	22	{'min_x': 307.19000244140625, 'min_y': 296.9750061035156, 'max_x': 526.38232421875, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB OCCAMS−SH−024 Eso−AdenoCA Cancer type 4:1687132−175651479 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 656 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.1790694 FDR fragment joints
45	3	Lower_Left	OCCAMS-SH-051	1:160780664−178102081	4, 6	13	{'min_x': 46.56990051269531, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB OCCAMS−SH−051 Eso−AdenoCA Cancer type 1:160780664−178102081 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 450 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 13 CN segments
45	4	Lower_Right	OCCAMS-ST-033	1:10953691−246705970	7, 13	17	{'min_x': 345.70001220703125, 'min_y': 731.9749755859375, 'max_x': 514.6918334960938, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB OCCAMS−ST−033 Eso−AdenoCA Cancer type 1:10953691−246705970 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 131 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 17 CN segments
46	1	Upper_Left	OCCAMS-ST-033	2:13178329−233510064	7, 10	18	{'min_x': 56.46989822387695, 'min_y': 296.9750061035156, 'max_x': 235.411865234375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB OCCAMS−ST−033 Eso−AdenoCA Cancer type 2:13178329−233510064 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 2 131 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 18 CN segments 0.01020027 FDR fragment joints
46	2	Upper_Right	OCCAMS-ST-035	12:6443759−117567030	7, 7	7	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	30 MB 60 MB 90 MB OCCAMS−ST−035 Eso−AdenoCA Cancer type 12:6443759−117567030 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 1; SV types t2tINV: 0; TRA: 1 137 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.05741733 FDR fragment joints
46	3	Lower_Left	OCCAMS-WG-001	3:269704−5196742	5, 5	5	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 225.59181213378906, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB OCCAMS−WG−001 Eso−AdenoCA Cancer type 3:269704−5196742 Position 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 1; SV types t2tINV: 3; TRA: 1 151 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
46	4	Lower_Right	OCCAMS-WG-005	5:12714338−161549623	11, 11	11	{'min_x': 349.7799987792969, 'min_y': 731.9749755859375, 'max_x': 558.0020751953125, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB OCCAMS−WG−005 Eso−AdenoCA Cancer type 5:12714338−161549623 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 277 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
47	1	Upper_Left	OCCAMS-WG-008	3:9406366−148985299	9, 36	36	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB OCCAMS−WG−008 Eso−AdenoCA Cancer type 3:9406366−148985299 Position 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 4 357 SVs in sample 9, 36 Oscillating CN (2 and 3 states) 36 CN segments 0.9000538 FDR fragment joints
47	2	Upper_Right	OCCAMS-WG-008	X:6894656−154973534	14, 18	18	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB OCCAMS−WG−008 Eso−AdenoCA Cancer type X:6894656−154973534 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 2 357 SVs in sample 14, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.129004 FDR fragment joints
47	3	Lower_Left	OCCAMS-WG-009	2:85478953−232558623	11, 19	51	{'min_x': 35.360198974609375, 'min_y': 731.9749755859375, 'max_x': 228.48207092285156, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 200 MB OCCAMS−WG−009 Eso−AdenoCA Cancer type 2:85478953−232558623 Position 14 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 5; TRA: 8 490 SVs in sample 11, 19 Oscillating CN (2 and 3 states) 51 CN segments 0.615458 FDR fragment joints
47	4	Lower_Right	OCCAMS-WG-009	11:7867256−37730507	7, 11	16	{'min_x': 308.010009765625, 'min_y': 731.9749755859375, 'max_x': 551.9622802734375, 'max_y': 831.8338012695312}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB OCCAMS−WG−009 Eso−AdenoCA Cancer type 11:7867256−37730507 Position 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 4 490 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 16 CN segments
48	1	Upper_Left	OCCAMS-WG-009	17:28749738−71397421	7, 10	33	{'min_x': 33.68980026245117, 'min_y': 296.9750061035156, 'max_x': 268.7699279785156, 'max_y': 411.343994140625}	40 MB 60 MB 80 MB OCCAMS−WG−009 Eso−AdenoCA Cancer type 17:28749738−71397421 Position 5 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 9 490 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 33 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
48	2	Upper_Right	OCCAMS-WG-019	6:18740622−21421268	5, 5	5	{'min_x': 307.9800109863281, 'min_y': 296.9750061035156, 'max_x': 555.3720092773438, 'max_y': 406.2539978027344}	0 MB 40 MB 80 MB 120 MB 160 MB OCCAMS−WG−019 Eso−AdenoCA Cancer type 6:18740622−21421268 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 263 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 1 FDR fragment joints
48	3	Lower_Left	OCCAMS-ZZ-009	16:14176787−87458987	13, 21	25	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	30 MB 50 MB 70 MB OCCAMS−ZZ−009 Eso−AdenoCA Cancer type 16:14176787−87458987 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 8; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 2 353 SVs in sample 13, 21 Oscillating CN (2 and 3 states) 25 CN segments
48	4	Lower_Right	3e5f451a-5882-4914-ae1a-95c898c2bcca	3:980214−174918572	9, 17	33	{'min_x': 308.1300048828125, 'min_y': 731.9749755859375, 'max_x': 537.3599853515625, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 3e5f451a−5882−4914−ae1a−95c898c2bcca Head−SCC Cancer type 3:980214−174918572 Position 1 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 15; DUP: 4; h2hINV: 1; SV types t2tINV: 0; TRA: 5 362 SVs in sample 9, 17 Oscillating CN (2 and 3 states) 33 CN segments
49	1	Upper_Left	3e5f451a-5882-4914-ae1a-95c898c2bcca	4:17276274−182542010	15, 22	38	{'min_x': 39.86989974975586, 'min_y': 296.9750061035156, 'max_x': 247.85995483398438, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 3e5f451a−5882−4914−ae1a−95c898c2bcca Head−SCC Cancer type 4:17276274−182542010 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 9; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 2 362 SVs in sample 15, 22 Oscillating CN (2 and 3 states) 38 CN segments 0.1321718 FDR fragment joints
49	2	Upper_Right	ad6c9d09-2c03-4786-a72d-dd2aa5f603d4	4:52783484−187472712	8, 13	44	{'min_x': 328.57000732421875, 'min_y': 296.9750061035156, 'max_x': 538.159912109375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB ad6c9d09−2c03−4786−a72d−dd2aa5f603d4 Head−SCC Cancer type 4:52783484−187472712 Position 7 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 8 360 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 44 CN segments 0.925252 FDR fragment joints
49	3	Lower_Left	c1f50a22-38df-41cc-a1f4-f7985504a7ac	1:22744462−211294614	11, 11	20	{'min_x': 41.86989974975586, 'min_y': 731.9749755859375, 'max_x': 245.85595703125, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB c1f50a22−38df−41cc−a1f4−f7985504a7ac Head−SCC Cancer type 1:22744462−211294614 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 0 61 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 20 CN segments
49	4	Lower_Right	cb99fb14-641c-4fb3-bf1d-17efb8cd982a	6:720079−25769089	6, 7	13	{'min_x': 330.3800048828125, 'min_y': 731.9749755859375, 'max_x': 536.3458251953125, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB 50 MB cb99fb14−641c−4fb3−bf1d−17efb8cd982a Head−SCC Cancer type 6:720079−25769089 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 96 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 13 CN segments
50	1	Upper_Left	e7d49212-e9cb-4cd7-923a-bdfc82a4a150	3:194529547−197519861	10, 13	13	{'min_x': 39.210201263427734, 'min_y': 296.9750061035156, 'max_x': 248.51995849609375, 'max_y': 406.2539978027344}	100 MB 150 MB e7d49212−e9cb−4cd7−923a−bdfc82a4a150 Head−SCC Cancer type 3:194529547−197519861 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 149 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.6776251 FDR fragment joints
50	2	Upper_Right	e8ac39e6-377a-412c-b18d-f6c4fc654ec6	7:1981292−145607230	7, 9	20	{'min_x': 329.8699951171875, 'min_y': 296.9750061035156, 'max_x': 536.8618774414062, 'max_y': 406.2539978027344}	50 MB 100 MB e8ac39e6−377a−412c−b18d−f6c4fc654ec6 Head−SCC Cancer type 7:1981292−145607230 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 8; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 1 183 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 20 CN segments 0.1013295 FDR fragment joints
50	3	Lower_Left	9fc40b03-0b56-4b1f-93ed-dbc455ae3fd9	3:10505042−131382838	11, 11	15	{'min_x': 40.210201263427734, 'min_y': 731.9749755859375, 'max_x': 258.721923828125, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 9fc40b03−0b56−4b1f−93ed−dbc455ae3fd9 Kidney−RCC Cancer type 3:10505042−131382838 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 10; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 166 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 15 CN segments
50	4	Lower_Right	9fc40b03-0b56-4b1f-93ed-dbc455ae3fd9	4:69152238−129221201	6, 9	9	{'min_x': 307.69000244140625, 'min_y': 731.9749755859375, 'max_x': 537.0138549804688, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 9fc40b03−0b56−4b1f−93ed−dbc455ae3fd9 Kidney−RCC Cancer type 4:69152238−129221201 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 1 166 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments
51	1	Upper_Left	C0052	6:3555069−44962683	6, 12	12	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 254.5220184326172, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB C0052 Kidney−RCC Cancer type 6:3555069−44962683 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 1 26 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints
51	2	Upper_Right	06ac44e9-1226-4202-828b-6f224766d7ac	1:8058341−244930271	5, 7	13	{'min_x': 329.20001220703125, 'min_y': 296.9750061035156, 'max_x': 537.5299682617188, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 06ac44e9−1226−4202−828b−6f224766d7ac Liver−HCC Cancer type 1:8058341−244930271 Position 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 3 53 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.9625775 FDR fragment joints
51	3	Lower_Left	1987b453-f97d-45c7-9c89-b9a33313d645	1:9273332−226103050	30, 40	46	{'min_x': 35.360198974609375, 'min_y': 731.0599975585938, 'max_x': 248.35995483398438, 'max_y': 832.6138916015625}	1987b453−f97d−45c7−9c89−b9a33313d645 50 MB 100 MB 150 MB 200 MB Liver−HCC Cancer type 1:9273332−226103050 Position 4 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 24 524 SVs in sample 30, 40 Oscillating CN (2 and 3 states) 46 CN segments 0.8505431 FDR fragment joints
51	4	Lower_Right	1987b453-f97d-45c7-9c89-b9a33313d645	9:6482278−127861801	12, 12	12	{'min_x': 328.8699951171875, 'min_y': 731.9749755859375, 'max_x': 547.0322875976562, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 9:6482278−127861801 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 6 524 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
52	1	Upper_Left	1987b453-f97d-45c7-9c89-b9a33313d645	11:9340114−77018016	7, 15	15	{'min_x': 31.689800262451172, 'min_y': 296.9750061035156, 'max_x': 248.35995483398438, 'max_y': 411.343994140625}	30 MB 60 MB 90 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 11:9340114−77018016 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 9 524 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.02158923 FDR fragment joints 0.19 FDR chr. breakp. enrich.
52	2	Upper_Right	1987b453-f97d-45c7-9c89-b9a33313d645	17:6752376−73621734	7, 11	12	{'min_x': 321.5199890136719, 'min_y': 296.9750061035156, 'max_x': 537.8599243164062, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 17:6752376−73621734 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 7 524 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 12 CN segments 0.07579048 FDR fragment joints 0.14 FDR chr. breakp. enrich.
52	3	Lower_Left	1987b453-f97d-45c7-9c89-b9a33313d645	X:31286763−116414502	8, 14	14	{'min_x': 39.36989974975586, 'min_y': 731.9749755859375, 'max_x': 248.35995483398438, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type X:31286763−116414502 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 524 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments
52	4	Lower_Right	440375d7-cdcd-418a-8992-0a8ca42d290d	4:15852769−177944792	14, 16	45	{'min_x': 328.0400085449219, 'min_y': 731.9749755859375, 'max_x': 538.6879272460938, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 4:15852769−177944792 Position 2 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 690 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 45 CN segments
53	1	Upper_Left	440375d7-cdcd-418a-8992-0a8ca42d290d	5:130189137−149619578	4, 6	25	{'min_x': 38.539798736572266, 'min_y': 296.9750061035156, 'max_x': 249.18795776367188, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 5:130189137−149619578 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 2; SV types t2tINV: 1; TRA: 0 690 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 25 CN segments 0.5435077 FDR fragment joints
53	2	Upper_Right	440375d7-cdcd-418a-8992-0a8ca42d290d	6:42615061−100972584	9, 18	25	{'min_x': 328.0400085449219, 'min_y': 296.9750061035156, 'max_x': 538.6879272460938, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 6:42615061−100972584 Position 3 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 690 SVs in sample 9, 18 Oscillating CN (2 and 3 states) 25 CN segments 0.04139017 FDR fragment joints
53	3	Lower_Left	440375d7-cdcd-418a-8992-0a8ca42d290d	8:94743333−136006935	9, 9	30	{'min_x': 38.539798736572266, 'min_y': 731.9749755859375, 'max_x': 249.18795776367188, 'max_y': 831.8338012695312}	50 MB 100 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 8:94743333−136006935 Position 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 1 690 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 30 CN segments
53	4	Lower_Right	440375d7-cdcd-418a-8992-0a8ca42d290d	9:33405632−37129539	7, 10	14	{'min_x': 328.0400085449219, 'min_y': 731.9749755859375, 'max_x': 547.3720092773438, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 9:33405632−37129539 Position 5 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 690 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 14 CN segments
54	1	Upper_Left	440375d7-cdcd-418a-8992-0a8ca42d290d	15:25612423−95231017	13, 16	30	{'min_x': 38.539798736572266, 'min_y': 296.9750061035156, 'max_x': 249.18795776367188, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 15:25612423−95231017 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 16; h2hINV: 0; SV types t2tINV: 0; TRA: 3 690 SVs in sample 13, 16 Oscillating CN (2 and 3 states) 30 CN segments 2.780978e−05 FDR fragment joints
54	2	Upper_Right	440375d7-cdcd-418a-8992-0a8ca42d290d	18:2523032−72108189	15, 15	15	{'min_x': 328.0400085449219, 'min_y': 296.9750061035156, 'max_x': 538.6879272460938, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 18:2523032−72108189 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 1; TRA: 1 690 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.01333161 FDR fragment joints
54	3	Lower_Left	440375d7-cdcd-418a-8992-0a8ca42d290d	22:17910494−50713692	17, 17	23	{'min_x': 38.539798736572266, 'min_y': 731.9749755859375, 'max_x': 263.9401550292969, 'max_y': 831.8338012695312}	30 MB 40 MB 50 MB 440375d7−cdcd−418a−8992−0a8ca42d290d Liver−HCC Cancer type 22:17910494−50713692 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 2 690 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 23 CN segments
54	4	Lower_Right	457cca7c-a8b4-414e-a3c0-7fccf0ee2034	8:41016513−53511362	5, 5	5	{'min_x': 322.4599914550781, 'min_y': 731.9749755859375, 'max_x': 550.9019775390625, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 457cca7c−a8b4−414e−a3c0−7fccf0ee2034 Liver−HCC Cancer type 8:41016513−53511362 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 0 137 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
55	1	Upper_Left	4bbdbe77-f3cb-4b64-9826-72debb734784	1:53503836−192549016	11, 25	42	{'min_x': 37.03010177612305, 'min_y': 296.9750061035156, 'max_x': 249.17996215820312, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB 4bbdbe77−f3cb−4b64−9826−72debb734784 Liver−HCC Cancer type 1:53503836−192549016 Position 4 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 25 445 SVs in sample 11, 25 Oscillating CN (2 and 3 states) 42 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
55	2	Upper_Right	4bbdbe77-f3cb-4b64-9826-72debb734784	2:85528204−99868582	4, 4	4	{'min_x': 328.04998779296875, 'min_y': 296.9750061035156, 'max_x': 538.6798706054688, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 4bbdbe77−f3cb−4b64−9826−72debb734784 Liver−HCC Cancer type 2:85528204−99868582 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 0 445 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.8653243 FDR fragment joints
55	3	Lower_Left	56403463-1727-4c23-a709-de5f168c4073	1:3589401−30700898	5, 5	11	{'min_x': 39.86989974975586, 'min_y': 731.9749755859375, 'max_x': 247.85995483398438, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 56403463−1727−4c23−a709−de5f168c4073 Liver−HCC Cancer type 1:3589401−30700898 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 309 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 11 CN segments
55	4	Lower_Right	56403463-1727-4c23-a709-de5f168c4073	9:4927905−30615811	9, 9	9	{'min_x': 329.3699951171875, 'min_y': 731.9749755859375, 'max_x': 537.3599243164062, 'max_y': 831.8338012695312}	50 MB 100 MB 56403463−1727−4c23−a709−de5f168c4073 Liver−HCC Cancer type 9:4927905−30615811 Position 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 309 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
56	1	Upper_Left	670c1cbc-4494-45f1-bb8b-18db82d4f7e0	5:40899212−124664734	4, 8	21	{'min_x': 39.54999923706055, 'min_y': 296.9750061035156, 'max_x': 268.71185302734375, 'max_y': 406.2539978027344}	80 MB 120 MB 160 MB 670c1cbc−4494−45f1−bb8b−18db82d4f7e0 Liver−HCC Cancer type 5:40899212−124664734 Position 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 0; SV types t2tINV: 1; TRA: 2 89 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints
56	2	Upper_Right	68015cc7-d3a1-4c90-b8fb-5d14143d9960	3:101275−159910152	10, 22	22	{'min_x': 309.2799987792969, 'min_y': 296.9750061035156, 'max_x': 560.5322265625, 'max_y': 406.2539978027344}	0 MB 40 MB 80 MB 120 MB 160 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 3:101275−159910152 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 5 231 SVs in sample 10, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.129004 FDR fragment joints
56	3	Lower_Left	68015cc7-d3a1-4c90-b8fb-5d14143d9960	5:21799697−173208906	18, 18	25	{'min_x': 39.210201263427734, 'min_y': 731.9749755859375, 'max_x': 248.51995849609375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 5:21799697−173208906 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 14; h2hINV: 0; SV types t2tINV: 0; TRA: 3 231 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 25 CN segments
56	4	Lower_Right	68015cc7-d3a1-4c90-b8fb-5d14143d9960	6:26485750−163374875	16, 16	16	{'min_x': 328.7099914550781, 'min_y': 731.9749755859375, 'max_x': 554.7219848632812, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 6:26485750−163374875 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 231 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
57	1	Upper_Left	68015cc7-d3a1-4c90-b8fb-5d14143d9960	8:12730205−130589835	12, 12	12	{'min_x': 39.210201263427734, 'min_y': 296.9750061035156, 'max_x': 259.96185302734375, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 8:12730205−130589835 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 231 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.006736868 FDR fragment joints
57	2	Upper_Right	68015cc7-d3a1-4c90-b8fb-5d14143d9960	10:26398455−118039623	21, 21	21	{'min_x': 328.7099914550781, 'min_y': 296.9750061035156, 'max_x': 538.0198974609375, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 10:26398455−118039623 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 12; h2hINV: 0; SV types t2tINV: 0; TRA: 2 231 SVs in sample 21, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.001880701 FDR fragment joints
57	3	Lower_Left	68015cc7-d3a1-4c90-b8fb-5d14143d9960	12:6565847−129085870	14, 14	14	{'min_x': 39.210201263427734, 'min_y': 731.9749755859375, 'max_x': 263.2118225097656, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 12:6565847−129085870 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 231 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
57	4	Lower_Right	6c79f64b-63fe-46f5-bf7b-77208231b0f2	4:13197519−166464059	4, 4	4	{'min_x': 331.5799865722656, 'min_y': 731.9749755859375, 'max_x': 550.6719360351562, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 6c79f64b−63fe−46f5−bf7b−77208231b0f2 Liver−HCC Cancer type 4:13197519−166464059 Position 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 13 125 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments
58	1	Upper_Left	6dcfc418-ab28-4365-95ea-c1ae254f2341	12:1508040−124042273	7, 17	25	{'min_x': 33.68980026245117, 'min_y': 296.0599670410156, 'max_x': 272.7117919921875, 'max_y': 407.0240173339844}	6dcfc418−ab28−4365−95ea−c1ae254f2341 25 MB 50 MB 75 MB 100 MB 125 MB Liver−HCC Cancer type 12:1508040−124042273 Position 1 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 2; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 16 572 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 25 CN segments 0.1517838 FDR fragment joints 0.57 FDR chr. breakp. enrich.
58	2	Upper_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	2:7896145−234951998	10, 16	34	{'min_x': 328.5400085449219, 'min_y': 296.9750061035156, 'max_x': 538.1898803710938, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 2:7896145−234951998 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 13; h2hINV: 2; SV types t2tINV: 0; TRA: 5 301 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 34 CN segments 0.04139017 FDR fragment joints
58	3	Lower_Left	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	6:17536286−142324409	14, 23	26	{'min_x': 39.039798736572266, 'min_y': 731.9749755859375, 'max_x': 248.68995666503906, 'max_y': 831.8338012695312}	50 MB 100 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 6:17536286−142324409 Position 1 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 0; DUP: 15; h2hINV: 0; SV types t2tINV: 1; TRA: 3 301 SVs in sample 14, 23 Oscillating CN (2 and 3 states) 26 CN segments
58	4	Lower_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	8:793195−126571971	8, 14	14	{'min_x': 307.9700012207031, 'min_y': 731.9749755859375, 'max_x': 557.5223388671875, 'max_y': 831.8338012695312}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 8:793195−126571971 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 1 301 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments
59	1	Upper_Left	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	9:2531011−138963230	8, 15	20	{'min_x': 39.039798736572266, 'min_y': 296.9750061035156, 'max_x': 248.68995666503906, 'max_y': 406.2539978027344}	50 MB 100 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 9:2531011−138963230 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 1 301 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 20 CN segments 0.01020027 FDR fragment joints
59	2	Upper_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	11:1792398−105876405	8, 11	18	{'min_x': 324.8599853515625, 'min_y': 296.9750061035156, 'max_x': 547.3821411132812, 'max_y': 411.343994140625}	25 MB 50 MB 75 MB 100 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 11:1792398−105876405 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 5 301 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 18 CN segments 0.08549 FDR fragment joints 1 FDR chr. breakp. enrich.
59	3	Lower_Left	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	15:41329339−78831198	10, 10	10	{'min_x': 39.039798736572266, 'min_y': 731.9749755859375, 'max_x': 248.68995666503906, 'max_y': 831.8338012695312}	50 MB 60 MB 70 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 15:41329339−78831198 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 301 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
59	4	Lower_Right	c52abac9-07da-4b3d-bf8a-2161cacf9682	3:17621629−171986122	7, 12	12	{'min_x': 329.3800048828125, 'min_y': 731.9749755859375, 'max_x': 542.4920043945312, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB c52abac9−07da−4b3d−bf8a−2161cacf9682 Liver−HCC Cancer type 3:17621629−171986122 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 75 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
60	1	Upper_Left	d680df09-368e-42b5-b540-45c41ed31042	1:62587390−232902623	4, 6	6	{'min_x': 39.210201263427734, 'min_y': 296.9750061035156, 'max_x': 248.51995849609375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB d680df09−368e−42b5−b540−45c41ed31042 Liver−HCC Cancer type 1:62587390−232902623 Position 8 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 0; SV types t2tINV: 2; TRA: 15 82 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.615458 FDR fragment joints
60	2	Upper_Right	ee63c44b-91f4-4004-8dea-192eab527036	17:19411292−80161265	6, 10	41	{'min_x': 309.7099914550781, 'min_y': 296.9750061035156, 'max_x': 557.3400268554688, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB 80 MB ee63c44b−91f4−4004−8dea−192eab527036 Liver−HCC Cancer type 17:19411292−80161265 Position 10 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 5; SV types t2tINV: 0; TRA: 15 405 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 41 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
60	3	Lower_Left	f6e5979d-d6a9-4408-bd1b-1b37d1064e83	3:18657637−137367416	8, 8	8	{'min_x': 38.88010025024414, 'min_y': 731.9749755859375, 'max_x': 248.84996032714844, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB f6e5979d−d6a9−4408−bd1b−1b37d1064e83 Liver−HCC Cancer type 3:18657637−137367416 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 111 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
60	4	Lower_Right	HX11	16:7537773−31271320	4, 4	12	{'min_x': 331.4200134277344, 'min_y': 731.9749755859375, 'max_x': 546.1001586914062, 'max_y': 831.8338012695312}	10 MB 15 MB 20 MB 25 MB 30 MB HX11 Liver−HCC Cancer type 16:7537773−31271320 Position 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 42 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 12 CN segments
61	1	Upper_Left	HX17	11:19730216−113168096	7, 7	7	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 238.3918914794922, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB HX17 Liver−HCC Cancer type 11:19730216−113168096 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 1 44 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.1013295 FDR fragment joints
61	2	Upper_Right	HX32	1:8099405−215842951	10, 18	20	{'min_x': 326.5299987792969, 'min_y': 296.9750061035156, 'max_x': 524.3619995117188, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB HX32 Liver−HCC Cancer type 1:8099405−215842951 Position 1 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 2; DUP: 14; h2hINV: 1; SV types t2tINV: 0; TRA: 16 237 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 20 CN segments 0.01020027 FDR fragment joints 0 FDR chr. breakp. enrich.
61	3	Lower_Left	HX32	2:48452073−217017336	11, 13	15	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 247.61181640625, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB HX32 Liver−HCC Cancer type 2:48452073−217017336 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 4 237 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 15 CN segments
61	4	Lower_Right	HX32	19:1285753−47756167	14, 14	14	{'min_x': 350.75, 'min_y': 731.9749755859375, 'max_x': 519.9500122070312, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB HX32 Liver−HCC Cancer type 19:1285753−47756167 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 3 237 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
62	1	Upper_Left	RK042	8:30371255−87560417	7, 10	10	{'min_x': 56.83013916015625, 'min_y': 296.9750061035156, 'max_x': 238.46005249023438, 'max_y': 406.2539978027344}	40 MB 50 MB 60 MB 70 MB 80 MB RK042 Liver−HCC Cancer type 8:30371255−87560417 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 93 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.1278363 FDR fragment joints
62	2	Upper_Right	RK053	3:60740057−188119821	10, 10	10	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	100 MB 150 MB RK053 Liver−HCC Cancer type 3:60740057−188119821 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 7; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 81 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.05741733 FDR fragment joints
62	3	Lower_Left	RK070	11:2547255−132275890	7, 19	19	{'min_x': 61.849998474121094, 'min_y': 731.9749755859375, 'max_x': 225.87779235839844, 'max_y': 831.8338012695312}	50 MB 100 MB RK070 Liver−HCC Cancer type 11:2547255−132275890 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 1; SV types t2tINV: 0; TRA: 2 281 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 19 CN segments
62	4	Lower_Right	RK107	1:26503377−220160009	9, 21	66	{'min_x': 319.8599853515625, 'min_y': 726.7400512695312, 'max_x': 524.3518676757812, 'max_y': 837.7042236328125}	RK107 50 MB 100 MB 150 MB 200 MB Liver−HCC Cancer type 1:26503377−220160009 Position 9 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 4; SV types t2tINV: 4; TRA: 26 616 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 66 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
63	1	Upper_Left	RK107	11:65126119−117045448	9, 9	50	{'min_x': 33.68980026245117, 'min_y': 291.7399597167969, 'max_x': 258.1520690917969, 'max_y': 412.114013671875}	RK107 50 MB 100 MB 150 MB 200 MB Liver−HCC Cancer type 2:2119500−211577974 Position 1 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 7; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 20 616 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 50 CN segments 0.04139017 FDR fragment joints 0.9 FDR chr. breakp. enrich. 11:65126119−117045448;12:565831−121912249
63	2	Upper_Right	RK107	3:39802700−133489711	9, 22	40	{'min_x': 326.5299987792969, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB RK107 Liver−HCC Cancer type 3:39802700−133489711 Position 3 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 9 616 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 40 CN segments 0.6776251 FDR fragment joints 0.16 FDR chr. breakp. enrich.
63	3	Lower_Left	RK107	4:40323309−109722573	9, 10	13	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB RK107 Liver−HCC Cancer type 4:40323309−109722573 Position 3 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 10 616 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 13 CN segments
63	4	Lower_Right	RK107	10:75643021−104011740	11, 13	21	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	30 MB 60 MB 90 MB RK107 Liver−HCC Cancer type 10:75643021−104011740 Position 2 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 6 616 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 21 CN segments
64	1	Upper_Left	RK107	11:65126119−117045449	11, 12	41	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 268.9219970703125, 'max_y': 411.343994140625}	50 MB 75 MB 100 MB 125 MB RK107 Liver−HCC Cancer type 11:65126119−117045449 Position 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 6 616 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 41 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
64	2	Upper_Right	RK111	1:6300063−213681406	13, 15	15	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 545.1820068359375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB RK111 Liver−HCC Cancer type 1:6300063−213681406 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 176 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.02438658 FDR fragment joints
64	3	Lower_Left	RK111	19:14071846−46096435	14, 14	14	{'min_x': 60.70000076293945, 'min_y': 731.9749755859375, 'max_x': 225.03004455566406, 'max_y': 831.8338012695312}	20 MB 30 MB 40 MB RK111 Liver−HCC Cancer type 19:14071846−46096435 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 176 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
64	4	Lower_Right	RK120	9:28658249−39086583	4, 8	14	{'min_x': 352.95001220703125, 'min_y': 731.9749755859375, 'max_x': 535.4620361328125, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB RK120 Liver−HCC Cancer type 9:28658249−39086583 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 0 52 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 14 CN segments
65	1	Upper_Left	RK121	4:101126283−130852966	6, 6	6	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 237.53216552734375, 'max_y': 406.2539978027344}	80 MB 100 MB 120 MB RK121 Liver−HCC Cancer type 4:101126283−130852966 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 35 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints
65	2	Upper_Right	RK122	3:100989378−104690117	6, 6	6	{'min_x': 307.3800048828125, 'min_y': 296.9750061035156, 'max_x': 515.6820678710938, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB RK122 Liver−HCC Cancer type 3:100989378−104690117 Position 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 2 256 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints
65	3	Lower_Left	RK122	5:1296781−85032688	4, 6	6	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 233.28211975097656, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB RK122 Liver−HCC Cancer type 5:1296781−85032688 Position 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 256 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments
65	4	Lower_Right	RK148	5:42562425−154180295	11, 11	11	{'min_x': 322.8599853515625, 'min_y': 731.9749755859375, 'max_x': 551.76220703125, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 125 MB 150 MB RK148 Liver−HCC Cancer type 5:42562425−154180295 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 10; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
66	1	Upper_Left	RK148	7:1042254−150037666	13, 13	13	{'min_x': 61.849998474121094, 'min_y': 296.9750061035156, 'max_x': 270.8520812988281, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB RK148 Liver−HCC Cancer type 7:1042254−150037666 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 12; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 7.730001e−05 FDR fragment joints
66	2	Upper_Right	RK148	9:21975039−132836763	7, 11	11	{'min_x': 313.7799987792969, 'min_y': 296.9750061035156, 'max_x': 544.0919189453125, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB RK148 Liver−HCC Cancer type 9:21975039−132836763 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 195 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.05741733 FDR fragment joints
66	3	Lower_Left	RK148	12:9270007−123718833	13, 13	13	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 100 MB RK148 Liver−HCC Cancer type 12:9270007−123718833 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 8; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
66	4	Lower_Right	RK148	14:33101844−100726901	9, 10	10	{'min_x': 331.0199890136719, 'min_y': 731.9749755859375, 'max_x': 557.922119140625, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB RK148 Liver−HCC Cancer type 14:33101844−100726901 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments
67	1	Upper_Left	RK148	17:41536382−79640132	11, 11	11	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 270.010009765625, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB RK148 Liver−HCC Cancer type 17:41536382−79640132 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.01743054 FDR fragment joints
67	2	Upper_Right	RK148	22:24848675−42286407	16, 16	16	{'min_x': 309.4800109863281, 'min_y': 296.9750061035156, 'max_x': 528.2100830078125, 'max_y': 406.2539978027344}	25 MB 30 MB 35 MB 40 MB RK148 Liver−HCC Cancer type 22:24848675−42286407 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 9; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.002298705 FDR fragment joints
67	3	Lower_Left	RK177	8:50712276−144686189	14, 17	21	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB RK177 Liver−HCC Cancer type 8:50712276−144686189 Position 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 2; SV types t2tINV: 5; TRA: 1 139 SVs in sample 14, 17 Oscillating CN (2 and 3 states) 21 CN segments
67	4	Lower_Right	RK195	2:9090277−240897263	9, 11	11	{'min_x': 348.20001220703125, 'min_y': 731.9749755859375, 'max_x': 519.6920166015625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB RK195 Liver−HCC Cancer type 2:9090277−240897263 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 4 121 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments
68	1	Upper_Left	RK211	1:21930164−34131783	5, 13	21	{'min_x': 52.95000076293945, 'min_y': 296.9750061035156, 'max_x': 260.97198486328125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB RK211 Liver−HCC Cancer type 1:21930164−34131783 Position 55 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 15; DUP: 18; h2hINV: 10; SV types t2tINV: 12; TRA: 0 227 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints
68	2	Upper_Right	RK211	12:9969409−96771043	11, 12	12	{'min_x': 347.44000244140625, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB RK211 Liver−HCC Cancer type 12:9969409−96771043 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 227 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.04139017 FDR fragment joints
68	3	Lower_Left	RK211	15:51499432−90044037	12, 12	12	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 268.6999816894531, 'max_y': 831.8338012695312}	60 MB 70 MB 80 MB 90 MB RK211 Liver−HCC Cancer type 15:51499432−90044037 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 227 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
68	4	Lower_Right	RK280	1:25548581−217538998	7, 13	13	{'min_x': 336.8699951171875, 'min_y': 731.9749755859375, 'max_x': 539.332275390625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB RK280 Liver−HCC Cancer type 1:25548581−217538998 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 1; TRA: 1 111 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 13 CN segments
69	1	Upper_Left	RK280	3:37076321−196695607	11, 20	20	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB RK280 Liver−HCC Cancer type 3:37076321−196695607 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 2 111 SVs in sample 11, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.1013295 FDR fragment joints
69	2	Upper_Right	RK285	5:973432−156988868	10, 11	18	{'min_x': 308.1199951171875, 'min_y': 296.9750061035156, 'max_x': 529.4021606445312, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB RK285 Liver−HCC Cancer type 5:973432−156988868 Position 4 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 352 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 18 CN segments 1 FDR fragment joints
69	3	Lower_Left	RK285	6:158550050−163021558	7, 11	11	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 265.65203857421875, 'max_y': 831.8338012695312}	80 MB 120 MB 160 MB RK285 Liver−HCC Cancer type 6:158550050−163021558 Position 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 2 352 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments
69	4	Lower_Right	368e23f0-e573-4547-bf5a-14080baf737b	6:1715943−15332733	5, 7	7	{'min_x': 330.3699951171875, 'min_y': 731.9749755859375, 'max_x': 555.721923828125, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 368e23f0−e573−4547−bf5a−14080baf737b Lung−AdenoCA Cancer type 6:1715943−15332733 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 0 170 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments
70	1	Upper_Left	368e23f0-e573-4547-bf5a-14080baf737b	9:4921030−131320749	12, 15	15	{'min_x': 40.86989974975586, 'min_y': 296.9750061035156, 'max_x': 259.3719177246094, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 368e23f0−e573−4547−bf5a−14080baf737b Lung−AdenoCA Cancer type 9:4921030−131320749 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 170 SVs in sample 12, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.1178349 FDR fragment joints
70	2	Upper_Right	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	18:31523695−73471077	7, 18	18	{'min_x': 329.7099914550781, 'min_y': 296.9750061035156, 'max_x': 537.0219116210938, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 9f81c602−8afa−4588−b0b6−6e5a1a128d5a Lung−AdenoCA Cancer type 18:31523695−73471077 Position 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 5 84 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.7425546 FDR fragment joints
70	3	Lower_Left	c4d1e105-28b7-48df-abef-fbe09782fdb2	4:2178913−151296713	14, 14	14	{'min_x': 40.88010025024414, 'min_y': 731.9749755859375, 'max_x': 268.902099609375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB c4d1e105−28b7−48df−abef−fbe09782fdb2 Lung−AdenoCA Cancer type 4:2178913−151296713 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 136 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
70	4	Lower_Right	c4d1e105-28b7-48df-abef-fbe09782fdb2	6:11726247−162394717	8, 10	10	{'min_x': 330.3800048828125, 'min_y': 731.9749755859375, 'max_x': 556.7418823242188, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB c4d1e105−28b7−48df−abef−fbe09782fdb2 Lung−AdenoCA Cancer type 6:11726247−162394717 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 1; SV types t2tINV: 0; TRA: 0 136 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 10 CN segments
71	1	Upper_Left	f77cf4d3-9829-4fd3-95a1-b29aed9e94b8	X:147715186−154903339	5, 5	17	{'min_x': 40.539798736572266, 'min_y': 296.9750061035156, 'max_x': 247.1839599609375, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB f77cf4d3−9829−4fd3−95a1−b29aed9e94b8 Lung−AdenoCA Cancer type X:147715186−154903339 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 2; SV types t2tINV: 0; TRA: 1 155 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints
71	2	Upper_Right	037c57d1-b4a5-45dc-bda4-0550461d321b	1:51845048−55431534	4, 5	9	{'min_x': 308.5400085449219, 'min_y': 296.9750061035156, 'max_x': 539.0179443359375, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB 200 MB 037c57d1−b4a5−45dc−bda4−0550461d321b Lung−SCC Cancer type 1:51845048−55431534 Position 11 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 4; SV types t2tINV: 2; TRA: 3 307 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints
71	3	Lower_Left	037c57d1-b4a5-45dc-bda4-0550461d321b	2:32968870−222526259	7, 9	36	{'min_x': 38.210201263427734, 'min_y': 731.9749755859375, 'max_x': 249.51795959472656, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 037c57d1−b4a5−45dc−bda4−0550461d321b Lung−SCC Cancer type 2:32968870−222526259 Position 1 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 15; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 10 307 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 36 CN segments
71	4	Lower_Right	037c57d1-b4a5-45dc-bda4-0550461d321b	5:1852334−41793671	6, 10	22	{'min_x': 309.2300109863281, 'min_y': 731.9749755859375, 'max_x': 539.0179443359375, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 037c57d1−b4a5−45dc−bda4−0550461d321b Lung−SCC Cancer type 5:1852334−41793671 Position 6 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 5 307 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 22 CN segments
72	1	Upper_Left	1f6b2aca-7357-40d1-ba7a-99227d9900a2	6:47045197−150310817	9, 14	26	{'min_x': 39.36989974975586, 'min_y': 296.9750061035156, 'max_x': 270.25201416015625, 'max_y': 406.2539978027344}	75 MB 100 MB 125 MB 150 MB 1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 6:47045197−150310817 Position 9 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 6 602 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 26 CN segments 0.6776251 FDR fragment joints
72	2	Upper_Right	43abe847-4ba7-466e-8283-5d7b80b999a7	7:114953114−146032540	4, 6	26	{'min_x': 313.3599853515625, 'min_y': 296.9750061035156, 'max_x': 556.171875, 'max_y': 406.2539978027344}	70 MB 90 MB 110 MB 130 MB 150 MB 43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 7:114953114−146032540 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 500 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 26 CN segments 0.615458 FDR fragment joints
72	3	Lower_Left	7b982d5e-3a7d-40ac-bd25-6044c62879b6	10:89028540−98045877	5, 7	8	{'min_x': 38.36989974975586, 'min_y': 731.9749755859375, 'max_x': 249.3579559326172, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 7b982d5e−3a7d−40ac−bd25−6044c62879b6 Lung−SCC Cancer type 10:89028540−98045877 Position 6 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 13 349 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 8 CN segments
72	4	Lower_Right	87ac0ad4-8c9d-409e-9a86-1d201d01769d	1:15427220−247773092	17, 29	29	{'min_x': 328.0400085449219, 'min_y': 731.9749755859375, 'max_x': 562.6220703125, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 250 MB 87ac0ad4−8c9d−409e−9a86−1d201d01769d Lung−SCC Cancer type 1:15427220−247773092 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 13; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 0 168 SVs in sample 17, 29 Oscillating CN (2 and 3 states) 29 CN segments
73	1	Upper_Left	9a874b64-d0d6-416e-97bc-e9071ed0b16b	7:3406252−121161205	7, 22	22	{'min_x': 38.210201263427734, 'min_y': 296.9750061035156, 'max_x': 249.51795959472656, 'max_y': 406.2539978027344}	50 MB 100 MB 9a874b64−d0d6−416e−97bc−e9071ed0b16b Lung−SCC Cancer type 7:3406252−121161205 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 359 SVs in sample 7, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.1266611 FDR fragment joints
73	2	Upper_Right	aecf85cc-058c-46f3-9cdc-3573ac3b8438	11:400656−128835047	8, 8	11	{'min_x': 308.7099914550781, 'min_y': 296.9750061035156, 'max_x': 553.5121459960938, 'max_y': 406.2539978027344}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB aecf85cc−058c−46f3−9cdc−3573ac3b8438 Lung−SCC Cancer type 11:400656−128835047 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 232 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 11 CN segments 0.04139017 FDR fragment joints
73	3	Lower_Left	b913d254-8307-4b8a-8313-d978e32bb38f	1:10985224−229819545	7, 7	24	{'min_x': 39.039798736572266, 'min_y': 731.9749755859375, 'max_x': 248.68995666503906, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB b913d254−8307−4b8a−8313−d978e32bb38f Lung−SCC Cancer type 1:10985224−229819545 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 11; h2hINV: 0; SV types t2tINV: 3; TRA: 1 944 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 24 CN segments
73	4	Lower_Right	4111337	12:17128247−17295895	6, 7	9	{'min_x': 324.92999267578125, 'min_y': 731.9749755859375, 'max_x': 555.6919555664062, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 4111337 Lymph−BNHL Cancer type 12:17128247−17295895 Position 8 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 4; SV types t2tINV: 3; TRA: 30 226 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 9 CN segments
74	1	Upper_Left	4135099	2:53389576−199251373	12, 12	12	{'min_x': 51.18009948730469, 'min_y': 296.9750061035156, 'max_x': 271.9021301269531, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 4135099 Lymph−BNHL Cancer type 2:53389576−199251373 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 297 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.01743054 FDR fragment joints
74	2	Upper_Right	4135099	4:2735820−190587393	13, 17	17	{'min_x': 351.3500061035156, 'min_y': 296.9750061035156, 'max_x': 515.3778686523438, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 4135099 Lymph−BNHL Cancer type 4:2735820−190587393 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 13; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 297 SVs in sample 13, 17 Oscillating CN (2 and 3 states) 17 CN segments 4.035888e−05 FDR fragment joints
74	3	Lower_Left	4138527	4:15573682−189567466	7, 7	7	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 4138527 Lymph−BNHL Cancer type 4:15573682−189567466 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 2 187 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
74	4	Lower_Right	4138527	13:30136476−91861686	8, 8	8	{'min_x': 306.989990234375, 'min_y': 731.9749755859375, 'max_x': 544.4103393554688, 'max_y': 831.8338012695312}	30 MB 40 MB 50 MB 60 MB 70 MB 80 MB 90 MB 4138527 Lymph−BNHL Cancer type 13:30136476−91861686 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 187 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
75	1	Upper_Left	4138527	16:48053477−51323723	4, 4	4	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 261.6600036621094, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 4138527 Lymph−BNHL Cancer type 16:48053477−51323723 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 187 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.7735152 FDR fragment joints
75	2	Upper_Right	4145528	1:77006091−161744723	13, 18	63	{'min_x': 307.760009765625, 'min_y': 296.9750061035156, 'max_x': 561.462158203125, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB 4145528 Lymph−BNHL Cancer type 1:77006091−161744723 Position 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 2 1226 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 63 CN segments 0.7735152 FDR fragment joints
75	3	Lower_Left	4145528	3:111610899−188282688	12, 40	47	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 4145528 Lymph−BNHL Cancer type 3:111610899−188282688 Position 3 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 1226 SVs in sample 12, 40 Oscillating CN (2 and 3 states) 47 CN segments
75	4	Lower_Right	4145528	4:137343292−185113770	14, 28	33	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 515.9820556640625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 4145528 Lymph−BNHL Cancer type 4:137343292−185113770 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 1 1226 SVs in sample 14, 28 Oscillating CN (2 and 3 states) 33 CN segments
76	1	Upper_Left	4145528	8:3116649−136165687	20, 57	89	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 4145528 Lymph−BNHL Cancer type 8:3116649−136165687 Position 2 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 1; SV types t2tINV: 1; TRA: 6 1226 SVs in sample 20, 57 Oscillating CN (2 and 3 states) 89 CN segments 0.155439 FDR fragment joints
76	2	Upper_Right	4147968	4:30276216−125265483	7, 7	7	{'min_x': 350.3800048828125, 'min_y': 296.9750061035156, 'max_x': 535.69189453125, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 125 MB 4147968 Lymph−BNHL Cancer type 4:30276216−125265483 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 140 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.1013295 FDR fragment joints
76	3	Lower_Left	4176133	19:2022616−43007888	9, 10	10	{'min_x': 62.889801025390625, 'min_y': 731.9749755859375, 'max_x': 252.02999877929688, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB 4176133 Lymph−BNHL Cancer type 19:2022616−43007888 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 9; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 1 59 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments
76	4	Lower_Right	4188398	7:16592923−110490608	18, 20	20	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 100 MB 4188398 Lymph−BNHL Cancer type 7:16592923−110490608 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 5 119 SVs in sample 18, 20 Oscillating CN (2 and 3 states) 20 CN segments
77	1	Upper_Left	16	1:158895713−207110372	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 255.62196350097656, 'max_y': 406.2539978027344}	180 MB 200 MB 220 MB 240 MB 16 Lymph−CLL Cancer type 1:158895713−207110372 Position 6 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 19 82 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.8653243 FDR fragment joints
77	2	Upper_Right	16	6:87781500−137889692	11, 11	11	{'min_x': 338.0799865722656, 'min_y': 296.9750061035156, 'max_x': 555.232177734375, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 16 Lymph−CLL Cancer type 6:87781500−137889692 Position 11 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 25 82 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints
77	3	Lower_Left	AOCS-004	8:25228170−114295579	9, 10	12	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	30 MB 60 MB 90 MB AOCS−004 Ovary−AdenoCA Cancer type 8:25228170−114295579 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 121 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 12 CN segments
77	4	Lower_Right	AOCS-005	6:109475920−109661908	4, 5	5	{'min_x': 307.04998779296875, 'min_y': 731.9749755859375, 'max_x': 537.741943359375, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−005 Ovary−AdenoCA Cancer type 6:109475920−109661908 Position 11 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 10 399 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 5 CN segments
78	1	Upper_Left	AOCS-063	7:17651563−151348579	9, 9	9	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 267.6419372558594, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−063 Ovary−AdenoCA Cancer type 7:17651563−151348579 Position 4 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 3 146 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints
78	2	Upper_Right	AOCS-064	4:19583669−172211276	5, 8	22	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−064 Ovary−AdenoCA Cancer type 4:19583669−172211276 Position 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 0; SV types t2tINV: 3; TRA: 4 402 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 22 CN segments 0.615458 FDR fragment joints
78	3	Lower_Left	AOCS-065	2:42549921−220375355	12, 16	16	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 238.69187927246094, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB AOCS−065 Ovary−AdenoCA Cancer type 2:42549921−220375355 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 255 SVs in sample 12, 16 Oscillating CN (2 and 3 states) 16 CN segments
78	4	Lower_Right	AOCS-065	8:22020075−122183195	9, 10	20	{'min_x': 322.8599853515625, 'min_y': 731.9749755859375, 'max_x': 548.641845703125, 'max_y': 836.9337768554688}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−065 Ovary−AdenoCA Cancer type 8:22020075−122183195 Position 3 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 9 255 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 20 CN segments 0.9284301 FDR fragment joints
79	1	Upper_Left	AOCS-075	1:76045362−227389874	5, 11	11	{'min_x': 60.73979949951172, 'min_y': 296.9750061035156, 'max_x': 235.65199279785156, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB AOCS−075 Ovary−AdenoCA Cancer type 1:76045362−227389874 Position 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 6 166 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
79	2	Upper_Right	AOCS-078	10:10638409−126440995	18, 26	26	{'min_x': 336.1000061035156, 'min_y': 296.9750061035156, 'max_x': 557.5322265625, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−078 Ovary−AdenoCA Cancer type 10:10638409−126440995 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 15; h2hINV: 0; SV types t2tINV: 0; TRA: 2 457 SVs in sample 18, 26 Oscillating CN (2 and 3 states) 26 CN segments 6.6795e−05 FDR fragment joints
79	3	Lower_Left	AOCS-079	1:93975098−229706598	5, 8	36	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 229.27197265625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB AOCS−079 Ovary−AdenoCA Cancer type 1:93975098−229706598 Position 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 1; SV types t2tINV: 1; TRA: 2 310 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 36 CN segments
79	4	Lower_Right	AOCS-080	2:65178109−67917873	6, 6	6	{'min_x': 345.55999755859375, 'min_y': 731.9749755859375, 'max_x': 521.7718505859375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB AOCS−080 Ovary−AdenoCA Cancer type 2:65178109−67917873 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 207 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments
80	1	Upper_Left	AOCS-083	11:681299−115592442	7, 7	13	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB AOCS−083 Ovary−AdenoCA Cancer type 11:681299−115592442 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 242 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.01743054 FDR fragment joints
80	2	Upper_Right	AOCS-084	2:39660868−41960421	6, 8	8	{'min_x': 322.1700134277344, 'min_y': 296.9750061035156, 'max_x': 557.4022216796875, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB AOCS−084 Ovary−AdenoCA Cancer type 2:39660868−41960421 Position 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 146 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.8298498 FDR fragment joints
80	3	Lower_Left	AOCS-090	10:11417451−104002149	7, 11	11	{'min_x': 51.830101013183594, 'min_y': 731.9749755859375, 'max_x': 260.9322204589844, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB AOCS−090 Ovary−AdenoCA Cancer type 10:11417451−104002149 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 1; SV types t2tINV: 0; TRA: 2 334 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments
80	4	Lower_Right	AOCS-091	2:3886207−191136840	9, 14	27	{'min_x': 307.8500061035156, 'min_y': 731.9749755859375, 'max_x': 523.6419067382812, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB AOCS−091 Ovary−AdenoCA Cancer type 2:3886207−191136840 Position 8 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 5 347 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 27 CN segments
81	1	Upper_Left	AOCS-092	7:6073651−127466609	11, 17	22	{'min_x': 53.960201263427734, 'min_y': 296.9750061035156, 'max_x': 266.2220153808594, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−092 Ovary−AdenoCA Cancer type 7:6073651−127466609 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 0 209 SVs in sample 11, 17 Oscillating CN (2 and 3 states) 22 CN segments 0.1790694 FDR fragment joints
81	2	Upper_Right	AOCS-093	4:1895208−181137268	7, 9	9	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 520.3218383789062, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−093 Ovary−AdenoCA Cancer type 4:1895208−181137268 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 7; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 3 297 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.129004 FDR fragment joints
81	3	Lower_Left	AOCS-094	6:41123088−100990123	8, 29	29	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 263.3821716308594, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB AOCS−094 Ovary−AdenoCA Cancer type 6:41123088−100990123 Position 12 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 6 604 SVs in sample 8, 29 Oscillating CN (2 and 3 states) 29 CN segments
81	4	Lower_Right	AOCS-094	19:35566735−45168798	5, 7	13	{'min_x': 327.6700134277344, 'min_y': 731.9749755859375, 'max_x': 527.51025390625, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB AOCS−094 Ovary−AdenoCA Cancer type 19:35566735−45168798 Position 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 5; SV types t2tINV: 2; TRA: 2 604 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 13 CN segments
82	1	Upper_Left	AOCS-094	X:18850169−152426350	5, 12	19	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 265.43206787109375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−094 Ovary−AdenoCA Cancer type X:18850169−152426350 Position 9 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 5 604 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 19 CN segments 0.8988396 FDR fragment joints
82	2	Upper_Right	AOCS-095	4:14169897−31589123	6, 14	14	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 516.3617553710938, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−095 Ovary−AdenoCA Cancer type 4:14169897−31589123 Position 16 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 5; SV types t2tINV: 6; TRA: 2 209 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.615458 FDR fragment joints
82	3	Lower_Left	AOCS-108	8:36857660−141396458	7, 18	58	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 238.0719451904297, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 125 MB AOCS−108 Ovary−AdenoCA Cancer type 8:36857660−141396458 Position 3 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 19 415 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 58 CN segments
82	4	Lower_Right	AOCS-112	12:6016071−129897086	8, 8	33	{'min_x': 342.8399963378906, 'min_y': 731.9749755859375, 'max_x': 551.282470703125, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−112 Ovary−AdenoCA Cancer type 12:6016071−129897086 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 1 297 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 33 CN segments
83	1	Upper_Left	AOCS-112	22:29629715−46463921	13, 15	15	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 248.8902130126953, 'max_y': 406.2539978027344}	35 MB 40 MB 45 MB AOCS−112 Ovary−AdenoCA Cancer type 22:29629715−46463921 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 297 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.01743054 FDR fragment joints
83	2	Upper_Right	AOCS-116	5:6523540−170861278	12, 26	34	{'min_x': 309.3900146484375, 'min_y': 296.9750061035156, 'max_x': 532.2324829101562, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB AOCS−116 Ovary−AdenoCA Cancer type 5:6523540−170861278 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 2 481 SVs in sample 12, 26 Oscillating CN (2 and 3 states) 34 CN segments 0.1845613 FDR fragment joints
83	3	Lower_Left	AOCS-116	8:120799542−121389397	4, 7	9	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 100 MB AOCS−116 Ovary−AdenoCA Cancer type 8:120799542−121389397 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 481 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 9 CN segments
83	4	Lower_Right	AOCS-116	11:36110794−108039913	7, 24	27	{'min_x': 308.8699951171875, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB AOCS−116 Ovary−AdenoCA Cancer type 11:36110794−108039913 Position 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 8 481 SVs in sample 7, 24 Oscillating CN (2 and 3 states) 27 CN segments
84	1	Upper_Left	AOCS-117	3:202871−63948256	5, 6	17	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 229.58212280273438, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−117 Ovary−AdenoCA Cancer type 3:202871−63948256 Position 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 2 333 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 17 CN segments 0.7995907 FDR fragment joints
84	2	Upper_Right	AOCS-117	6:30232935−32110297	4, 6	6	{'min_x': 336.95001220703125, 'min_y': 296.9750061035156, 'max_x': 554.1322631835938, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB AOCS−117 Ovary−AdenoCA Cancer type 6:30232935−32110297 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 333 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints
84	3	Lower_Left	AOCS-117	11:6511167−122670130	9, 16	19	{'min_x': 51.960201263427734, 'min_y': 731.9749755859375, 'max_x': 257.9419860839844, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−117 Ovary−AdenoCA Cancer type 11:6511167−122670130 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 0 333 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 19 CN segments
84	4	Lower_Right	AOCS-119	X:73888460−94161009	8, 8	12	{'min_x': 334.8800048828125, 'min_y': 731.9749755859375, 'max_x': 556.6419677734375, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−119 Ovary−AdenoCA Cancer type X:73888460−94161009 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 1 375 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 12 CN segments
85	1	Upper_Left	AOCS-120	1:1708031−206256543	12, 21	61	{'min_x': 37.03010177612305, 'min_y': 296.9750061035156, 'max_x': 230.5019989013672, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB AOCS−120 Ovary−AdenoCA Cancer type 1:1708031−206256543 Position 4 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 23 790 SVs in sample 12, 21 Oscillating CN (2 and 3 states) 61 CN segments 0.5435077 FDR fragment joints 0.01 FDR chr. breakp. enrich.
85	2	Upper_Right	AOCS-120	1:1708031−206256542	11, 13	86	{'min_x': 308.6400146484375, 'min_y': 291.7399597167969, 'max_x': 543.5379638671875, 'max_y': 412.114013671875}	AOCS−120 0 MB 50 MB 100 MB 150 MB 200 MB Ovary−AdenoCA Cancer type 2:17888044−240960571 Position 12 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 28 790 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 86 CN segments 0.8135044 FDR fragment joints 0 FDR chr. breakp. enrich. 1:1708031−206256542;12:21770067−118615375
85	3	Lower_Left	AOCS-128	2:19515679−227555412	9, 15	40	{'min_x': 35.360198974609375, 'min_y': 731.0599975585938, 'max_x': 232.41183471679688, 'max_y': 832.6138916015625}	AOCS−128 50 MB 100 MB 150 MB 200 MB Ovary−AdenoCA Cancer type 2:19515679−227555412 Position 7 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 5; SV types t2tINV: 2; TRA: 18 496 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 40 CN segments 0.5435077 FDR fragment joints
85	4	Lower_Right	AOCS-128	20:11284294−25291268	8, 9	9	{'min_x': 346.8599853515625, 'min_y': 731.9749755859375, 'max_x': 547.7999267578125, 'max_y': 831.8338012695312}	20 MB 30 MB 40 MB 50 MB 60 MB AOCS−128 Ovary−AdenoCA Cancer type 20:11284294−25291268 Position 4 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 496 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 9 CN segments
86	1	Upper_Left	AOCS-138	5:96175581−171118223	10, 10	10	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 231.16188049316406, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−138 Ovary−AdenoCA Cancer type 5:96175581−171118223 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 323 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.1013295 FDR fragment joints
86	2	Upper_Right	AOCS-139	2:48598839−187592335	8, 19	45	{'min_x': 324.8599853515625, 'min_y': 296.9750061035156, 'max_x': 519.9522705078125, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB AOCS−139 Ovary−AdenoCA Cancer type 2:48598839−187592335 Position 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 7 542 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 45 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
86	3	Lower_Left	AOCS-139	6:7505549−166697296	10, 14	28	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 261.2021179199219, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB AOCS−139 Ovary−AdenoCA Cancer type 6:7505549−166697296 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 9 542 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 28 CN segments
86	4	Lower_Right	AOCS-139	8:48696966−144814173	8, 10	39	{'min_x': 323.19000244140625, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 836.9337768554688}	50 MB 100 MB AOCS−139 Ovary−AdenoCA Cancer type 8:48696966−144814173 Position 1 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 7 542 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 39 CN segments 0.1013295 FDR fragment joints
87	1	Upper_Left	AOCS-139	11:97517122−129852368	8, 11	11	{'min_x': 33.68980026245117, 'min_y': 296.9750061035156, 'max_x': 260.88214111328125, 'max_y': 411.343994140625}	50 MB 75 MB 100 MB 125 MB AOCS−139 Ovary−AdenoCA Cancer type 11:97517122−129852368 Position 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 6 542 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints 0.03 FDR chr. breakp. enrich.
87	2	Upper_Right	AOCS-150	5:175233−56407292	7, 8	9	{'min_x': 309.19000244140625, 'min_y': 296.9750061035156, 'max_x': 531.8421630859375, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB AOCS−150 Ovary−AdenoCA Cancer type 5:175233−56407292 Position 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 3 428 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 9 CN segments 0.8653243 FDR fragment joints
87	3	Lower_Left	AOCS-150	6:34474425−84968074	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 266.4020690917969, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB AOCS−150 Ovary−AdenoCA Cancer type 6:34474425−84968074 Position 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 3 428 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
87	4	Lower_Right	AOCS-159	15:45195576−78304180	11, 11	11	{'min_x': 340.9700012207031, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 60 MB 70 MB AOCS−159 Ovary−AdenoCA Cancer type 15:45195576−78304180 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 259 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
88	1	Upper_Left	AOCS-161	14:23318396−82349714	9, 12	12	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 260.0197448730469, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB AOCS−161 Ovary−AdenoCA Cancer type 14:23318396−82349714 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 255 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.1013295 FDR fragment joints
88	2	Upper_Right	AOCS-164	8:35352452−144225865	7, 16	21	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB AOCS−164 Ovary−AdenoCA Cancer type 8:35352452−144225865 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 5 253 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 21 CN segments 0.1817907 FDR fragment joints
88	3	Lower_Left	AOCS-165	5:56289678−56503515	4, 4	4	{'min_x': 46.539798736572266, 'min_y': 731.9749755859375, 'max_x': 254.9918975830078, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB AOCS−165 Ovary−AdenoCA Cancer type 5:56289678−56503515 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 0 139 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments
88	4	Lower_Right	AOCS-166	1:153869668−245318697	10, 10	10	{'min_x': 311.2200012207031, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB AOCS−166 Ovary−AdenoCA Cancer type 1:153869668−245318697 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 170 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
89	1	Upper_Left	AOCS-167	1:81903189−235162240	11, 11	11	{'min_x': 39.900001525878906, 'min_y': 296.9750061035156, 'max_x': 229.02200317382812, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB AOCS−167 Ovary−AdenoCA Cancer type 1:81903189−235162240 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 4 181 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.1178349 FDR fragment joints
89	2	Upper_Right	AOCS-169	3:68970737−174586485	10, 23	38	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB AOCS−169 Ovary−AdenoCA Cancer type 3:68970737−174586485 Position 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 1 413 SVs in sample 10, 23 Oscillating CN (2 and 3 states) 38 CN segments 0.01743054 FDR fragment joints
89	3	Lower_Left	AOCS-169	5:389649−170154621	10, 10	46	{'min_x': 61.849998474121094, 'min_y': 731.9749755859375, 'max_x': 243.51185607910156, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB AOCS−169 Ovary−AdenoCA Cancer type 5:389649−170154621 Position 1 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 2; DUP: 19; h2hINV: 0; SV types t2tINV: 0; TRA: 2 413 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 46 CN segments
89	4	Lower_Right	AOCS-170	1:58559059−225301156	13, 31	77	{'min_x': 350.1600036621094, 'min_y': 731.9749755859375, 'max_x': 562.3616943359375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 250 MB AOCS−170 Ovary−AdenoCA Cancer type 1:58559059−225301156 Position 6 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 15 773 SVs in sample 13, 31 Oscillating CN (2 and 3 states) 77 CN segments
90	1	Upper_Left	AOCS-170	2:145638253−166271367	10, 10	24	{'min_x': 62.61989974975586, 'min_y': 296.9750061035156, 'max_x': 232.30198669433594, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB AOCS−170 Ovary−AdenoCA Cancer type 2:145638253−166271367 Position 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 6 773 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 24 CN segments 0.615458 FDR fragment joints
90	2	Upper_Right	AOCS-170	12:18986632−111780873	7, 16	46	{'min_x': 349.44000244140625, 'min_y': 296.9750061035156, 'max_x': 549.1023559570312, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−170 Ovary−AdenoCA Cancer type 12:18986632−111780873 Position 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 2 773 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 46 CN segments 0.8653243 FDR fragment joints
90	3	Lower_Left	AOCS-170	13:26480205−114798981	10, 11	22	{'min_x': 61.849998474121094, 'min_y': 731.9749755859375, 'max_x': 232.24197387695312, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB AOCS−170 Ovary−AdenoCA Cancer type 13:26480205−114798981 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 1; SV types t2tINV: 0; TRA: 0 773 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 22 CN segments
90	4	Lower_Right	AOCS-170	15:92905679−93872883	4, 5	8	{'min_x': 321.69000244140625, 'min_y': 731.9749755859375, 'max_x': 542.8905029296875, 'max_y': 831.8338012695312}	40 MB 50 MB 60 MB 70 MB 80 MB 90 MB AOCS−170 Ovary−AdenoCA Cancer type 15:92905679−93872883 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 1; TRA: 0 773 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments
91	1	Upper_Left	AOCS-170	16:1456338−84616481	7, 12	36	{'min_x': 61.849998474121094, 'min_y': 296.9750061035156, 'max_x': 256.1498718261719, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB AOCS−170 Ovary−AdenoCA Cancer type 16:1456338−84616481 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 13; h2hINV: 1; SV types t2tINV: 0; TRA: 1 773 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 36 CN segments 0.0006748813 FDR fragment joints
91	2	Upper_Right	AOCS-171	8:9852651−142422526	12, 21	22	{'min_x': 351.3500061035156, 'min_y': 296.9750061035156, 'max_x': 515.3778686523438, 'max_y': 406.2539978027344}	50 MB 100 MB AOCS−171 Ovary−AdenoCA Cancer type 8:9852651−142422526 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 2 258 SVs in sample 12, 21 Oscillating CN (2 and 3 states) 22 CN segments 0.03151629 FDR fragment joints
91	3	Lower_Left	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	1:49064386−205747224	9, 9	47	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 246.1859588623047, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 200 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 1:49064386−205747224 Position 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 9 718 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 47 CN segments 0.7908979 FDR fragment joints
91	4	Lower_Right	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	5:32370239−40782660	4, 6	11	{'min_x': 331.0400085449219, 'min_y': 731.9749755859375, 'max_x': 535.6858520507812, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 5:32370239−40782660 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 1 718 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 11 CN segments
92	1	Upper_Left	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	9:1986986−134705327	7, 26	39	{'min_x': 41.539798736572266, 'min_y': 296.9750061035156, 'max_x': 246.1859588623047, 'max_y': 406.2539978027344}	50 MB 100 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 9:1986986−134705327 Position 1 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 0; DUP: 18; h2hINV: 1; SV types t2tINV: 0; TRA: 4 718 SVs in sample 7, 26 Oscillating CN (2 and 3 states) 39 CN segments 1.241524e−05 FDR fragment joints
92	2	Upper_Right	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	10:4932621−32240886	5, 6	22	{'min_x': 331.0400085449219, 'min_y': 296.9750061035156, 'max_x': 553.2420043945312, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 10:4932621−32240886 Position 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 3 718 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 22 CN segments 0.4695521 FDR fragment joints
92	3	Lower_Left	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	18:1815322−75311633	9, 29	40	{'min_x': 41.539798736572266, 'min_y': 731.9749755859375, 'max_x': 246.1859588623047, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 18:1815322−75311633 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 0; DUP: 19; h2hINV: 0; SV types t2tINV: 0; TRA: 1 718 SVs in sample 9, 29 Oscillating CN (2 and 3 states) 40 CN segments
92	4	Lower_Right	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	X:4890040−140268120	18, 19	71	{'min_x': 331.0400085449219, 'min_y': 731.9749755859375, 'max_x': 535.6858520507812, 'max_y': 831.8338012695312}	50 MB 100 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type X:4890040−140268120 Position 11 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 4; TRA: 7 718 SVs in sample 18, 19 Oscillating CN (2 and 3 states) 71 CN segments
93	1	Upper_Left	0a48873a-092a-4b25-822b-b0b3c18c08a8	5:66641825−177746139	8, 8	8	{'min_x': 38.70000076293945, 'min_y': 296.9750061035156, 'max_x': 266.0919189453125, 'max_y': 406.2539978027344}	75 MB 100 MB 125 MB 150 MB 175 MB 0a48873a−092a−4b25−822b−b0b3c18c08a8 Ovary−AdenoCA Cancer type 5:66641825−177746139 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 190 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1278363 FDR fragment joints
93	2	Upper_Right	0c1a2e7d-e7e4-481e-a012-ef214c444497	2:2471432−237349046	7, 15	24	{'min_x': 329.3699951171875, 'min_y': 296.9750061035156, 'max_x': 537.3599243164062, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 0c1a2e7d−e7e4−481e−a012−ef214c444497 Ovary−AdenoCA Cancer type 2:2471432−237349046 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 8 174 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 24 CN segments 0.1013295 FDR fragment joints
93	3	Lower_Left	0c1a2e7d-e7e4-481e-a012-ef214c444497	10:56404122−134361570	7, 10	10	{'min_x': 39.86989974975586, 'min_y': 731.9749755859375, 'max_x': 247.85995483398438, 'max_y': 831.8338012695312}	50 MB 100 MB 0c1a2e7d−e7e4−481e−a012−ef214c444497 Ovary−AdenoCA Cancer type 10:56404122−134361570 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 174 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments
93	4	Lower_Right	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	2:53884124−226741490	8, 10	13	{'min_x': 327.7099914550781, 'min_y': 731.9749755859375, 'max_x': 539.0178833007812, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB 15556b28−c6bd−455a−87b6−4b7b3e33d0e4 Ovary−AdenoCA Cancer type 2:53884124−226741490 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 1 154 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 13 CN segments
94	1	Upper_Left	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	7:3562493−155393789	7, 11	11	{'min_x': 38.210201263427734, 'min_y': 296.9750061035156, 'max_x': 249.51795959472656, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 15556b28−c6bd−455a−87b6−4b7b3e33d0e4 Ovary−AdenoCA Cancer type 7:3562493−155393789 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 154 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.1278363 FDR fragment joints
94	2	Upper_Right	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	10:28885088−61290339	7, 8	8	{'min_x': 327.7099914550781, 'min_y': 296.9750061035156, 'max_x': 539.0178833007812, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB 15556b28−c6bd−455a−87b6−4b7b3e33d0e4 Ovary−AdenoCA Cancer type 10:28885088−61290339 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 154 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1013295 FDR fragment joints
94	3	Lower_Left	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	1:8799389−247051701	14, 24	24	{'min_x': 41.38010025024414, 'min_y': 731.9749755859375, 'max_x': 246.34596252441406, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 21f6bf91−dfc6−4a59−8b76−88a0f95c7b47 Ovary−AdenoCA Cancer type 1:8799389−247051701 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 2 204 SVs in sample 14, 24 Oscillating CN (2 and 3 states) 24 CN segments
94	4	Lower_Right	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	3:15109935−168602841	8, 16	19	{'min_x': 330.8800048828125, 'min_y': 731.9749755859375, 'max_x': 547.7719116210938, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 21f6bf91−dfc6−4a59−8b76−88a0f95c7b47 Ovary−AdenoCA Cancer type 3:15109935−168602841 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 8; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 1 204 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 19 CN segments
95	1	Upper_Left	29949b65-2913-4c86-bbd7-b85c5df6f15e	1:11256059−246496102	12, 41	51	{'min_x': 39.710201263427734, 'min_y': 296.9750061035156, 'max_x': 248.02195739746094, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 29949b65−2913−4c86−bbd7−b85c5df6f15e Ovary−AdenoCA Cancer type 1:11256059−246496102 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 2; DUP: 15; h2hINV: 0; SV types t2tINV: 0; TRA: 3 360 SVs in sample 12, 41 Oscillating CN (2 and 3 states) 51 CN segments 0.002298705 FDR fragment joints
95	2	Upper_Right	29949b65-2913-4c86-bbd7-b85c5df6f15e	5:111950654−171572542	7, 17	24	{'min_x': 329.2099914550781, 'min_y': 296.9750061035156, 'max_x': 537.5219116210938, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 29949b65−2913−4c86−bbd7−b85c5df6f15e Ovary−AdenoCA Cancer type 5:111950654−171572542 Position 2 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 3 360 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 24 CN segments 0.1278363 FDR fragment joints
95	3	Lower_Left	29949b65-2913-4c86-bbd7-b85c5df6f15e	12:9762639−126691039	49, 49	58	{'min_x': 39.710201263427734, 'min_y': 731.9749755859375, 'max_x': 267.57196044921875, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 29949b65−2913−4c86−bbd7−b85c5df6f15e Ovary−AdenoCA Cancer type 12:9762639−126691039 Position 1 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 0; DUP: 26; h2hINV: 0; SV types t2tINV: 1; TRA: 1 360 SVs in sample 49, 49 Oscillating CN (2 and 3 states) 58 CN segments
95	4	Lower_Right	29949b65-2913-4c86-bbd7-b85c5df6f15e	18:41289568−74606040	8, 10	10	{'min_x': 329.2099914550781, 'min_y': 731.9749755859375, 'max_x': 537.5219116210938, 'max_y': 831.8338012695312}	50 MB 60 MB 70 MB 29949b65−2913−4c86−bbd7−b85c5df6f15e Ovary−AdenoCA Cancer type 18:41289568−74606040 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 360 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 10 CN segments
96	1	Upper_Left	3c037acf-f453-4513-a6dd-129163ddde2a	1:6281442−226959021	7, 14	14	{'min_x': 39.96989822387695, 'min_y': 296.9750061035156, 'max_x': 247.76185607910156, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB 3c037acf−f453−4513−a6dd−129163ddde2a Ovary−AdenoCA Cancer type 1:6281442−226959021 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 7; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 5 328 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.1013295 FDR fragment joints
96	2	Upper_Right	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	12:4470991−70144374	6, 10	29	{'min_x': 330.7099914550781, 'min_y': 296.9750061035156, 'max_x': 547.4718627929688, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 4c18d9cf−4af4−4a86−8b1c−f78795fbbd7e Ovary−AdenoCA Cancer type 12:4470991−70144374 Position 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 4; SV types t2tINV: 5; TRA: 1 96 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 29 CN segments 0.6776251 FDR fragment joints
96	3	Lower_Left	700e91bb-d675-41b2-bbbd-935767c7b447	2:85566821−169153622	10, 14	16	{'min_x': 37.88010025024414, 'min_y': 731.9749755859375, 'max_x': 249.84796142578125, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 200 MB 700e91bb−d675−41b2−bbbd−935767c7b447 Ovary−AdenoCA Cancer type 2:85566821−169153622 Position 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 6 686 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.615458 FDR fragment joints
96	4	Lower_Right	700e91bb-d675-41b2-bbbd-935767c7b447	4:21357758−186097187	9, 16	18	{'min_x': 319.8599853515625, 'min_y': 731.9749755859375, 'max_x': 539.3478393554688, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 700e91bb−d675−41b2−bbbd−935767c7b447 Ovary−AdenoCA Cancer type 4:21357758−186097187 Position 3 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 19 686 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints
97	1	Upper_Left	700e91bb-d675-41b2-bbbd-935767c7b447	12:16693692−123934826	9, 12	13	{'min_x': 37.88010025024414, 'min_y': 296.9750061035156, 'max_x': 272.91192626953125, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 700e91bb−d675−41b2−bbbd−935767c7b447 Ovary−AdenoCA Cancer type 12:16693692−123934826 Position 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 8 686 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 13 CN segments 0.9804396 FDR fragment joints
97	2	Upper_Right	700e91bb-d675-41b2-bbbd-935767c7b447	15:35363568−100501028	9, 15	15	{'min_x': 323.19000244140625, 'min_y': 296.9750061035156, 'max_x': 558.8023071289062, 'max_y': 411.343994140625}	40 MB 60 MB 80 MB 100 MB 700e91bb−d675−41b2−bbbd−935767c7b447 Ovary−AdenoCA Cancer type 15:35363568−100501028 Position 1 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 12; h2hINV: 0; SV types t2tINV: 0; TRA: 8 686 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.1013295 FDR fragment joints 0 FDR chr. breakp. enrich.
97	3	Lower_Left	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	5:32197937−154158016	9, 9	15	{'min_x': 38.88010025024414, 'min_y': 731.9749755859375, 'max_x': 263.04193115234375, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB 150 MB 7ca97692−0bf5−4bbd−81ce−10a051d04bd5 Ovary−AdenoCA Cancer type 5:32197937−154158016 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 9; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 275 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 15 CN segments
97	4	Lower_Right	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	8:28310047−134285132	10, 11	14	{'min_x': 328.3800048828125, 'min_y': 731.9749755859375, 'max_x': 540.19189453125, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 125 MB 7ca97692−0bf5−4bbd−81ce−10a051d04bd5 Ovary−AdenoCA Cancer type 8:28310047−134285132 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 275 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 14 CN segments
98	1	Upper_Left	7dcc809b-e33a-4453-b92a-c00786f48cb0	2:100265270−222653043	9, 12	60	{'min_x': 33.68980026245117, 'min_y': 296.0599670410156, 'max_x': 248.35995483398438, 'max_y': 407.0240173339844}	7dcc809b−e33a−4453−b92a−c00786f48cb0 50 MB 100 MB 150 MB 200 MB Ovary−AdenoCA Cancer type 2:100265270−222653043 Position 17 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 6; TRA: 16 665 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 60 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
98	2	Upper_Right	7dcc809b-e33a-4453-b92a-c00786f48cb0	3:101663947−139539104	7, 14	16	{'min_x': 308.2699890136719, 'min_y': 296.9750061035156, 'max_x': 537.8599243164062, 'max_y': 411.343994140625}	0 MB 50 MB 100 MB 150 MB 7dcc809b−e33a−4453−b92a−c00786f48cb0 Ovary−AdenoCA Cancer type 3:101663947−139539104 Position 15 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 7; h2hINV: 4; SV types t2tINV: 3; TRA: 4 665 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
98	3	Lower_Left	7dcc809b-e33a-4453-b92a-c00786f48cb0	5:73636560−135974128	7, 10	18	{'min_x': 39.36989974975586, 'min_y': 731.9749755859375, 'max_x': 256.7320861816406, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 7dcc809b−e33a−4453−b92a−c00786f48cb0 Ovary−AdenoCA Cancer type 5:73636560−135974128 Position 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 4 665 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 18 CN segments
98	4	Lower_Right	7dcc809b-e33a-4453-b92a-c00786f48cb0	12:1814222−68872525	9, 15	21	{'min_x': 323.19000244140625, 'min_y': 731.9749755859375, 'max_x': 560.7023315429688, 'max_y': 836.9337768554688}	25 MB 50 MB 75 MB 100 MB 7dcc809b−e33a−4453−b92a−c00786f48cb0 Ovary−AdenoCA Cancer type 12:1814222−68872525 Position 3 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 13 665 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 21 CN segments 0.615458 FDR fragment joints
99	1	Upper_Left	7dcc809b-e33a-4453-b92a-c00786f48cb0	17:4865503−75189371	8, 13	13	{'min_x': 39.36989974975586, 'min_y': 296.9750061035156, 'max_x': 266.86004638671875, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB 7dcc809b−e33a−4453−b92a−c00786f48cb0 Ovary−AdenoCA Cancer type 17:4865503−75189371 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 4 665 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.1457354 FDR fragment joints
99	2	Upper_Right	8a6d2ce3-cc57-451b-9b07-8263782aa23f	2:23974041−152146532	10, 11	54	{'min_x': 324.8599853515625, 'min_y': 296.0599670410156, 'max_x': 537.6898803710938, 'max_y': 407.0240173339844}	8a6d2ce3−cc57−451b−9b07−8263782aa23f 50 MB 100 MB 150 MB 200 MB Ovary−AdenoCA Cancer type 2:23974041−152146532 Position 6 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 22 704 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 54 CN segments 0.8653243 FDR fragment joints 0.02 FDR chr. breakp. enrich.
99	3	Lower_Left	8a6d2ce3-cc57-451b-9b07-8263782aa23f	6:21192197−101774595	4, 11	31	{'min_x': 33.68980026245117, 'min_y': 731.0599975585938, 'max_x': 248.18995666503906, 'max_y': 832.6138916015625}	8a6d2ce3−cc57−451b−9b07−8263782aa23f 40 MB 80 MB 120 MB Ovary−AdenoCA Cancer type 6:21192197−101774595 Position 7 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 12 704 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 31 CN segments 0.8653243 FDR fragment joints
99	4	Lower_Right	8a6d2ce3-cc57-451b-9b07-8263782aa23f	16:4412978−88870302	7, 10	26	{'min_x': 329.0400085449219, 'min_y': 731.9749755859375, 'max_x': 537.6898803710938, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 8a6d2ce3−cc57−451b−9b07−8263782aa23f Ovary−AdenoCA Cancer type 16:4412978−88870302 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 12 704 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 26 CN segments
100	1	Upper_Left	8a6d2ce3-cc57-451b-9b07-8263782aa23f	20:314995−46999237	10, 13	39	{'min_x': 37.03010177612305, 'min_y': 296.9750061035156, 'max_x': 248.18995666503906, 'max_y': 411.343994140625}	10 MB 20 MB 30 MB 40 MB 50 MB 8a6d2ce3−cc57−451b−9b07−8263782aa23f Ovary−AdenoCA Cancer type 20:314995−46999237 Position 5 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 16 704 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 39 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
100	2	Upper_Right	a5030259-cf9c-4a58-8710-b9da8ee59320	4:30207518−105576012	7, 10	10	{'min_x': 307.17999267578125, 'min_y': 296.9750061035156, 'max_x': 537.5299072265625, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB a5030259−cf9c−4a58−8710−b9da8ee59320 Ovary−AdenoCA Cancer type 4:30207518−105576012 Position 8 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 6 303 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.8988396 FDR fragment joints
100	3	Lower_Left	a5030259-cf9c-4a58-8710-b9da8ee59320	9:86423945−135994657	10, 10	10	{'min_x': 39.70000076293945, 'min_y': 731.9749755859375, 'max_x': 248.0299530029297, 'max_y': 831.8338012695312}	100 MB 110 MB 120 MB 130 MB a5030259−cf9c−4a58−8710−b9da8ee59320 Ovary−AdenoCA Cancer type 9:86423945−135994657 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 1 303 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
100	4	Lower_Right	c435627c-159d-4a6d-a819-30abac24bf4d	5:13995081−161235368	13, 14	15	{'min_x': 328.7099914550781, 'min_y': 731.9749755859375, 'max_x': 556.462158203125, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB c435627c−159d−4a6d−a819−30abac24bf4d Ovary−AdenoCA Cancer type 5:13995081−161235368 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 1 283 SVs in sample 13, 14 Oscillating CN (2 and 3 states) 15 CN segments
101	1	Upper_Left	c435627c-159d-4a6d-a819-30abac24bf4d	13:49228433−103426671	11, 15	15	{'min_x': 39.210201263427734, 'min_y': 296.9750061035156, 'max_x': 261.4618225097656, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB c435627c−159d−4a6d−a819−30abac24bf4d Ovary−AdenoCA Cancer type 13:49228433−103426671 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 1 283 SVs in sample 11, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.04139017 FDR fragment joints
101	2	Upper_Right	c9e28934-8379-4511-817c-d787f2c4ca3a	11:40526511−125429660	10, 18	35	{'min_x': 309.0299987792969, 'min_y': 296.9750061035156, 'max_x': 548.6021118164062, 'max_y': 406.2539978027344}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB c9e28934−8379−4511−817c−d787f2c4ca3a Ovary−AdenoCA Cancer type 11:40526511−125429660 Position 5 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 7 377 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 35 CN segments 0.9284301 FDR fragment joints
101	3	Lower_Left	eeb9d147-608d-4692-8adf-2f601d23a8ff	2:28986695−219321806	7, 15	15	{'min_x': 41.210201263427734, 'min_y': 731.9749755859375, 'max_x': 247.48219299316406, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB eeb9d147−608d−4692−8adf−2f601d23a8ff Ovary−AdenoCA Cancer type 2:28986695−219321806 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 1; SV types t2tINV: 0; TRA: 2 239 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 15 CN segments
101	4	Lower_Right	eeb9d147-608d-4692-8adf-2f601d23a8ff	11:28168070−90773179	9, 10	10	{'min_x': 316.739990234375, 'min_y': 731.9749755859375, 'max_x': 536.015869140625, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB eeb9d147−608d−4692−8adf−2f601d23a8ff Ovary−AdenoCA Cancer type 11:28168070−90773179 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 4 239 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments
102	1	Upper_Left	f0c353fd-947c-41e2-b643-3ecc0d69796c	2:27633198−216960765	7, 16	25	{'min_x': 40.210201263427734, 'min_y': 296.9750061035156, 'max_x': 252.3020782470703, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB f0c353fd−947c−41e2−b643−3ecc0d69796c Ovary−AdenoCA Cancer type 2:27633198−216960765 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 8; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 6 288 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 25 CN segments 0.129004 FDR fragment joints
102	2	Upper_Right	f34aa3b6-e966-49c6-bc55-130545772c53	8:23038721−142905466	8, 9	19	{'min_x': 329.20001220703125, 'min_y': 296.9750061035156, 'max_x': 537.5299072265625, 'max_y': 406.2539978027344}	50 MB 100 MB f34aa3b6−e966−49c6−bc55−130545772c53 Ovary−AdenoCA Cancer type 8:23038721−142905466 Position 5 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 5 235 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 19 CN segments 0.8572806 FDR fragment joints
102	3	Lower_Left	ICGC_0025	1:152793278−227429822	5, 8	8	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 242.50210571289062, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB ICGC_0025 Panc−AdenoCA Cancer type 1:152793278−227429822 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 118 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments
102	4	Lower_Right	ICGC_0025	6:17053808−162631121	10, 10	10	{'min_x': 342.9800109863281, 'min_y': 731.9749755859375, 'max_x': 550.8118896484375, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB ICGC_0025 Panc−AdenoCA Cancer type 6:17053808−162631121 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 8; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 1 118 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
103	1	Upper_Left	ICGC_0037	1:240179982−240688305	12, 12	12	{'min_x': 44.080101013183594, 'min_y': 296.9750061035156, 'max_x': 227.24195861816406, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB ICGC_0037 Panc−AdenoCA Cancer type 1:240179982−240688305 Position 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 6; SV types t2tINV: 5; TRA: 0 165 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.7568568 FDR fragment joints
103	2	Upper_Right	ICGC_0054	5:1796643−175760299	13, 14	14	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 526.241943359375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB ICGC_0054 Panc−AdenoCA Cancer type 5:1796643−175760299 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 1 156 SVs in sample 13, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.01743054 FDR fragment joints
103	3	Lower_Left	ICGC_0115	X:94245698−150684659	8, 11	12	{'min_x': 39.56019973754883, 'min_y': 731.9749755859375, 'max_x': 268.1119384765625, 'max_y': 831.8338012695312}	100 MB 110 MB 120 MB 130 MB 140 MB 150 MB ICGC_0115 Panc−AdenoCA Cancer type X:94245698−150684659 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 104 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 12 CN segments
103	4	Lower_Right	ICGC_0140	11:32758465−75006148	10, 10	10	{'min_x': 347.0299987792969, 'min_y': 731.9749755859375, 'max_x': 531.1202392578125, 'max_y': 831.8338012695312}	40 MB 50 MB 60 MB 70 MB ICGC_0140 Panc−AdenoCA Cancer type 11:32758465−75006148 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 163 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
104	1	Upper_Left	ICGC_0140	17:28840466−79518858	8, 14	16	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 271.1500244140625, 'max_y': 406.2539978027344}	40 MB 50 MB 60 MB 70 MB 80 MB ICGC_0140 Panc−AdenoCA Cancer type 17:28840466−79518858 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 1; TRA: 1 163 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.05741733 FDR fragment joints
104	2	Upper_Right	ICGC_0205	1:26994187−245430132	7, 7	7	{'min_x': 343.29998779296875, 'min_y': 296.9750061035156, 'max_x': 515.0918579101562, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB ICGC_0205 Panc−AdenoCA Cancer type 1:26994187−245430132 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 127 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.05741733 FDR fragment joints
104	3	Lower_Left	ICGC_0214	5:98391041−178563199	10, 10	10	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	120 MB 140 MB 160 MB ICGC_0214 Panc−AdenoCA Cancer type 5:98391041−178563199 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 2 254 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
104	4	Lower_Right	ICGC_0214	X:98103871−154466373	7, 11	11	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 552.0321655273438, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB 150 MB ICGC_0214 Panc−AdenoCA Cancer type X:98103871−154466373 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 1 254 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments
105	1	Upper_Left	ICGC_0417	17:34974437−49255446	5, 6	6	{'min_x': 59.139801025390625, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	35 MB 40 MB 45 MB ICGC_0417 Panc−AdenoCA Cancer type 17:34974437−49255446 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 0 47 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.615458 FDR fragment joints
105	2	Upper_Right	ICGC_0420	3:149207002−151596957	6, 10	13	{'min_x': 307.3299865722656, 'min_y': 296.9750061035156, 'max_x': 523.001953125, 'max_y': 406.2539978027344}	80 MB 100 MB 120 MB 140 MB ICGC_0420 Panc−AdenoCA Cancer type 3:149207002−151596957 Position 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 0 90 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 13 CN segments 0.9804396 FDR fragment joints
105	3	Lower_Left	PCSI_0015	1:3415964−191894581	13, 18	30	{'min_x': 35.360198974609375, 'min_y': 731.0599975585938, 'max_x': 228.882080078125, 'max_y': 832.6138916015625}	PCSI_0015 50 MB 100 MB 150 MB 200 MB Panc−AdenoCA Cancer type 1:3415964−191894581 Position 4 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 3; TRA: 25 541 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 30 CN segments 0.6776251 FDR fragment joints
105	4	Lower_Right	PCSI_0023	2:14191317−219852324	8, 8	8	{'min_x': 347.6600036621094, 'min_y': 731.9749755859375, 'max_x': 538.1320190429688, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB PCSI_0023 Panc−AdenoCA Cancer type 2:14191317−219852324 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 114 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
106	1	Upper_Left	PCSI_0104	4:42227398−156834083	9, 9	9	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 257.152099609375, 'max_y': 406.2539978027344}	75 MB 100 MB 125 MB 150 MB PCSI_0104 Panc−AdenoCA Cancer type 4:42227398−156834083 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 107 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.1013295 FDR fragment joints
106	2	Upper_Right	PCSI_0104	18:4126494−66021548	7, 10	10	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 536.0099487304688, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB PCSI_0104 Panc−AdenoCA Cancer type 18:4126494−66021548 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 107 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.1013295 FDR fragment joints
106	3	Lower_Left	PCSI_0145	2:184795438−237271575	10, 18	18	{'min_x': 53.0, 'min_y': 731.9749755859375, 'max_x': 227.3520050048828, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB PCSI_0145 Panc−AdenoCA Cancer type 2:184795438−237271575 Position 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 1 550 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 18 CN segments
106	4	Lower_Right	PCSI_0161	2:4154479−223101138	13, 13	13	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 536.0618896484375, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB PCSI_0161 Panc−AdenoCA Cancer type 2:4154479−223101138 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 0 187 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
107	1	Upper_Left	PCSI_0170	19:28426608−34375994	4, 5	11	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 244.9800262451172, 'max_y': 406.2539978027344}	35 MB 40 MB 45 MB PCSI_0170 Panc−AdenoCA Cancer type 19:28426608−34375994 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 1 33 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
107	2	Upper_Right	PCSI_0217	1:10731806−237345673	8, 9	23	{'min_x': 346.3599853515625, 'min_y': 296.9750061035156, 'max_x': 517.0418090820312, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB PCSI_0217 Panc−AdenoCA Cancer type 1:10731806−237345673 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 9; h2hINV: 0; SV types t2tINV: 1; TRA: 0 152 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 23 CN segments 0.01020027 FDR fragment joints
107	3	Lower_Left	PCSI_0233	18:6611362−22580219	4, 8	19	{'min_x': 61.110198974609375, 'min_y': 731.9749755859375, 'max_x': 256.92999267578125, 'max_y': 831.8338012695312}	10 MB 15 MB 20 MB 25 MB PCSI_0233 Panc−AdenoCA Cancer type 18:6611362−22580219 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 4; TRA: 0 71 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 19 CN segments
107	4	Lower_Right	PCSI_0268	10:126851447−127077192	5, 7	8	{'min_x': 332.3299865722656, 'min_y': 731.9749755859375, 'max_x': 529.4520263671875, 'max_y': 831.8338012695312}	80 MB 90 MB 100 MB 110 MB 120 MB PCSI_0268 Panc−AdenoCA Cancer type 10:126851447−127077192 Position 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 104 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 8 CN segments
108	1	Upper_Left	PCSI_0274	4:174934602−188504783	8, 13	17	{'min_x': 60.29999923706055, 'min_y': 296.9750061035156, 'max_x': 242.4521026611328, 'max_y': 406.2539978027344}	100 MB 125 MB 150 MB 175 MB PCSI_0274 Panc−AdenoCA Cancer type 4:174934602−188504783 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 202 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints
108	2	Upper_Right	PCSI_0287	2:71708971−242161284	9, 9	9	{'min_x': 343.8299865722656, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	100 MB 150 MB 200 MB PCSI_0287 Panc−AdenoCA Cancer type 2:71708971−242161284 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 8; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 152 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.02438658 FDR fragment joints
108	3	Lower_Left	PCSI_0287	10:324176−99514412	12, 12	12	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 272.0321044921875, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB PCSI_0287 Panc−AdenoCA Cancer type 10:324176−99514412 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 152 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
108	4	Lower_Right	PCSI_0300	X:116539582−151569032	9, 15	15	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 557.9221801757812, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB PCSI_0300 Panc−AdenoCA Cancer type X:116539582−151569032 Position 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 2 208 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 15 CN segments
109	1	Upper_Left	PCSI_0324	7:5562244−151748583	9, 9	9	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 268.141845703125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB PCSI_0324 Panc−AdenoCA Cancer type 7:5562244−151748583 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 204 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.006736868 FDR fragment joints
109	2	Upper_Right	PCSI_0338	2:11368327−241973077	24, 24	24	{'min_x': 346.1400146484375, 'min_y': 296.9750061035156, 'max_x': 518.4120483398438, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB PCSI_0338 Panc−AdenoCA Cancer type 2:11368327−241973077 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 24, 24 Oscillating CN (2 and 3 states) 24 CN segments 2.670882e−05 FDR fragment joints
109	3	Lower_Left	PCSI_0338	10:3589818−132244293	11, 11	13	{'min_x': 56.38010025024414, 'min_y': 731.9749755859375, 'max_x': 257.9118347167969, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB PCSI_0338 Panc−AdenoCA Cancer type 10:3589818−132244293 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 2 225 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 13 CN segments
109	4	Lower_Right	PCSI_0338	11:6595768−111354727	19, 19	19	{'min_x': 351.3500061035156, 'min_y': 731.9749755859375, 'max_x': 515.3778686523438, 'max_y': 831.8338012695312}	30 MB 60 MB 90 MB PCSI_0338 Panc−AdenoCA Cancer type 11:6595768−111354727 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments
110	1	Upper_Left	PCSI_0338	12:41463414−118730813	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	60 MB 80 MB 100 MB PCSI_0338 Panc−AdenoCA Cancer type 12:41463414−118730813 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.04139017 FDR fragment joints
110	2	Upper_Right	PCSI_0338	13:37711193−107329558	8, 8	8	{'min_x': 315.07000732421875, 'min_y': 296.9750061035156, 'max_x': 536.1119995117188, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB PCSI_0338 Panc−AdenoCA Cancer type 13:37711193−107329558 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.04139017 FDR fragment joints
110	3	Lower_Left	PCSI_0338	15:41500002−86542658	8, 8	8	{'min_x': 61.53010177612305, 'min_y': 731.9749755859375, 'max_x': 235.4399871826172, 'max_y': 831.8338012695312}	50 MB 60 MB 70 MB 80 MB PCSI_0338 Panc−AdenoCA Cancer type 15:41500002−86542658 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
110	4	Lower_Right	PCSI_0338	X:21484632−147888022	18, 18	18	{'min_x': 351.3500061035156, 'min_y': 731.9749755859375, 'max_x': 515.3778686523438, 'max_y': 831.8338012695312}	50 MB 100 MB PCSI_0338 Panc−AdenoCA Cancer type X:21484632−147888022 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 0 225 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments
111	1	Upper_Left	PCSI_0341	6:17057806−89560240	9, 14	16	{'min_x': 48.039798736572266, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	30 MB 60 MB 90 MB PCSI_0341 Panc−AdenoCA Cancer type 6:17057806−89560240 Position 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 1 210 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints
111	2	Upper_Right	PCSI_0375	19:2792845−58974327	7, 8	9	{'min_x': 337.0799865722656, 'min_y': 296.9750061035156, 'max_x': 521.599853515625, 'max_y': 406.2539978027344}	10 MB 20 MB 30 MB 40 MB 50 MB PCSI_0375 Panc−AdenoCA Cancer type 19:2792845−58974327 Position 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 0 32 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints
111	3	Lower_Left	PCSI_0468	18:18690328−27595848	7, 7	34	{'min_x': 51.919898986816406, 'min_y': 731.9749755859375, 'max_x': 227.61009216308594, 'max_y': 831.8338012695312}	20 MB 22 MB 24 MB 26 MB PCSI_0468 Panc−AdenoCA Cancer type 18:18690328−27595848 Position 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 13; SV types t2tINV: 8; TRA: 0 105 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 34 CN segments
111	4	Lower_Right	PCSI_0469	14:21422830−96805524	6, 10	19	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 544.92236328125, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB PCSI_0469 Panc−AdenoCA Cancer type 14:21422830−96805524 Position 17 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 3; SV types t2tINV: 3; TRA: 11 61 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 19 CN segments
112	1	Upper_Left	PCSI_0476	1:46749168−249168364	7, 24	24	{'min_x': 33.68980026245117, 'min_y': 296.9750061035156, 'max_x': 271.7520751953125, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB 250 MB PCSI_0476 Panc−AdenoCA Cancer type 1:46749168−249168364 Position 4 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 4; SV types t2tINV: 2; TRA: 8 360 SVs in sample 7, 24 Oscillating CN (2 and 3 states) 24 CN segments 0.9501265 FDR fragment joints 0.01 FDR chr. breakp. enrich.
112	2	Upper_Right	PCSI_0476	17:27499370−63215539	8, 16	22	{'min_x': 314.57000732421875, 'min_y': 296.9750061035156, 'max_x': 557.0501098632812, 'max_y': 406.2539978027344}	20 MB 40 MB 60 MB 80 MB PCSI_0476 Panc−AdenoCA Cancer type 17:27499370−63215539 Position 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 6 360 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints
112	3	Lower_Left	ITNET-0100	10:12507104−76356326	8, 8	8	{'min_x': 45.06019973754883, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB ITNET−0100 Panc−Endocrine Cancer type 10:12507104−76356326 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 160 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
112	4	Lower_Right	CPCG0040	7:8940200−20434202	10, 10	10	{'min_x': 351.55999755859375, 'min_y': 731.9749755859375, 'max_x': 562.1021118164062, 'max_y': 831.8338012695312}	30 MB 60 MB 90 MB 120 MB CPCG0040 Prost−AdenoCA Cancer type 7:8940200−20434202 Position 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 86 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
113	1	Upper_Left	CPCG0094	13:23582500−33221383	5, 5	5	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 241.69003295898438, 'max_y': 406.2539978027344}	30 MB 35 MB 40 MB 45 MB CPCG0094 Prost−AdenoCA Cancer type 13:23582500−33221383 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 75 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9284301 FDR fragment joints
113	2	Upper_Right	CPCG0128	4:18477094−35223917	14, 14	14	{'min_x': 352.1600036621094, 'min_y': 296.9750061035156, 'max_x': 516.0616455078125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CPCG0128 Prost−AdenoCA Cancer type 4:18477094−35223917 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 0 84 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints
113	3	Lower_Left	CPCG0199	6:64700080−152466236	6, 6	6	{'min_x': 60.53010177612305, 'min_y': 731.9749755859375, 'max_x': 233.322021484375, 'max_y': 831.8338012695312}	75 MB 100 MB 125 MB 150 MB CPCG0199 Prost−AdenoCA Cancer type 6:64700080−152466236 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 109 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments
113	4	Lower_Right	CPCG0201	1:189273295−197948284	7, 7	7	{'min_x': 342.6300048828125, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB CPCG0201 Prost−AdenoCA Cancer type 1:189273295−197948284 Position 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 3 350 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
114	1	Upper_Left	CPCG0201	4:114833795−189168661	17, 17	17	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CPCG0201 Prost−AdenoCA Cancer type 4:114833795−189168661 Position 22 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 5; SV types t2tINV: 3; TRA: 3 350 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints
114	2	Upper_Right	CPCG0210	2:191297296−204765227	5, 5	5	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 542.9022216796875, 'max_y': 406.2539978027344}	160 MB 180 MB 200 MB CPCG0210 Prost−AdenoCA Cancer type 2:191297296−204765227 Position 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 0 74 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.615458 FDR fragment joints
114	3	Lower_Left	CPCG0232	3:70605253−72494755	5, 5	5	{'min_x': 35.03010177612305, 'min_y': 731.9749755859375, 'max_x': 259.3822021484375, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB CPCG0232 Prost−AdenoCA Cancer type 3:70605253−72494755 Position 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 2 235 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
114	4	Lower_Right	CPCG0233	2:117469455−186106088	13, 25	25	{'min_x': 319.8599853515625, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB CPCG0233 Prost−AdenoCA Cancer type 2:117469455−186106088 Position 11 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 6 348 SVs in sample 13, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.9934091 FDR fragment joints
115	1	Upper_Left	CPCG0233	10:59290168−98438172	11, 11	11	{'min_x': 63.41991424560547, 'min_y': 296.9750061035156, 'max_x': 227.60205078125, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB CPCG0233 Prost−AdenoCA Cancer type 10:59290168−98438172 Position 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 2 348 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints
115	2	Upper_Right	CPCG0249	13:82314051−113900734	8, 11	11	{'min_x': 315.92999267578125, 'min_y': 296.9750061035156, 'max_x': 518.5918579101562, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB CPCG0249 Prost−AdenoCA Cancer type 13:82314051−113900734 Position 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 6 458 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
115	3	Lower_Left	CPCG0268	4:134635808−137495825	6, 6	6	{'min_x': 58.480098724365234, 'min_y': 731.9749755859375, 'max_x': 270.072021484375, 'max_y': 831.8338012695312}	60 MB 90 MB 120 MB 150 MB 180 MB CPCG0268 Prost−AdenoCA Cancer type 4:134635808−137495825 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 135 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments
115	4	Lower_Right	CPCG0331	2:71318777−235597578	5, 9	27	{'min_x': 324.8599853515625, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 836.9337768554688}	100 MB 150 MB 200 MB CPCG0331 Prost−AdenoCA Cancer type 2:71318777−235597578 Position 7 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 12 123 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 27 CN segments 0.9348624 FDR fragment joints
116	1	Upper_Left	CPCG0360	2:146919033−148848088	4, 6	11	{'min_x': 47.169898986816406, 'min_y': 296.9750061035156, 'max_x': 248.57191467285156, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CPCG0360 Prost−AdenoCA Cancer type 2:146919033−148848088 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 0 171 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.8653243 FDR fragment joints
116	2	Upper_Right	CPCG0360	4:57981759−63188151	5, 5	5	{'min_x': 347.239990234375, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB CPCG0360 Prost−AdenoCA Cancer type 4:57981759−63188151 Position 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 171 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9723381 FDR fragment joints
116	3	Lower_Left	CPCG0366	13:20995521−107382176	5, 5	11	{'min_x': 30.360200881958008, 'min_y': 731.9749755859375, 'max_x': 251.19190979003906, 'max_y': 836.9337768554688}	40 MB 60 MB 80 MB 100 MB CPCG0366 Prost−AdenoCA Cancer type 13:20995521−107382176 Position 25 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 5; SV types t2tINV: 7; TRA: 8 213 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.780201 FDR fragment joints
116	4	Lower_Right	CPCG0388	3:30946713−151480649	8, 14	14	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 520.44189453125, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB CPCG0388 Prost−AdenoCA Cancer type 3:30946713−151480649 Position 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 11 212 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments
117	1	Upper_Left	0077_CRUK_PC_0077	8:50216666−93610639	9, 9	9	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 8:50216666−93610639 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 198 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.9284301 FDR fragment joints
117	2	Upper_Right	0078_CRUK_PC_0078	4:32885214−180841057	21, 21	21	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 517.7221069335938, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 0078_CRUK_PC_0078 Prost−AdenoCA Cancer type 4:32885214−180841057 Position 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 5 95 SVs in sample 21, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.8653243 FDR fragment joints
117	3	Lower_Left	0089_CRUK_PC_0089	11:103634542−133363653	6, 10	10	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 252.44224548339844, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 125 MB 0089_CRUK_PC_0089 Prost−AdenoCA Cancer type 11:103634542−133363653 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 52 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 10 CN segments
117	4	Lower_Right	0090_CRUK_PC_0090	5:41539060−97372926	7, 7	7	{'min_x': 337.9800109863281, 'min_y': 731.9749755859375, 'max_x': 544.3919067382812, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 0090_CRUK_PC_0090 Prost−AdenoCA Cancer type 5:41539060−97372926 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 194 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
118	1	Upper_Left	0090_CRUK_PC_0090	8:4593970−79446086	9, 14	16	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 0090_CRUK_PC_0090 Prost−AdenoCA Cancer type 8:4593970−79446086 Position 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 6; SV types t2tINV: 3; TRA: 1 194 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 16 CN segments 0.7257048 FDR fragment joints
118	2	Upper_Right	0090_CRUK_PC_0090	11:90271061−99662500	5, 5	5	{'min_x': 306.010009765625, 'min_y': 296.9750061035156, 'max_x': 545.4820556640625, 'max_y': 406.2539978027344}	90 MB 100 MB 110 MB 120 MB 130 MB 0090_CRUK_PC_0090 Prost−AdenoCA Cancer type 11:90271061−99662500 Position 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 2 194 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9284301 FDR fragment joints
118	3	Lower_Left	0091_CRUK_PC_0091	1:166331375−177156264	17, 17	17	{'min_x': 55.019901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 1:166331375−177156264 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 308 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
118	4	Lower_Right	0091_CRUK_PC_0091	3:69780654−86522449	23, 27	27	{'min_x': 320.04998779296875, 'min_y': 731.9749755859375, 'max_x': 522.8919067382812, 'max_y': 831.8338012695312}	75 MB 100 MB 125 MB 150 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 3:69780654−86522449 Position 21 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 1 308 SVs in sample 23, 27 Oscillating CN (2 and 3 states) 27 CN segments
119	1	Upper_Left	0091_CRUK_PC_0091	7:82954981−145981427	9, 17	26	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	50 MB 100 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 7:82954981−145981427 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 0 308 SVs in sample 9, 17 Oscillating CN (2 and 3 states) 26 CN segments 0.9625775 FDR fragment joints
119	2	Upper_Right	A10-0015_CRUK_PC_0015	2:163214471−184193586	5, 12	19	{'min_x': 343.8900146484375, 'min_y': 296.9750061035156, 'max_x': 518.0620727539062, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 2:163214471−184193586 Position 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 2 547 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 19 CN segments 0.6776251 FDR fragment joints
119	3	Lower_Left	A10-0015_CRUK_PC_0015	9:1409842−138981764	23, 23	23	{'min_x': 61.36989974975586, 'min_y': 731.9749755859375, 'max_x': 226.35601806640625, 'max_y': 831.8338012695312}	50 MB 100 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 9:1409842−138981764 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 17; h2hINV: 1; SV types t2tINV: 1; TRA: 0 547 SVs in sample 23, 23 Oscillating CN (2 and 3 states) 23 CN segments
119	4	Lower_Right	A10-0015_CRUK_PC_0015	11:2176926−134862526	7, 22	22	{'min_x': 350.8699951171875, 'min_y': 731.9749755859375, 'max_x': 515.8560180664062, 'max_y': 831.8338012695312}	50 MB 100 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 11:2176926−134862526 Position 1 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 0; DUP: 15; h2hINV: 0; SV types t2tINV: 0; TRA: 6 547 SVs in sample 7, 22 Oscillating CN (2 and 3 states) 22 CN segments
120	1	Upper_Left	A10-0015_CRUK_PC_0015	12:620605−125885779	16, 37	37	{'min_x': 61.36989974975586, 'min_y': 296.9750061035156, 'max_x': 269.27203369140625, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 12:620605−125885779 Position 4 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 4 547 SVs in sample 16, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.1165322 FDR fragment joints
120	2	Upper_Right	A10-0015_CRUK_PC_0015	14:22609121−95699997	18, 18	25	{'min_x': 350.8699951171875, 'min_y': 296.9750061035156, 'max_x': 515.8560180664062, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 14:22609121−95699997 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 12; h2hINV: 0; SV types t2tINV: 0; TRA: 0 547 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 25 CN segments 0.0004583196 FDR fragment joints
120	3	Lower_Left	A10-0015_CRUK_PC_0015	15:41980634−78763235	7, 10	10	{'min_x': 61.36989974975586, 'min_y': 731.9749755859375, 'max_x': 226.35601806640625, 'max_y': 831.8338012695312}	50 MB 60 MB 70 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 15:41980634−78763235 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 1 547 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments
120	4	Lower_Right	A10-0015_CRUK_PC_0015	18:274859−74026630	10, 10	10	{'min_x': 308.57000732421875, 'min_y': 731.9749755859375, 'max_x': 515.8560180664062, 'max_y': 831.8338012695312}	0 MB 20 MB 40 MB 60 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 18:274859−74026630 Position 1 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 1; SV types t2tINV: 0; TRA: 1 547 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
121	1	Upper_Left	A10-0015_CRUK_PC_0015	X:23125163−133708183	12, 20	33	{'min_x': 61.36989974975586, 'min_y': 296.9750061035156, 'max_x': 226.35601806640625, 'max_y': 406.2539978027344}	50 MB 100 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type X:23125163−133708183 Position 3 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 8 547 SVs in sample 12, 20 Oscillating CN (2 and 3 states) 33 CN segments 0.5435077 FDR fragment joints
121	2	Upper_Right	A17-0095_CRUK_PC_0095	10:1424131−123537842	16, 46	56	{'min_x': 307.3800048828125, 'min_y': 291.7399597167969, 'max_x': 543.5379638671875, 'max_y': 412.114013671875}	A17−0095_CRUK_PC_0095 0 MB 50 MB 100 MB 150 MB 200 MB Prost−AdenoCA Cancer type 2:29177870−206548845 Position 5 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 22 772 SVs in sample 16, 46 Oscillating CN (2 and 3 states) 56 CN segments 1 FDR fragment joints 0.07 FDR chr. breakp. enrich. 10:1424131−123537842;14:21843858−93753838
121	3	Lower_Left	A17-0095_CRUK_PC_0095	3:18799507−143335634	21, 30	30	{'min_x': 33.68980026245117, 'min_y': 731.0599975585938, 'max_x': 226.35601806640625, 'max_y': 832.6138916015625}	A17−0095_CRUK_PC_0095 50 MB 100 MB 150 MB Prost−AdenoCA Cancer type 3:18799507−143335634 Position 9 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 15 772 SVs in sample 21, 30 Oscillating CN (2 and 3 states) 30 CN segments 0.9723381 FDR fragment joints
121	4	Lower_Right	A17-0095_CRUK_PC_0095	4:679859−171367419	16, 32	32	{'min_x': 308.510009765625, 'min_y': 731.0599975585938, 'max_x': 531.5218505859375, 'max_y': 832.6138916015625}	A17−0095_CRUK_PC_0095 0 MB 50 MB 100 MB 150 MB Prost−AdenoCA Cancer type 4:679859−171367419 Position 1 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 0; DUP: 16; h2hINV: 0; SV types t2tINV: 0; TRA: 26 772 SVs in sample 16, 32 Oscillating CN (2 and 3 states) 32 CN segments 0.01449201 FDR fragment joints
122	1	Upper_Left	A17-0095_CRUK_PC_0095	6:17635126−170579356	10, 34	34	{'min_x': 51.76020050048828, 'min_y': 296.9750061035156, 'max_x': 254.63258361816406, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type 6:17635126−170579356 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 3 772 SVs in sample 10, 34 Oscillating CN (2 and 3 states) 34 CN segments 0.002321411 FDR fragment joints
122	2	Upper_Right	A17-0095_CRUK_PC_0095	16:1802279−88025685	22, 22	58	{'min_x': 308.32000732421875, 'min_y': 291.7399597167969, 'max_x': 553.22216796875, 'max_y': 412.114013671875}	A17−0095_CRUK_PC_0095 0 MB 50 MB 100 MB 150 MB Prost−AdenoCA Cancer type 7:740003−154793672 Position 1 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 2; DUP: 24; h2hINV: 1; SV types t2tINV: 0; TRA: 22 772 SVs in sample 22, 22 Oscillating CN (2 and 3 states) 58 CN segments 2.325443e−05 FDR fragment joints 0.01 FDR chr. breakp. enrich. 16:1802279−88025685;17:14089050−74031570
122	3	Lower_Left	A17-0095_CRUK_PC_0095	10:1424131−123537843	17, 37	37	{'min_x': 33.68980026245117, 'min_y': 731.0599975585938, 'max_x': 226.43215942382812, 'max_y': 832.6138916015625}	A17−0095_CRUK_PC_0095 25 MB 50 MB 75 MB 100 MB Prost−AdenoCA Cancer type 10:1424131−123537843 Position 1 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 0; DUP: 18; h2hINV: 0; SV types t2tINV: 0; TRA: 14 772 SVs in sample 17, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.001356589 FDR fragment joints
122	4	Lower_Right	A17-0095_CRUK_PC_0095	11:22270950−133333955	16, 19	47	{'min_x': 321.5199890136719, 'min_y': 731.0599975585938, 'max_x': 515.8560180664062, 'max_y': 832.6138916015625}	A17−0095_CRUK_PC_0095 50 MB 100 MB Prost−AdenoCA Cancer type 11:22270950−133333955 Position 1 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 0; DUP: 21; h2hINV: 0; SV types t2tINV: 1; TRA: 16 772 SVs in sample 16, 19 Oscillating CN (2 and 3 states) 47 CN segments 5.842961e−07 FDR fragment joints
123	1	Upper_Left	A17-0095_CRUK_PC_0095	12:10913800−112566167	10, 28	42	{'min_x': 32.019901275634766, 'min_y': 296.9750061035156, 'max_x': 267.6321105957031, 'max_y': 411.343994140625}	30 MB 60 MB 90 MB 120 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type 12:10913800−112566167 Position 1 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 1; DUP: 20; h2hINV: 0; SV types t2tINV: 0; TRA: 13 772 SVs in sample 10, 28 Oscillating CN (2 and 3 states) 42 CN segments 5.842961e−07 FDR fragment joints 0.07 FDR chr. breakp. enrich.
123	2	Upper_Right	A17-0095_CRUK_PC_0095	14:21843858−93753839	13, 18	31	{'min_x': 323.19000244140625, 'min_y': 296.9750061035156, 'max_x': 549.3721313476562, 'max_y': 411.343994140625}	40 MB 60 MB 80 MB 100 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type 14:21843858−93753839 Position 1 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 1; SV types t2tINV: 0; TRA: 11 772 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 31 CN segments 0.02438658 FDR fragment joints 0.01 FDR chr. breakp. enrich.
123	3	Lower_Left	A17-0095_CRUK_PC_0095	16:1802279−88025686	9, 24	24	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 246.9499053955078, 'max_y': 836.9337768554688}	20 MB 40 MB 60 MB 80 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type 16:1802279−88025686 Position 1 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 1; SV types t2tINV: 0; TRA: 10 772 SVs in sample 9, 24 Oscillating CN (2 and 3 states) 24 CN segments 0.006730063 FDR fragment joints
123	4	Lower_Right	A17-0095_CRUK_PC_0095	21:10575654−45753258	13, 17	17	{'min_x': 350.8699951171875, 'min_y': 731.9749755859375, 'max_x': 520.7199096679688, 'max_y': 831.8338012695312}	20 MB 30 MB 40 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type 21:10575654−45753258 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 772 SVs in sample 13, 17 Oscillating CN (2 and 3 states) 17 CN segments
124	1	Upper_Left	A17-0095_CRUK_PC_0095	X:6702691−131010344	13, 22	22	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 259.7519836425781, 'max_y': 411.343994140625}	25 MB 50 MB 75 MB 100 MB 125 MB A17−0095_CRUK_PC_0095 Prost−AdenoCA Cancer type X:6702691−131010344 Position 1 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 0; SV types t2tINV: 0; TRA: 5 772 SVs in sample 13, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.0001919551 FDR fragment joints 0.06 FDR chr. breakp. enrich.
124	2	Upper_Right	A32-0019_CRUK_PC_0019	11:6457815−6743499	7, 7	7	{'min_x': 350.8699951171875, 'min_y': 296.9750061035156, 'max_x': 515.8560180664062, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB A32−0019_CRUK_PC_0019 Prost−AdenoCA Cancer type 11:6457815−6743499 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 0 192 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.615458 FDR fragment joints
124	3	Lower_Left	A34-0022_CRUK_PC_0022	2:31507439−200933013	11, 14	30	{'min_x': 56.91019821166992, 'min_y': 731.9749755859375, 'max_x': 232.8719940185547, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB A34−0022_CRUK_PC_0022 Prost−AdenoCA Cancer type 2:31507439−200933013 Position 13 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 34 461 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 30 CN segments
124	4	Lower_Right	73f875cb-bcfc-43ba-ab97-4e94caf836d4	3:20035036−181045916	9, 9	9	{'min_x': 330.0400085449219, 'min_y': 731.9749755859375, 'max_x': 536.6838989257812, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 73f875cb−bcfc−43ba−ab97−4e94caf836d4 Prost−AdenoCA Cancer type 3:20035036−181045916 Position 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 3 144 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
125	1	Upper_Left	73f875cb-bcfc-43ba-ab97-4e94caf836d4	5:121533482−170643022	9, 9	9	{'min_x': 40.539798736572266, 'min_y': 296.9750061035156, 'max_x': 255.17198181152344, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 73f875cb−bcfc−43ba−ab97−4e94caf836d4 Prost−AdenoCA Cancer type 5:121533482−170643022 Position 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 2 144 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.615458 FDR fragment joints
125	2	Upper_Right	c039014f-821c-43d6-9d3c-914f9c8d98fa	4:130270320−162657668	13, 13	13	{'min_x': 330.3699951171875, 'min_y': 296.9750061035156, 'max_x': 536.3538818359375, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 4:130270320−162657668 Position 5 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 222 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.9625775 FDR fragment joints
125	3	Lower_Left	f6381367-142c-45d0-92b3-c1727d1813ce	13:21438649−100617984	4, 6	9	{'min_x': 39.539798736572266, 'min_y': 731.9749755859375, 'max_x': 269.1020812988281, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB f6381367−142c−45d0−92b3−c1727d1813ce Prost−AdenoCA Cancer type 13:21438649−100617984 Position 12 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 20 133 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 9 CN segments
125	4	Lower_Right	MELA-0002	3:69823911−79435315	8, 11	31	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB MELA−0002 Skin−Melanoma Cancer type 3:69823911−79435315 Position 25 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 9; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 3 748 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 31 CN segments
126	1	Upper_Left	MELA-0002	17:63710548−71955453	4, 7	18	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 265.76019287109375, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB 80 MB MELA−0002 Skin−Melanoma Cancer type 17:63710548−71955453 Position 10 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 11 748 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.8882853 FDR fragment joints 0 FDR chr. breakp. enrich.
126	2	Upper_Right	MELA-0005	5:1027171−19705107	5, 6	25	{'min_x': 308.0400085449219, 'min_y': 296.9750061035156, 'max_x': 530.3120727539062, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 150 MB MELA−0005 Skin−Melanoma Cancer type 5:1027171−19705107 Position 13 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 25 220 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 25 CN segments 0.8784945 FDR fragment joints
126	3	Lower_Left	MELA-0008	9:21711690−22977175	7, 7	7	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 257.4618225097656, 'max_y': 831.8338012695312}	50 MB 75 MB 100 MB 125 MB MELA−0008 Skin−Melanoma Cancer type 9:21711690−22977175 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 0 142 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
126	4	Lower_Right	MELA-0008	16:86186241−90105121	4, 6	10	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 517.1697387695312, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB MELA−0008 Skin−Melanoma Cancer type 16:86186241−90105121 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 142 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 10 CN segments
127	1	Upper_Left	MELA-0012	3:131435629−180741702	5, 15	24	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 268.8521423339844, 'max_y': 406.2539978027344}	120 MB 140 MB 160 MB 180 MB MELA−0012 Skin−Melanoma Cancer type 3:131435629−180741702 Position 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 4 508 SVs in sample 5, 15 Oscillating CN (2 and 3 states) 24 CN segments 0.7425546 FDR fragment joints
127	2	Upper_Right	MELA-0015	2:12998893−180541994	11, 16	18	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 518.3421020507812, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB MELA−0015 Skin−Melanoma Cancer type 2:12998893−180541994 Position 1 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 1; SV types t2tINV: 0; TRA: 2 201 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.06620197 FDR fragment joints
127	3	Lower_Left	MELA-0015	16:57509089−84708915	7, 7	7	{'min_x': 39.110198974609375, 'min_y': 731.9749755859375, 'max_x': 229.01010131835938, 'max_y': 831.8338012695312}	60 MB 65 MB 70 MB 75 MB 80 MB MELA−0015 Skin−Melanoma Cancer type 16:57509089−84708915 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 201 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
127	4	Lower_Right	MELA-0048	4:6102625−46953792	4, 5	63	{'min_x': 328.20001220703125, 'min_y': 731.9749755859375, 'max_x': 517.9019775390625, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB MELA−0048 Skin−Melanoma Cancer type 4:6102625−46953792 Position 26 Interleaved intrachr. SVs 72 Total SVs (intrachr. + transl.) DEL: 10; DUP: 4; h2hINV: 8; SV types t2tINV: 4; TRA: 46 444 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 63 CN segments 0.8039763 FDR fragment joints
128	1	Upper_Left	MELA-0061	2:96865382−106123131	4, 8	11	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 230.80210876464844, 'max_y': 406.2539978027344}	100 MB 150 MB 200 MB MELA−0061 Skin−Melanoma Cancer type 2:96865382−106123131 Position 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 0 101 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints
128	2	Upper_Right	MELA-0061	4:168818150−175974913	5, 6	6	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 524.4020385742188, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB MELA−0061 Skin−Melanoma Cancer type 4:168818150−175974913 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 101 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints
128	3	Lower_Left	MELA-0066	3:77541575−89022426	4, 7	7	{'min_x': 59.98979949951172, 'min_y': 731.9749755859375, 'max_x': 230.8919219970703, 'max_y': 831.8338012695312}	100 MB 125 MB 150 MB 175 MB MELA−0066 Skin−Melanoma Cancer type 3:77541575−89022426 Position 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 355 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 7 CN segments
128	4	Lower_Right	MELA-0066	14:71471614−102112284	4, 6	12	{'min_x': 353.0199890136719, 'min_y': 731.9749755859375, 'max_x': 544.5020141601562, 'max_y': 831.8338012695312}	80 MB 90 MB 100 MB MELA−0066 Skin−Melanoma Cancer type 14:71471614−102112284 Position 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 5; SV types t2tINV: 3; TRA: 13 355 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 12 CN segments
129	1	Upper_Left	MELA-0174	2:36739938−238611839	6, 8	8	{'min_x': 38.70000076293945, 'min_y': 296.9750061035156, 'max_x': 225.23216247558594, 'max_y': 411.343994140625}	100 MB 150 MB 200 MB MELA−0174 Skin−Melanoma Cancer type 2:36739938−238611839 Position 7 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 40 249 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.6661788 FDR fragment joints 0 FDR chr. breakp. enrich.
129	2	Upper_Right	MELA-0223	6:53940949−143661562	4, 5	14	{'min_x': 336.70001220703125, 'min_y': 296.9750061035156, 'max_x': 546.22216796875, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB MELA−0223 Skin−Melanoma Cancer type 6:53940949−143661562 Position 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 104 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.8572806 FDR fragment joints
129	3	Lower_Left	1404791b-86bf-4dfd-85b4-c8ff356f109c	8:118357384−142919752	10, 13	13	{'min_x': 38.70000076293945, 'min_y': 731.9749755859375, 'max_x': 245.84796142578125, 'max_y': 836.9337768554688}	50 MB 100 MB 1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 8:118357384−142919752 Position 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 10 573 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.2123773 FDR fragment joints
129	4	Lower_Right	1404791b-86bf-4dfd-85b4-c8ff356f109c	19:32205724−58908289	14, 19	28	{'min_x': 323.19000244140625, 'min_y': 731.0599975585938, 'max_x': 535.3478393554688, 'max_y': 832.6138916015625}	1404791b−86bf−4dfd−85b4−c8ff356f109c 30 MB 40 MB 50 MB Skin−Melanoma Cancer type 19:32205724−58908289 Position 3 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 28 573 SVs in sample 14, 19 Oscillating CN (2 and 3 states) 28 CN segments 0.8653243 FDR fragment joints
130	1	Upper_Left	238111f9-a08b-49b4-9035-cc43026330e7	4:139483168−167110416	8, 8	16	{'min_x': 39.70000076293945, 'min_y': 296.9750061035156, 'max_x': 248.0299530029297, 'max_y': 406.2539978027344}	90 MB 120 MB 150 MB 238111f9−a08b−49b4−9035−cc43026330e7 Skin−Melanoma Cancer type 4:139483168−167110416 Position 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 87 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints
130	2	Upper_Right	3409f118-1798-48d6-9556-12a5c77ebefb	1:115652442−144998190	4, 4	12	{'min_x': 329.7099914550781, 'min_y': 296.9750061035156, 'max_x': 537.02197265625, 'max_y': 406.2539978027344}	90 MB 110 MB 130 MB 3409f118−1798−48d6−9556−12a5c77ebefb Skin−Melanoma Cancer type 1:115652442−144998190 Position 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 0 36 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints
130	3	Lower_Left	3429967f-4f77-4894-bf27-c4a22698ca92	1:155839251−204554164	6, 10	13	{'min_x': 41.20000076293945, 'min_y': 731.9749755859375, 'max_x': 264.4521179199219, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB 3429967f−4f77−4894−bf27−c4a22698ca92 Skin−Melanoma Cancer type 1:155839251−204554164 Position 14 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 5; TRA: 22 107 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 13 CN segments
130	4	Lower_Right	3fea3f02-2db3-44e0-984e-c61130d92c9b	3:98573207−109821728	4, 8	18	{'min_x': 308.7300109863281, 'min_y': 731.9749755859375, 'max_x': 537.1618041992188, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 3fea3f02−2db3−44e0−984e−c61130d92c9b Skin−Melanoma Cancer type 3:98573207−109821728 Position 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 2 262 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 18 CN segments
131	1	Upper_Left	40e17bf8-6c19-4e5e-b60d-ad54f504a970	8:50784712−66016345	8, 8	8	{'min_x': 40.039798736572266, 'min_y': 296.9750061035156, 'max_x': 261.05999755859375, 'max_y': 406.2539978027344}	60 MB 70 MB 80 MB 40e17bf8−6c19−4e5e−b60d−ad54f504a970 Skin−Melanoma Cancer type 8:50784712−66016345 Position 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 8 140 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.8066159 FDR fragment joints
131	2	Upper_Right	5bc515c8-7727-4d69-98e9-31bbcb748550	X:92816571−93649590	14, 16	18	{'min_x': 328.0400085449219, 'min_y': 296.9750061035156, 'max_x': 538.6879272460938, 'max_y': 406.2539978027344}	50 MB 100 MB 5bc515c8−7727−4d69−98e9−31bbcb748550 Skin−Melanoma Cancer type X:92816571−93649590 Position 26 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 6; SV types t2tINV: 5; TRA: 0 178 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.9179372 FDR fragment joints
131	3	Lower_Left	5f6df69c-4ebf-4811-8b28-ad393dfbe1a3	6:80713179−118504284	7, 7	7	{'min_x': 41.04999923706055, 'min_y': 731.9749755859375, 'max_x': 266.7821960449219, 'max_y': 831.8338012695312}	80 MB 100 MB 120 MB 140 MB 160 MB 5f6df69c−4ebf−4811−8b28−ad393dfbe1a3 Skin−Melanoma Cancer type 6:80713179−118504284 Position 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 4 160 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
131	4	Lower_Right	d8eac750-9daf-4465-b672-9e31fd369057	3:66947406−89593615	4, 6	11	{'min_x': 329.5400085449219, 'min_y': 731.9749755859375, 'max_x': 537.19189453125, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB d8eac750−9daf−4465−b672−9e31fd369057 Skin−Melanoma Cancer type 3:66947406−89593615 Position 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 1 266 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 11 CN segments
132	1	Upper_Left	5a64f7e9-3833-4a3c-962b-13eb3e305c69	7:4154645−125672436	8, 8	8	{'min_x': 39.70000076293945, 'min_y': 296.9750061035156, 'max_x': 269.63214111328125, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB 5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 7:4154645−125672436 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 339 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.1013295 FDR fragment joints
132	2	Upper_Right	9c9b53e5-cdbe-4510-a839-4a3b5039681b	7:78585846−144766064	7, 12	20	{'min_x': 313.45001220703125, 'min_y': 296.9750061035156, 'max_x': 554.4321899414062, 'max_y': 406.2539978027344}	70 MB 90 MB 110 MB 130 MB 150 MB 9c9b53e5−cdbe−4510−a839−4a3b5039681b SoftTissue−Leiomyo Cancer type 7:78585846−144766064 Position 4 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 4 240 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 20 CN segments 0.5435077 FDR fragment joints
132	3	Lower_Left	ea3a524b-6ee3-4904-8924-29fcaa20985c	11:22633386−33675388	5, 5	5	{'min_x': 39.86989974975586, 'min_y': 731.9749755859375, 'max_x': 247.85995483398438, 'max_y': 831.8338012695312}	25 MB 27.5 MB 30 MB 32.5 MB ea3a524b−6ee3−4904−8924−29fcaa20985c SoftTissue−Leiomyo Cancer type 11:22633386−33675388 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 0 318 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
132	4	Lower_Right	b5f27002-4277-418d-90b0-cc5a2742692e	X:115283407−149711207	8, 8	8	{'min_x': 329.0400085449219, 'min_y': 731.9749755859375, 'max_x': 560.8521728515625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB b5f27002−4277−418d−90b0−cc5a2742692e SoftTissue−Liposarc Cancer type X:115283407−149711207 Position 21 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 5; SV types t2tINV: 4; TRA: 10 895 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
133	1	Upper_Left	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	5:1295334−20553339	5, 5	18	{'min_x': 35.360198974609375, 'min_y': 296.9750061035156, 'max_x': 248.9499053955078, 'max_y': 411.343994140625}	10 MB 20 MB 30 MB e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 5:1295334−20553339 Position 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 13 696 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich.
133	2	Upper_Right	CGP_donor_GC00002	2:13611641−233338366	9, 13	23	{'min_x': 345.70001220703125, 'min_y': 296.9750061035156, 'max_x': 525.3919067382812, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_GC00002 Stomach−AdenoCA Cancer type 2:13611641−233338366 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 1; DUP: 10; h2hINV: 0; SV types t2tINV: 0; TRA: 11 442 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 23 CN segments 0.1148725 FDR fragment joints
133	3	Lower_Left	CGP_donor_GC00002	13:73586014−105196786	8, 11	11	{'min_x': 63.519901275634766, 'min_y': 731.9749755859375, 'max_x': 224.2118682861328, 'max_y': 831.8338012695312}	50 MB 70 MB 90 MB CGP_donor_GC00002 Stomach−AdenoCA Cancer type 13:73586014−105196786 Position 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 2 442 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments
133	4	Lower_Right	CGP_donor_GC00002	20:16117248−21865896	10, 10	10	{'min_x': 337.29998779296875, 'min_y': 731.9749755859375, 'max_x': 546.3101806640625, 'max_y': 831.8338012695312}	10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_GC00002 Stomach−AdenoCA Cancer type 20:16117248−21865896 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 442 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
134	1	Upper_Left	CGP_donor_GC00004	3:41357782−183461229	7, 15	33	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 224.2118682861328, 'max_y': 406.2539978027344}	80 MB 120 MB 160 MB CGP_donor_GC00004 Stomach−AdenoCA Cancer type 3:41357782−183461229 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 9; DUP: 6; h2hINV: 1; SV types t2tINV: 0; TRA: 4 339 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 33 CN segments 0.05741733 FDR fragment joints
134	2	Upper_Right	CGP_donor_GC00004	12:71919868−132958560	5, 9	29	{'min_x': 318.5, 'min_y': 296.9750061035156, 'max_x': 543.7721557617188, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_GC00004 Stomach−AdenoCA Cancer type 12:71919868−132958560 Position 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 3 339 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 29 CN segments 0.6776251 FDR fragment joints
134	3	Lower_Left	CGP_donor_GC00008	10:2847784−76828663	6, 9	23	{'min_x': 60.18009948730469, 'min_y': 731.9749755859375, 'max_x': 249.9321746826172, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB CGP_donor_GC00008 Stomach−AdenoCA Cancer type 10:2847784−76828663 Position 40 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 11; SV types t2tINV: 9; TRA: 1 307 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 23 CN segments
134	4	Lower_Right	CGP_donor_GC00022	2:8672161−139745881	4, 7	8	{'min_x': 308.8500061035156, 'min_y': 731.9749755859375, 'max_x': 529.1919555664062, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB 200 MB CGP_donor_GC00022 Stomach−AdenoCA Cancer type 2:8672161−139745881 Position 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 149 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 8 CN segments
135	1	Upper_Left	CGP_donor_GC00033	2:120552045−179365153	11, 12	12	{'min_x': 59.710201263427734, 'min_y': 296.9750061035156, 'max_x': 231.0321807861328, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_GC00033 Stomach−AdenoCA Cancer type 2:120552045−179365153 Position 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 1 925 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.9723381 FDR fragment joints
135	2	Upper_Right	CGP_donor_GC00033	8:80936461−141686980	6, 7	51	{'min_x': 353.0199890136719, 'min_y': 296.9750061035156, 'max_x': 513.7119140625, 'max_y': 406.2539978027344}	50 MB 100 MB CGP_donor_GC00033 Stomach−AdenoCA Cancer type 8:80936461−141686980 Position 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 0; SV types t2tINV: 1; TRA: 3 925 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 51 CN segments 0.5435077 FDR fragment joints
135	3	Lower_Left	CGP_donor_GC00033	16:353528−81417990	10, 26	27	{'min_x': 61.849998474121094, 'min_y': 731.9749755859375, 'max_x': 264.91986083984375, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB CGP_donor_GC00033 Stomach−AdenoCA Cancer type 16:353528−81417990 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 5 925 SVs in sample 10, 26 Oscillating CN (2 and 3 states) 27 CN segments
135	4	Lower_Right	CGP_donor_GC00033	18:26736270−68720210	10, 13	25	{'min_x': 352.4700012207031, 'min_y': 731.9749755859375, 'max_x': 513.7119140625, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB CGP_donor_GC00033 Stomach−AdenoCA Cancer type 18:26736270−68720210 Position 2 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 2 925 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 25 CN segments
136	1	Upper_Left	CGP_donor_GC00049	1:32164458−236360311	8, 9	17	{'min_x': 63.519901275634766, 'min_y': 296.9750061035156, 'max_x': 235.22198486328125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_GC00049 Stomach−AdenoCA Cancer type 1:32164458−236360311 Position 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 5 223 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 17 CN segments 0.9723381 FDR fragment joints
136	2	Upper_Right	CGP_donor_GC00052	2:5620025−231799627	7, 22	28	{'min_x': 351.3500061035156, 'min_y': 296.9750061035156, 'max_x': 527.9617309570312, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 200 MB CGP_donor_GC00052 Stomach−AdenoCA Cancer type 2:5620025−231799627 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 11; h2hINV: 0; SV types t2tINV: 1; TRA: 1 309 SVs in sample 7, 22 Oscillating CN (2 and 3 states) 28 CN segments 0.09737474 FDR fragment joints
136	3	Lower_Left	CGP_donor_GC00054	1:20036804−231461837	5, 11	67	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 225.88218688964844, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 200 MB CGP_donor_GC00054 Stomach−AdenoCA Cancer type 1:20036804−231461837 Position 14 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 14 550 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 67 CN segments 0.615458 FDR fragment joints
136	4	Lower_Right	CGP_donor_GC00054	17:37680918−49117586	5, 5	20	{'min_x': 318.1400146484375, 'min_y': 731.9749755859375, 'max_x': 558.3904418945312, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB CGP_donor_GC00054 Stomach−AdenoCA Cancer type 17:37680918−49117586 Position 9 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 4; SV types t2tINV: 5; TRA: 3 550 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 20 CN segments
137	1	Upper_Left	CGP_donor_GC00054	19:28404001−30805308	5, 5	20	{'min_x': 54.96989822387695, 'min_y': 296.9750061035156, 'max_x': 243.7799835205078, 'max_y': 406.2539978027344}	10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_GC00054 Stomach−AdenoCA Cancer type 19:28404001−30805308 Position 12 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 5; TRA: 3 550 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 20 CN segments 0.615458 FDR fragment joints
137	2	Upper_Right	0aecac64-5982-4d76-8f31-958f6a00951d	2:9254169−220466625	7, 11	23	{'min_x': 324.8599853515625, 'min_y': 296.9750061035156, 'max_x': 538.0520629882812, 'max_y': 411.343994140625}	50 MB 100 MB 150 MB 200 MB 0aecac64−5982−4d76−8f31−958f6a00951d Stomach−AdenoCA Cancer type 2:9254169−220466625 Position 1 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 6 332 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 23 CN segments 0.01333161 FDR fragment joints 0.52 FDR chr. breakp. enrich.
137	3	Lower_Left	0aecac64-5982-4d76-8f31-958f6a00951d	3:4802945−186280725	12, 20	31	{'min_x': 40.36989974975586, 'min_y': 731.9749755859375, 'max_x': 247.36195373535156, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 0aecac64−5982−4d76−8f31−958f6a00951d Stomach−AdenoCA Cancer type 3:4802945−186280725 Position 1 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 15; h2hINV: 0; SV types t2tINV: 0; TRA: 7 332 SVs in sample 12, 20 Oscillating CN (2 and 3 states) 31 CN segments
137	4	Lower_Right	0aecac64-5982-4d76-8f31-958f6a00951d	13:30969347−99319808	8, 8	8	{'min_x': 329.8699951171875, 'min_y': 731.9749755859375, 'max_x': 536.8619384765625, 'max_y': 831.8338012695312}	50 MB 70 MB 90 MB 0aecac64−5982−4d76−8f31−958f6a00951d Stomach−AdenoCA Cancer type 13:30969347−99319808 Position 1 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 332 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
138	1	Upper_Left	1ca3c5e0-32b0-4467-8ec0-ca212e35d2b3	5:85673816−175159134	7, 11	18	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 248.8579559326172, 'max_y': 406.2539978027344}	100 MB 120 MB 140 MB 160 MB 1ca3c5e0−32b0−4467−8ec0−ca212e35d2b3 Stomach−AdenoCA Cancer type 5:85673816−175159134 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 313 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 18 CN segments 0.1178349 FDR fragment joints
138	2	Upper_Right	1ca3c5e0-32b0-4467-8ec0-ca212e35d2b3	10:14710620−131823830	5, 8	29	{'min_x': 307.6400146484375, 'min_y': 296.9750061035156, 'max_x': 548.372314453125, 'max_y': 406.2539978027344}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB 1ca3c5e0−32b0−4467−8ec0−ca212e35d2b3 Stomach−AdenoCA Cancer type 10:14710620−131823830 Position 12 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 3 313 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 29 CN segments 0.925252 FDR fragment joints
138	3	Lower_Left	1ca3c5e0-32b0-4467-8ec0-ca212e35d2b3	11:17850371−130169015	5, 7	56	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 261.6719665527344, 'max_y': 836.9337768554688}	25 MB 50 MB 75 MB 100 MB 125 MB 1ca3c5e0−32b0−4467−8ec0−ca212e35d2b3 Stomach−AdenoCA Cancer type 11:17850371−130169015 Position 7 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 2; TRA: 16 313 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 56 CN segments 0.615458 FDR fragment joints
138	4	Lower_Right	2b4f014f-74e9-4dda-a1ad-abcbd124fc44	2:32631150−203682926	10, 10	10	{'min_x': 329.739990234375, 'min_y': 731.9749755859375, 'max_x': 555.4418334960938, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 2b4f014f−74e9−4dda−a1ad−abcbd124fc44 Stomach−AdenoCA Cancer type 2:32631150−203682926 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 94 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
139	1	Upper_Left	337819d2-5281-4b41-9583-a476924bc837	10:43843093−98387881	10, 10	10	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 248.8579559326172, 'max_y': 406.2539978027344}	50 MB 60 MB 70 MB 80 MB 90 MB 337819d2−5281−4b41−9583−a476924bc837 Stomach−AdenoCA Cancer type 10:43843093−98387881 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 3 210 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.1488029 FDR fragment joints
139	2	Upper_Right	53086e20-a727-40d6-b42d-8030109b5130	7:24323683−116135143	9, 9	30	{'min_x': 328.20001220703125, 'min_y': 296.9750061035156, 'max_x': 538.5279541015625, 'max_y': 406.2539978027344}	50 MB 100 MB 53086e20−a727−40d6−b42d−8030109b5130 Stomach−AdenoCA Cancer type 7:24323683−116135143 Position 34 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 9; SV types t2tINV: 8; TRA: 3 246 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 30 CN segments 0.9787948 FDR fragment joints
139	3	Lower_Left	5b7e557a-6aee-4077-b3cd-c96179e643ae	1:43676646−240124427	9, 16	46	{'min_x': 33.68980026245117, 'min_y': 731.0599975585938, 'max_x': 248.8579559326172, 'max_y': 832.6138916015625}	5b7e557a−6aee−4077−b3cd−c96179e643ae 50 MB 100 MB 150 MB 200 MB Stomach−AdenoCA Cancer type 1:43676646−240124427 Position 6 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 32 1150 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 46 CN segments 0.8784945 FDR fragment joints
139	4	Lower_Right	5b7e557a-6aee-4077-b3cd-c96179e643ae	3:83906659−165520150	4, 11	26	{'min_x': 309.32000732421875, 'min_y': 731.9749755859375, 'max_x': 538.35791015625, 'max_y': 836.9337768554688}	0 MB 50 MB 100 MB 150 MB 5b7e557a−6aee−4077−b3cd−c96179e643ae Stomach−AdenoCA Cancer type 3:83906659−165520150 Position 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 4 1150 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 26 CN segments 0.7995907 FDR fragment joints
140	1	Upper_Left	5b7e557a-6aee-4077-b3cd-c96179e643ae	5:53410286−157767053	7, 10	29	{'min_x': 38.86989974975586, 'min_y': 296.9750061035156, 'max_x': 248.8579559326172, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 5b7e557a−6aee−4077−b3cd−c96179e643ae Stomach−AdenoCA Cancer type 5:53410286−157767053 Position 15 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 5; SV types t2tINV: 3; TRA: 5 1150 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 29 CN segments 0.6776251 FDR fragment joints
140	2	Upper_Right	5b7e557a-6aee-4077-b3cd-c96179e643ae	8:21266054−103900103	9, 11	33	{'min_x': 321.5199890136719, 'min_y': 296.0599670410156, 'max_x': 538.35791015625, 'max_y': 407.0240173339844}	5b7e557a−6aee−4077−b3cd−c96179e643ae 50 MB 100 MB Stomach−AdenoCA Cancer type 8:21266054−103900103 Position 10 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 14 1150 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 33 CN segments 0.7568568 FDR fragment joints 0.01 FDR chr. breakp. enrich.
140	3	Lower_Left	5b7e557a-6aee-4077-b3cd-c96179e643ae	14:21910299−106251175	9, 21	21	{'min_x': 38.86989974975586, 'min_y': 731.9749755859375, 'max_x': 253.80203247070312, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB 5b7e557a−6aee−4077−b3cd−c96179e643ae Stomach−AdenoCA Cancer type 14:21910299−106251175 Position 1 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 0; DUP: 21; h2hINV: 1; SV types t2tINV: 1; TRA: 5 1150 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 21 CN segments
140	4	Lower_Right	5b7e557a-6aee-4077-b3cd-c96179e643ae	17:9703698−79150095	8, 19	27	{'min_x': 328.3699951171875, 'min_y': 731.9749755859375, 'max_x': 559.0999755859375, 'max_y': 831.8338012695312}	20 MB 40 MB 60 MB 80 MB 5b7e557a−6aee−4077−b3cd−c96179e643ae Stomach−AdenoCA Cancer type 17:9703698−79150095 Position 1 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 2; DUP: 13; h2hINV: 2; SV types t2tINV: 2; TRA: 8 1150 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 27 CN segments
141	1	Upper_Left	5b7e557a-6aee-4077-b3cd-c96179e643ae	19:1335997−58908317	7, 12	15	{'min_x': 35.360198974609375, 'min_y': 296.0599670410156, 'max_x': 248.8579559326172, 'max_y': 407.0240173339844}	5b7e557a−6aee−4077−b3cd−c96179e643ae 10 MB 20 MB 30 MB 40 MB 50 MB Stomach−AdenoCA Cancer type 19:1335997−58908317 Position 1 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 12; h2hINV: 0; SV types t2tINV: 0; TRA: 12 1150 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 15 CN segments 0.02326306 FDR fragment joints 0.1 FDR chr. breakp. enrich.
141	2	Upper_Right	5b7e557a-6aee-4077-b3cd-c96179e643ae	1:43676646−240124426	10, 11	27	{'min_x': 308.7799987792969, 'min_y': 291.7399597167969, 'max_x': 552.8601684570312, 'max_y': 412.114013671875}	5b7e557a−6aee−4077−b3cd−c96179e643ae 0 MB 20 MB 40 MB 60 MB Stomach−AdenoCA Cancer type 20:30101824−57105676 Position 3 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 22 1150 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 27 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. 1:43676646−240124426;11:686421−122325230
141	3	Lower_Left	5b7e557a-6aee-4077-b3cd-c96179e643ae	21:15908074−46609729	8, 8	8	{'min_x': 38.86989974975586, 'min_y': 731.9749755859375, 'max_x': 248.8579559326172, 'max_y': 831.8338012695312}	20 MB 30 MB 40 MB 5b7e557a−6aee−4077−b3cd−c96179e643ae Stomach−AdenoCA Cancer type 21:15908074−46609729 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 1 1150 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
141	4	Lower_Right	60879669-96c2-4710-82e0-0ae9d0e5b242	10:5810804−124150825	11, 18	24	{'min_x': 328.5299987792969, 'min_y': 731.9749755859375, 'max_x': 562.0618896484375, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB 60879669−96c2−4710−82e0−0ae9d0e5b242 Stomach−AdenoCA Cancer type 10:5810804−124150825 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 13; h2hINV: 0; SV types t2tINV: 1; TRA: 1 413 SVs in sample 11, 18 Oscillating CN (2 and 3 states) 24 CN segments
142	1	Upper_Left	60879669-96c2-4710-82e0-0ae9d0e5b242	11:2015155−118632987	15, 23	35	{'min_x': 39.03010177612305, 'min_y': 296.9750061035156, 'max_x': 271.2918701171875, 'max_y': 406.2539978027344}	30 MB 60 MB 90 MB 120 MB 60879669−96c2−4710−82e0−0ae9d0e5b242 Stomach−AdenoCA Cancer type 11:2015155−118632987 Position 1 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 0; DUP: 16; h2hINV: 0; SV types t2tINV: 0; TRA: 6 413 SVs in sample 15, 23 Oscillating CN (2 and 3 states) 35 CN segments 3.697029e−05 FDR fragment joints
142	2	Upper_Right	60879669-96c2-4710-82e0-0ae9d0e5b242	12:5197209−121876052	10, 18	32	{'min_x': 328.5299987792969, 'min_y': 296.9750061035156, 'max_x': 556.6919555664062, 'max_y': 406.2539978027344}	30 MB 60 MB 90 MB 120 MB 60879669−96c2−4710−82e0−0ae9d0e5b242 Stomach−AdenoCA Cancer type 12:5197209−121876052 Position 1 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 13; h2hINV: 0; SV types t2tINV: 0; TRA: 3 413 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 32 CN segments 0.002321411 FDR fragment joints
142	3	Lower_Left	60879669-96c2-4710-82e0-0ae9d0e5b242	16:57284825−84641398	9, 10	10	{'min_x': 39.03010177612305, 'min_y': 731.9749755859375, 'max_x': 248.6979522705078, 'max_y': 831.8338012695312}	60 MB 65 MB 70 MB 75 MB 80 MB 60879669−96c2−4710−82e0−0ae9d0e5b242 Stomach−AdenoCA Cancer type 16:57284825−84641398 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 413 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments
142	4	Lower_Right	8cb0144b-be6b-40a1-86a2-708f96d9b615	6:2029950−166153467	10, 15	15	{'min_x': 328.5400085449219, 'min_y': 731.9749755859375, 'max_x': 551.7522583007812, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 8cb0144b−be6b−40a1−86a2−708f96d9b615 Stomach−AdenoCA Cancer type 6:2029950−166153467 Position 1 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 0; SV types t2tINV: 0; TRA: 4 507 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 15 CN segments
143	1	Upper_Left	8cb0144b-be6b-40a1-86a2-708f96d9b615	9:3506571−139604450	7, 18	18	{'min_x': 39.039798736572266, 'min_y': 296.9750061035156, 'max_x': 248.68995666503906, 'max_y': 406.2539978027344}	50 MB 100 MB 8cb0144b−be6b−40a1−86a2−708f96d9b615 Stomach−AdenoCA Cancer type 9:3506571−139604450 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 0 507 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.02438658 FDR fragment joints
143	2	Upper_Right	8cb0144b-be6b-40a1-86a2-708f96d9b615	15:30184284−91364444	11, 11	11	{'min_x': 328.5400085449219, 'min_y': 296.9750061035156, 'max_x': 538.18994140625, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 8cb0144b−be6b−40a1−86a2−708f96d9b615 Stomach−AdenoCA Cancer type 15:30184284−91364444 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 507 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.05741733 FDR fragment joints
143	3	Lower_Left	8cb0144b-be6b-40a1-86a2-708f96d9b615	17:17470449−77164988	12, 12	19	{'min_x': 33.68980026245117, 'min_y': 731.9749755859375, 'max_x': 248.68995666503906, 'max_y': 836.9337768554688}	40 MB 60 MB 8cb0144b−be6b−40a1−86a2−708f96d9b615 Stomach−AdenoCA Cancer type 17:17470449−77164988 Position 1 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 1; DUP: 12; h2hINV: 0; SV types t2tINV: 1; TRA: 10 507 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 19 CN segments 0.1165322 FDR fragment joints
143	4	Lower_Right	aef8d98f-7a1c-47f3-b5a7-a3cb299c70de	3:931341−178546466	7, 14	14	{'min_x': 308.2200012207031, 'min_y': 731.9749755859375, 'max_x': 536.513916015625, 'max_y': 831.8338012695312}	0 MB 50 MB 100 MB 150 MB aef8d98f−7a1c−47f3−b5a7−a3cb299c70de Stomach−AdenoCA Cancer type 3:931341−178546466 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 29 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments
144	1	Upper_Left	b8a1c8c7-3945-4d84-8f58-3a1a1eb10730	7:25279771−28095993	5, 11	14	{'min_x': 39.539798736572266, 'min_y': 296.9750061035156, 'max_x': 248.18994140625, 'max_y': 406.2539978027344}	50 MB 75 MB 100 MB 125 MB b8a1c8c7−3945−4d84−8f58−3a1a1eb10730 Stomach−AdenoCA Cancer type 7:25279771−28095993 Position 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 298 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 14 CN segments 0.9000538 FDR fragment joints
144	2	Upper_Right	b8a1c8c7-3945-4d84-8f58-3a1a1eb10730	14:24923256−100767511	9, 12	13	{'min_x': 329.0400085449219, 'min_y': 296.9750061035156, 'max_x': 558.0722045898438, 'max_y': 406.2539978027344}	40 MB 60 MB 80 MB 100 MB b8a1c8c7−3945−4d84−8f58−3a1a1eb10730 Stomach−AdenoCA Cancer type 14:24923256−100767511 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 298 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 13 CN segments 0.1278363 FDR fragment joints
144	3	Lower_Left	cb622cd6-776d-4681-8a67-4addd61c66b8	2:72710938−179446562	5, 7	58	{'min_x': 38.269901275634766, 'min_y': 731.9749755859375, 'max_x': 249.45773315429688, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 2:72710938−179446562 Position 6 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 14 1322 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 58 CN segments
144	4	Lower_Right	cb622cd6-776d-4681-8a67-4addd61c66b8	3:12028186−62799589	5, 12	269	{'min_x': 327.7699890136719, 'min_y': 731.9749755859375, 'max_x': 538.9576416015625, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 3:12028186−62799589 Position 118 Interleaved intrachr. SVs 298 Total SVs (intrachr. + transl.) DEL: 32; DUP: 27; h2hINV: 35; SV types t2tINV: 24; TRA: 180 1322 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 269 CN segments
145	1	Upper_Left	cb622cd6-776d-4681-8a67-4addd61c66b8	4:101648717−156904507	5, 9	27	{'min_x': 38.269901275634766, 'min_y': 296.9750061035156, 'max_x': 249.45773315429688, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 4:101648717−156904507 Position 13 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 4 1322 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 27 CN segments 0.615458 FDR fragment joints
145	2	Upper_Right	cb622cd6-776d-4681-8a67-4addd61c66b8	14:23478242−105206733	11, 16	30	{'min_x': 324.8599853515625, 'min_y': 296.9750061035156, 'max_x': 545.7021484375, 'max_y': 411.343994140625}	40 MB 60 MB 80 MB 100 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 14:23478242−105206733 Position 1 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 0; DUP: 12; h2hINV: 0; SV types t2tINV: 1; TRA: 16 1322 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 30 CN segments 0.1148725 FDR fragment joints 0.26 FDR chr. breakp. enrich.
145	3	Lower_Left	e2aaabd9-f4ba-4763-a28a-c14d46a4bc5d	3:20118117−84053508	9, 23	23	{'min_x': 39.039798736572266, 'min_y': 731.9749755859375, 'max_x': 248.68995666503906, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB e2aaabd9−f4ba−4763−a28a−c14d46a4bc5d Stomach−AdenoCA Cancer type 3:20118117−84053508 Position 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 4 565 SVs in sample 9, 23 Oscillating CN (2 and 3 states) 23 CN segments
145	4	Lower_Right	e2aaabd9-f4ba-4763-a28a-c14d46a4bc5d	5:3587780−163844373	14, 22	22	{'min_x': 328.5400085449219, 'min_y': 731.9749755859375, 'max_x': 545.6021118164062, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB e2aaabd9−f4ba−4763−a28a−c14d46a4bc5d Stomach−AdenoCA Cancer type 5:3587780−163844373 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 11; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 4 565 SVs in sample 14, 22 Oscillating CN (2 and 3 states) 22 CN segments
146	1	Upper_Left	e2aaabd9-f4ba-4763-a28a-c14d46a4bc5d	9:3273649−130381646	9, 11	24	{'min_x': 39.039798736572266, 'min_y': 296.9750061035156, 'max_x': 261.1418762207031, 'max_y': 406.2539978027344}	25 MB 50 MB 75 MB 100 MB 125 MB e2aaabd9−f4ba−4763−a28a−c14d46a4bc5d Stomach−AdenoCA Cancer type 9:3273649−130381646 Position 1 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 10; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 565 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 24 CN segments 0.04139017 FDR fragment joints
146	2	Upper_Right	16e69011-c295-479f-b521-86e66fba498d	6:30689459−162853873	10, 10	10	{'min_x': 323.739990234375, 'min_y': 296.9750061035156, 'max_x': 555.4221801757812, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 16e69011−c295−479f−b521−86e66fba498d Uterus−AdenoCA Cancer type 6:30689459−162853873 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 137 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.05741733 FDR fragment joints
146	3	Lower_Left	16e69011-c295-479f-b521-86e66fba498d	14:24826217−105404171	13, 13	15	{'min_x': 40.210201263427734, 'min_y': 731.9749755859375, 'max_x': 255.43222045898438, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 100 MB 16e69011−c295−479f−b521−86e66fba498d Uterus−AdenoCA Cancer type 14:24826217−105404171 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 8; h2hINV: 0; SV types t2tINV: 0; TRA: 1 137 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 15 CN segments
146	4	Lower_Right	79ecc142-8f6e-4260-a7ce-c8e2a6212c35	3:13693655−180270905	8, 9	27	{'min_x': 324.8599853515625, 'min_y': 731.9749755859375, 'max_x': 537.199951171875, 'max_y': 836.9337768554688}	50 MB 100 MB 150 MB 79ecc142−8f6e−4260−a7ce−c8e2a6212c35 Uterus−AdenoCA Cancer type 3:13693655−180270905 Position 1 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 1; DUP: 12; h2hINV: 0; SV types t2tINV: 1; TRA: 10 794 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 27 CN segments 0.1165322 FDR fragment joints
147	1	Upper_Left	79ecc142-8f6e-4260-a7ce-c8e2a6212c35	17:7101046−80011712	4, 10	32	{'min_x': 33.68980026245117, 'min_y': 296.9750061035156, 'max_x': 268.9300231933594, 'max_y': 411.343994140625}	20 MB 40 MB 60 MB 80 MB 79ecc142−8f6e−4260−a7ce−c8e2a6212c35 Uterus−AdenoCA Cancer type 17:7101046−80011712 Position 8 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 14 794 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 32 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
147	2	Upper_Right	7b9947d5-e86b-4006-8890-ea5209584a88	9:106282−38107794	4, 9	21	{'min_x': 309.25, 'min_y': 296.9750061035156, 'max_x': 538.35791015625, 'max_y': 406.2539978027344}	0 MB 50 MB 100 MB 7b9947d5−e86b−4006−8890−ea5209584a88 Uterus−AdenoCA Cancer type 9:106282−38107794 Position 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 7 276 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints
147	3	Lower_Left	7dce4215-01f6-43e9-9378-9e22c26c23a2	2:47389795−203229105	11, 11	11	{'min_x': 39.86989974975586, 'min_y': 731.9749755859375, 'max_x': 266.12200927734375, 'max_y': 831.8338012695312}	100 MB 150 MB 200 MB 7dce4215−01f6−43e9−9378−9e22c26c23a2 Uterus−AdenoCA Cancer type 2:47389795−203229105 Position 1 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 7; h2hINV: 0; SV types t2tINV: 0; TRA: 0 120 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
147	4	Lower_Right	7dce4215-01f6-43e9-9378-9e22c26c23a2	3:10044478−169928464	7, 10	10	{'min_x': 329.3699951171875, 'min_y': 731.9749755859375, 'max_x': 546.0820922851562, 'max_y': 831.8338012695312}	40 MB 80 MB 120 MB 160 MB 7dce4215−01f6−43e9−9378−9e22c26c23a2 Uterus−AdenoCA Cancer type 3:10044478−169928464 Position 1 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 4 120 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments
148	1	Upper_Left	8d9e4917-334b-4c76-aee1-1e22be772db0	3:23738446−169522007	7, 27	53	{'min_x': 38.539798736572266, 'min_y': 296.9750061035156, 'max_x': 249.18795776367188, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 8d9e4917−334b−4c76−aee1−1e22be772db0 Uterus−AdenoCA Cancer type 3:23738446−169522007 Position 6 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 3; TRA: 4 422 SVs in sample 7, 27 Oscillating CN (2 and 3 states) 53 CN segments 0.6776251 FDR fragment joints
148	2	Upper_Right	8d9e4917-334b-4c76-aee1-1e22be772db0	6:51901142−155973305	10, 10	23	{'min_x': 328.0400085449219, 'min_y': 296.9750061035156, 'max_x': 548.4523315429688, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB 8d9e4917−334b−4c76−aee1−1e22be772db0 Uterus−AdenoCA Cancer type 6:51901142−155973305 Position 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 5 422 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 23 CN segments 0.6776251 FDR fragment joints
148	3	Lower_Left	9205c164-7975-421a-90c3-edfe8def595c	2:30991919−219707625	7, 16	35	{'min_x': 38.68009948730469, 'min_y': 731.9749755859375, 'max_x': 247.33213806152344, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 200 MB 9205c164−7975−421a−90c3−edfe8def595c Uterus−AdenoCA Cancer type 2:30991919−219707625 Position 1 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 3; DUP: 16; h2hINV: 0; SV types t2tINV: 0; TRA: 4 226 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 35 CN segments
148	4	Lower_Right	9205c164-7975-421a-90c3-edfe8def595c	7:18503282−139455166	8, 10	10	{'min_x': 329.8999938964844, 'min_y': 731.9749755859375, 'max_x': 536.8321533203125, 'max_y': 831.8338012695312}	50 MB 100 MB 9205c164−7975−421a−90c3−edfe8def595c Uterus−AdenoCA Cancer type 7:18503282−139455166 Position 1 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 0 226 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 10 CN segments
149	1	Upper_Left	944a102f-3475-45aa-9e30-4b92d1449f00	22:32093117−32660408	4, 5	9	{'min_x': 40.36989974975586, 'min_y': 296.9750061035156, 'max_x': 268.4601135253906, 'max_y': 406.2539978027344}	36 MB 40 MB 44 MB 944a102f−3475−45aa−9e30−4b92d1449f00 Uterus−AdenoCA Cancer type 22:32093117−32660408 Position 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 0 189 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints
149	2	Upper_Right	94817e78-78f5-4556-9394-610df65605e2	3:42025446−172171958	9, 11	11	{'min_x': 330.0400085449219, 'min_y': 296.9750061035156, 'max_x': 536.69189453125, 'max_y': 406.2539978027344}	50 MB 100 MB 150 MB 94817e78−78f5−4556−9394−610df65605e2 Uterus−AdenoCA Cancer type 3:42025446−172171958 Position 1 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 2 283 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.1178349 FDR fragment joints
149	3	Lower_Left	94817e78-78f5-4556-9394-610df65605e2	16:67590378−89462801	5, 5	5	{'min_x': 40.539798736572266, 'min_y': 731.9749755859375, 'max_x': 247.19195556640625, 'max_y': 831.8338012695312}	40 MB 60 MB 80 MB 94817e78−78f5−4556−9394−610df65605e2 Uterus−AdenoCA Cancer type 16:67590378−89462801 Position 17 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 3; SV types t2tINV: 5; TRA: 2 283 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments
149	4	Lower_Right	95e6d327-9ab7-45de-9527-f5634b3995c3	3:13471312−168163898	8, 8	17	{'min_x': 328.8699951171875, 'min_y': 731.9749755859375, 'max_x': 537.8599243164062, 'max_y': 831.8338012695312}	50 MB 100 MB 150 MB 95e6d327−9ab7−45de−9527−f5634b3995c3 Uterus−AdenoCA Cancer type 3:13471312−168163898 Position 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 4 141 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 17 CN segments
150	1	Upper_Left	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	4:92341870−169784344	10, 10	10	{'min_x': 42.080101013183594, 'min_y': 296.9750061035156, 'max_x': 271.5521240234375, 'max_y': 406.2539978027344}	110 MB 130 MB 150 MB 170 MB af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 4:92341870−169784344 Position 1 Interleaved intrachr. SVs 5 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 0 315 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.1013295 FDR fragment joints
150	2	Upper_Right	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	6:6931110−166548418	20, 20	23	{'min_x': 331.5799865722656, 'min_y': 296.9750061035156, 'max_x': 550.9421997070312, 'max_y': 406.2539978027344}	40 MB 80 MB 120 MB 160 MB af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 6:6931110−166548418 Position 1 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 12; h2hINV: 0; SV types t2tINV: 1; TRA: 4 315 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 23 CN segments 0.01832315 FDR fragment joints
150	3	Lower_Left	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	10:294814−131732983	11, 11	23	{'min_x': 42.080101013183594, 'min_y': 731.9749755859375, 'max_x': 259.0821838378906, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 10:294814−131732983 Position 1 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 11; h2hINV: 0; SV types t2tINV: 1; TRA: 1 315 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 23 CN segments
150	4	Lower_Right	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	12:24679746−80152939	12, 14	14	{'min_x': 314.2099914550781, 'min_y': 731.9749755859375, 'max_x': 545.0020141601562, 'max_y': 831.8338012695312}	25 MB 50 MB 75 MB 100 MB 125 MB af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 12:24679746−80152939 Position 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 7 315 SVs in sample 12, 14 Oscillating CN (2 and 3 states) 14 CN segments
151	1	Upper_Left	BTCA_donor_A035		77, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB BTCA_donor_A035 Biliary−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 80 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.77, 2.01 Purity, ploidy
151	2	Upper_Right	BTCA_donor_A035		77, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB BTCA_donor_A035 Biliary−AdenoCA Cancer type 9 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 80 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.77, 2.01 Purity, ploidy
151	3	Lower_Left	RK159		7, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB RK159 Biliary−AdenoCA Cancer type 2 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 1 24 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
151	4	Lower_Right	RK310		8, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB RK310 Biliary−AdenoCA Cancer type 1 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 24 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
152	1	Upper_Left	24f21425-b001-4986-aedf-5b4dd851c6ad		64, 3		{'min_x': 30.75, 'min_y': 283.9250183105469, 'max_x': 256.1520080566406, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 24f21425−b001−4986−aedf−5b4dd851c6ad Bladder−TCC Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 271 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.64, 3.43 Purity, ploidy
152	2	Upper_Right	419deaac-ea45-4bdd-9fa0-b5cd8429b44f		66, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 545.822021484375, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 419deaac−ea45−4bdd−9fa0−b5cd8429b44f Bladder−TCC Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 62 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.66, 1.96 Purity, ploidy
152	3	Lower_Left	8c1dd7f7-b74a-4fa2-b6a7-86f0348d2567		7, 8		{'min_x': 31.589799880981445, 'min_y': 718.9249877929688, 'max_x': 255.3240203857422, 'max_y': 830.013916015625}	50 MB 100 MB 8c1dd7f7−b74a−4fa2−b6a7−86f0348d2567 Bladder−TCC Cancer type 8 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 80 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
152	4	Lower_Right	CGP_donor_1691134		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB CGP_donor_1691134 Bone−Epith Cancer type 2 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 32 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
153	1	Upper_Left	CGP_donor_1347723		48, 4		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CGP_donor_1347723 Breast−AdenoCA Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 144 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.48, 4.22 Purity, ploidy
153	2	Upper_Right	CGP_donor_1397278		42, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 30 MB 60 MB 90 MB CGP_donor_1397278 Breast−AdenoCA Cancer type 13 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 340 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 17 CN segments 0.42, 2.02 Purity, ploidy
153	3	Lower_Left	CGP_donor_1069291		8, 6		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 242.43215942382812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB CGP_donor_1069291 Breast−AdenoCA Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 277 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
153	4	Lower_Right	CGP_donor_1069291		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 555.0601806640625, 'max_y': 830.013916015625}	0 MB 20 MB 40 MB 60 MB 80 MB CGP_donor_1069291 Breast−AdenoCA Cancer type 17 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 277 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
154	1	Upper_Left	CGP_donor_1347720		37, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CGP_donor_1347720 Breast−AdenoCA Cancer type 4 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 173 SVs in sample 10, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.37, 1.59 Purity, ploidy
154	2	Upper_Right	CGP_donor_1347720		37, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB CGP_donor_1347720 Breast−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 173 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 10 CN segments 0.37, 1.59 Purity, ploidy
154	3	Lower_Left	CGP_donor_1353432		9, 3		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 273.2117919921875, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1353432 Breast−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 185 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
154	4	Lower_Right	CGP_donor_1363963		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 552.59033203125, 'max_y': 830.013916015625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_1363963 Breast−AdenoCA Cancer type 22 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 324 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
155	1	Upper_Left	CGP_donor_1374619		38, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CGP_donor_1374619 Breast−AdenoCA Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 273 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 10 CN segments 0.38, 1.62 Purity, ploidy
155	2	Upper_Right	CGP_donor_1472394		7, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 552.5719604492188, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB CGP_donor_1472394 Breast−AdenoCA Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 366 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 17 CN segments 0.7, 1.76 Purity, ploidy
155	3	Lower_Left	1549dc64-3dab-43fc-96e9-b07d520957e1		7, 0		{'min_x': 30.219900131225586, 'min_y': 718.9249877929688, 'max_x': 256.6899719238281, 'max_y': 830.013916015625}	50 MB 100 MB 1549dc64−3dab−43fc−96e9−b07d520957e1 Breast−AdenoCA Cancer type 12 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 226 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
155	4	Lower_Right	174850b4-5ec2-462b-a890-89bd1716b3c2		14, 15		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 554.7123413085938, 'max_y': 830.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB 174850b4−5ec2−462b−a890−89bd1716b3c2 Breast−AdenoCA Cancer type 15 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 456 SVs in sample 14, Oscillating CN in chr (2 and 3 states)
156	1	Upper_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82		38, 2		{'min_x': 29.88010025024414, 'min_y': 283.9250183105469, 'max_x': 257.0279541015625, 'max_y': 413.843994140625}	20 MB 40 MB 60 MB 5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 18 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 475 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 18 CN segments 0.38, 2.04 Purity, ploidy
156	2	Upper_Right	6956473b-92e5-4069-a26b-b48e280e76f2		56, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 545.8599243164062, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB 6956473b−92e5−4069−a26b−b48e280e76f2 Breast−AdenoCA Cancer type 16 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 227 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.56, 1.61 Purity, ploidy
156	3	Lower_Left	75113445-d2d6-44a0-866c-c9175e6d214b		7, 5		{'min_x': 29.719900131225586, 'min_y': 718.9249877929688, 'max_x': 257.19793701171875, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 75113445−d2d6−44a0−866c−c9175e6d214b Breast−AdenoCA Cancer type 5 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 212 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
156	4	Lower_Right	790ff5db-b7f3-4946-aaed-305f66b1dd6a		9, 7		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.652099609375, 'max_y': 830.013916015625}	0 MB 40 MB 80 MB 120 MB 160 MB 790ff5db−b7f3−4946−aaed−305f66b1dd6a Breast−AdenoCA Cancer type 7 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 455 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
157	1	Upper_Left	88db1340-e4bf-451a-87c0-6e9168296f5e		53, 1		{'min_x': 31.219900131225586, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 88db1340−e4bf−451a−87c0−6e9168296f5e Breast−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 415 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 34 CN segments 0.53, 1.49 Purity, ploidy
157	2	Upper_Right	9f6be944-83de-42ab-8738-f0022f475e61		6, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.5238647460938, 'max_y': 413.843994140625}	0 MB 10 MB 20 MB 30 MB 40 MB 9f6be944−83de−42ab−8738−f0022f475e61 Breast−AdenoCA Cancer type 21 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 864 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 10 CN segments 0.6, 3.26 Purity, ploidy
157	3	Lower_Left	a9b7d7fe-be31-4f71-afee-c1bfdf511888		7, 5		{'min_x': 32.960201263427734, 'min_y': 718.9249877929688, 'max_x': 253.9580078125, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB a9b7d7fe−be31−4f71−afee−c1bfdf511888 Breast−AdenoCA Cancer type 5 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 460 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
157	4	Lower_Right	a9b7d7fe-be31-4f71-afee-c1bfdf511888		9, 9		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 543.4579467773438, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB a9b7d7fe−be31−4f71−afee−c1bfdf511888 Breast−AdenoCA Cancer type 9 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 460 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
158	1	Upper_Left	d2f2560c-ec80-4fea-9474-c47a2e85ea95		67, 3		{'min_x': 31.58009910583496, 'min_y': 283.9250183105469, 'max_x': 263.072021484375, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB d2f2560c−ec80−4fea−9474−c47a2e85ea95 Breast−AdenoCA Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 546 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 41 CN segments 0.67, 3.45 Purity, ploidy
158	2	Upper_Right	e4fc0909-f284-4471-866d-d8967b6adcbc		49, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 545.52197265625, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 0 630 SVs in sample 15, Oscillating CN in chr (2 and 3 states) 60 CN segments 0.49, 2.63 Purity, ploidy
158	3	Lower_Left	f05d314c-5ec5-4e2a-b785-9a702716f111		8, 0		{'min_x': 31.38010025024414, 'min_y': 718.9249877929688, 'max_x': 265.56011962890625, 'max_y': 830.013916015625}	20 MB 40 MB 60 MB 80 MB f05d314c−5ec5−4e2a−b785−9a702716f111 Breast−AdenoCA Cancer type 17 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 16 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
158	4	Lower_Right	CGP_donor_1451422		12, 22		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB CGP_donor_1451422 Breast−LobularCA Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 22 SVs in sample 12, Oscillating CN in chr (2 and 3 states)
159	1	Upper_Left	a3be445a-a592-4073-815b-47ae41f9c4a0		77, 3		{'min_x': 30.719900131225586, 'min_y': 283.9250183105469, 'max_x': 256.199951171875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB a3be445a−a592−4073−815b−47ae41f9c4a0 Cervix−AdenoCA Cancer type 4 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 44 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.77, 3.59 Purity, ploidy
159	2	Upper_Right	941f75a1-fea4-4539-ba69-60bb11608f6d		68, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.6541137695312, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB 100 MB 941f75a1−fea4−4539−ba69−60bb11608f6d Cervix−SCC Cancer type 14 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 58 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.68, 2.71 Purity, ploidy
159	3	Lower_Left	941f75a1-fea4-4539-ba69-60bb11608f6d		13, 17		{'min_x': 31.75, 'min_y': 718.9249877929688, 'max_x': 265.56011962890625, 'max_y': 830.013916015625}	20 MB 40 MB 60 MB 80 MB 941f75a1−fea4−4539−ba69−60bb11608f6d Cervix−SCC Cancer type 17 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 58 SVs in sample 13, Oscillating CN in chr (2 and 3 states)
159	4	Lower_Right	e733f289-a0ec-478c-aad9-1378ad26ddfa		7, 7		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.652099609375, 'max_y': 830.013916015625}	0 MB 40 MB 80 MB 120 MB 160 MB e733f289−a0ec−478c−aad9−1378ad26ddfa Cervix−SCC Cancer type 7 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 63 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
160	1	Upper_Left	eb59cf69-1997-41b9-bf69-69ad7da292a1		4, 3		{'min_x': 30.889799118041992, 'min_y': 283.9250183105469, 'max_x': 256.02197265625, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB eb59cf69−1997−41b9−bf69−69ad7da292a1 Cervix−SCC Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 63 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.4, 3.41 Purity, ploidy
160	2	Upper_Right	17dffffc-65d6-4209-9075-18a441001f0f		48, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 542.349853515625, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 17dffffc−65d6−4209−9075−18a441001f0f CNS−GBM Cancer type 5 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 93 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.48, 1.95 Purity, ploidy
160	3	Lower_Left	3258cb3b-f63b-463c-b2e4-d638149157c5		9, 2		{'min_x': 30.219900131225586, 'min_y': 718.9249877929688, 'max_x': 256.6899719238281, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 3258cb3b−f63b−463c−b2e4−d638149157c5 CNS−GBM Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 59 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
160	4	Lower_Right	6e6962d8-34b8-431c-8220-42b0b92a410b		11, 14		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 546.8579711914062, 'max_y': 830.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB 6e6962d8−34b8−431c−8220−42b0b92a410b CNS−GBM Cancer type 14 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 86 SVs in sample 11, Oscillating CN in chr (2 and 3 states)
161	1	Upper_Left	a515cf2d-e918-4958-9bf6-e611b425a97e		53, 2		{'min_x': 31.219900131225586, 'min_y': 283.9250183105469, 'max_x': 255.69195556640625, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB a515cf2d−e918−4958−9bf6−e611b425a97e CNS−GBM Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 39 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.53, 2.77 Purity, ploidy
161	2	Upper_Right	be3a7ef3-34ed-40e1-9d9c-187940596b26		71, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 546.0299072265625, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB be3a7ef3−34ed−40e1−9d9c−187940596b26 CNS−GBM Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 0 93 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.71, 1.97 Purity, ploidy
161	3	Lower_Left	ICGC_MB36		10, 17		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 271.6021423339844, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 250 MB ICGC_MB36 CNS−Medullo Cancer type 1 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 17 SVs in sample 10, Oscillating CN in chr (2 and 3 states)
161	4	Lower_Right	490eabca-4575-4bd6-9604-6b6e23d069ce		8, 8		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 546.85791015625, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 490eabca−4575−4bd6−9604−6b6e23d069ce ColoRect−AdenoCA Cancer type 8 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 95 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
162	1	Upper_Left	bfb07784-693b-4c25-874e-4ad6e04a5d46		58, 2		{'min_x': 30.219900131225586, 'min_y': 283.9250183105469, 'max_x': 263.072021484375, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB bfb07784−693b−4c25−874e−4ad6e04a5d46 ColoRect−AdenoCA Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 154 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.58, 2.21 Purity, ploidy
162	2	Upper_Right	c83d38fc-e011-4f75-a100-96513611f3e9		56, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.1939086914062, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB c83d38fc−e011−4f75−a100−96513611f3e9 ColoRect−AdenoCA Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 18 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.56, 3.79 Purity, ploidy
162	3	Lower_Left	fafd4576-0709-49e1-926f-ad1ee09907ec		8, 4		{'min_x': 32.04999923706055, 'min_y': 718.9249877929688, 'max_x': 254.8539581298828, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB fafd4576−0709−49e1−926f−ad1ee09907ec ColoRect−AdenoCA Cancer type 4 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 146 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
162	4	Lower_Right	0bb786ee-07cf-4853-9b49-ec95cd14e282		7, 0		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 546.0299072265625, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 0bb786ee−07cf−4853−9b49−ec95cd14e282 ColoRect−AdenoCA Cancer type 12 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 46 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
163	1	Upper_Left	8feb0e8f-d09b-437d-8651-0cdecfe776bf		75, 1		{'min_x': 32.11989974975586, 'min_y': 283.9250183105469, 'max_x': 272.1520080566406, 'max_y': 413.843994140625}	40 MB 80 MB 120 MB 160 MB 8feb0e8f−d09b−437d−8651−0cdecfe776bf ColoRect−AdenoCA Cancer type 7 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 603 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.75, 1.99 Purity, ploidy
163	2	Upper_Right	8feb0e8f-d09b-437d-8651-0cdecfe776bf		75, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.285888671875, 'max_y': 413.843994140625}	0 MB 30 MB 60 MB 90 MB 8feb0e8f−d09b−437d−8651−0cdecfe776bf ColoRect−AdenoCA Cancer type 13 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 603 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.75, 1.99 Purity, ploidy
163	3	Lower_Left	OCCAMS-AH-071		7, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB OCCAMS−AH−071 Eso−AdenoCA Cancer type 11 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 134 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
163	4	Lower_Right	OCCAMS-AH-131		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB OCCAMS−AH−131 Eso−AdenoCA Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 266 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
164	1	Upper_Left	OCCAMS-AH-135		55, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB OCCAMS−AH−135 Eso−AdenoCA Cancer type 10 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 298 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 53 CN segments 0.55, 2.85 Purity, ploidy
164	2	Upper_Right	OCCAMS-AH-135		55, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB OCCAMS−AH−135 Eso−AdenoCA Cancer type 16 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 298 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 17 CN segments 0.55, 2.85 Purity, ploidy
164	3	Lower_Left	OCCAMS-AH-143		7, 4		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB OCCAMS−AH−143 Eso−AdenoCA Cancer type 4 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 596 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
164	4	Lower_Right	OCCAMS-AH-213		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB OCCAMS−AH−213 Eso−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 283 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
165	1	Upper_Left	OCCAMS-WG-005		38, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB OCCAMS−WG−005 Eso−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 277 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 25 CN segments 0.38, 2.47 Purity, ploidy
165	2	Upper_Right	OCCAMS-WG-008		4, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.10205078125, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB OCCAMS−WG−008 Eso−AdenoCA Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 357 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 30 CN segments 0.4, 2.6 Purity, ploidy
165	3	Lower_Left	05fbd98c-28bd-41bc-ae60-16ac0c16c723		19, 2		{'min_x': 30.219900131225586, 'min_y': 718.9249877929688, 'max_x': 256.6899719238281, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 05fbd98c−28bd−41bc−ae60−16ac0c16c723 Head−SCC Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 143 SVs in sample 19, Oscillating CN in chr (2 and 3 states)
165	4	Lower_Right	05fbd98c-28bd-41bc-ae60-16ac0c16c723				{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 552.5719604492188, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 05fbd98c−28bd−41bc−ae60−16ac0c16c723 Head−SCC Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 143 SVs in sample 11, Oscillating CN in chr (2 and 3 states)
166	1	Upper_Left	0956bc67-dd55-4c54-a56a-f22f2856662a		75, 1		{'min_x': 31.25, 'min_y': 283.9250183105469, 'max_x': 271.6021423339844, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 250 MB 0956bc67−dd55−4c54−a56a−f22f2856662a Head−SCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 130 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 14 CN segments 0.75, 1.71 Purity, ploidy
166	2	Upper_Right	ba9d4568-71a8-41fc-a2be-0bf784e36d6a		8, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 554.7123413085938, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB 100 MB ba9d4568−71a8−41fc−a2be−0bf784e36d6a Head−SCC Cancer type 15 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 54 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.8, 1.95 Purity, ploidy
166	3	Lower_Left	ba9d4568-71a8-41fc-a2be-0bf784e36d6a		7, 0		{'min_x': 30.889799118041992, 'min_y': 718.9249877929688, 'max_x': 263.090087890625, 'max_y': 830.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB ba9d4568−71a8−41fc−a2be−0bf784e36d6a Head−SCC Cancer type 22 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 54 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
166	4	Lower_Right	e8ac39e6-377a-412c-b18d-f6c4fc654ec6		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 545.0219116210938, 'max_y': 830.013916015625}	0 MB 25 MB 50 MB 75 MB e8ac39e6−377a−412c−b18d−f6c4fc654ec6 Head−SCC Cancer type 16 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 183 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
167	1	Upper_Left	OSCC-GB_012501		55, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB OSCC−GB_012501 Head−SCC Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 64 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.55, 2 Purity, ploidy
167	2	Upper_Right	b08dfba8-6afb-4217-9259-72be6f1f3363		77, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.1858520507812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB b08dfba8−6afb−4217−9259−72be6f1f3363 Kidney−ChRCC Cancer type 4 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 37 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.77, 2.95 Purity, ploidy
167	3	Lower_Left	9da334ed-314c-4445-ba29-ffd9bb42403c				{'min_x': 30.719900131225586, 'min_y': 718.9249877929688, 'max_x': 263.072021484375, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 9da334ed−314c−4445−ba29−ffd9bb42403c Kidney−RCC Cancer type X Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 15 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
167	4	Lower_Right	71b35cd8-ecee-4599-bb24-b1ef78118423		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 546.1898803710938, 'max_y': 830.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB 71b35cd8−ecee−4599−bb24−b1ef78118423 Kidney−RCC Cancer type 14 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 9 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
168	1	Upper_Left	C0009		41, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB C0009 Kidney−RCC Cancer type 2 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 1 18 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.41, 1.95 Purity, ploidy
168	2	Upper_Right	C0046		46, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 562.7122192382812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB C0046 Kidney−RCC Cancer type 3 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 11 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.46, 1.87 Purity, ploidy
168	3	Lower_Left	C0075		7, 1		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB C0075 Kidney−RCC Cancer type 10 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 18 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
168	4	Lower_Right	18c08546-bed3-4ed9-b223-479afe633c8e				{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 552.5719604492188, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 18c08546−bed3−4ed9−b223−479afe633c8e Liver−HCC Cancer type X Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 21 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
169	1	Upper_Left	4bbdbe77-f3cb-4b64-9826-72debb734784		82, 2		{'min_x': 29.560199737548828, 'min_y': 283.9250183105469, 'max_x': 257.3499755859375, 'max_y': 413.843994140625}	10 MB 20 MB 30 MB 40 MB 50 MB 4bbdbe77−f3cb−4b64−9826−72debb734784 Liver−HCC Cancer type 19 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 445 SVs in sample 13, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.82, 2.08 Purity, ploidy
169	2	Upper_Right	4bbdbe77-f3cb-4b64-9826-72debb734784		82, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 552.59033203125, 'max_y': 413.843994140625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB 4bbdbe77−f3cb−4b64−9826−72debb734784 Liver−HCC Cancer type 22 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 445 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 26 CN segments 0.82, 2.08 Purity, ploidy
169	3	Lower_Left	68015cc7-d3a1-4c90-b8fb-5d14143d9960		10, 11		{'min_x': 30.219900131225586, 'min_y': 718.9249877929688, 'max_x': 256.6899719238281, 'max_y': 830.013916015625}	50 MB 100 MB 68015cc7−d3a1−4c90−b8fb−5d14143d9960 Liver−HCC Cancer type 11 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 231 SVs in sample 10, Oscillating CN in chr (2 and 3 states)
169	4	Lower_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4		17, 3		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 562.7122192382812, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 301 SVs in sample 17, Oscillating CN in chr (2 and 3 states)
170	1	Upper_Left	8afa3140-dcbd-44c0-ab13-4ada6a0444d4		84, 3		{'min_x': 30.060199737548828, 'min_y': 283.9250183105469, 'max_x': 256.8599548339844, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 301 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 26 CN segments 0.84, 3.54 Purity, ploidy
170	2	Upper_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4		84, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 546.3599243164062, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 301 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 36 CN segments 0.84, 3.54 Purity, ploidy
170	3	Lower_Left	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd		10, 8		{'min_x': 33.730098724365234, 'min_y': 718.9249877929688, 'max_x': 253.17996215820312, 'max_y': 830.013916015625}	50 MB 100 MB bd48fa5e−0152−46f0−a4fa−8cf723ff2dcd Liver−HCC Cancer type 8 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 2; TRA: 0 394 SVs in sample 10, Oscillating CN in chr (2 and 3 states)
170	4	Lower_Right	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd		13, 9		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 542.6798706054688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB bd48fa5e−0152−46f0−a4fa−8cf723ff2dcd Liver−HCC Cancer type 9 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 394 SVs in sample 13, Oscillating CN in chr (2 and 3 states)
171	1	Upper_Left	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd		57, 2		{'min_x': 33.730098724365234, 'min_y': 283.9250183105469, 'max_x': 253.17996215820312, 'max_y': 413.843994140625}	50 MB 100 MB bd48fa5e−0152−46f0−a4fa−8cf723ff2dcd Liver−HCC Cancer type 10 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 394 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 15 CN segments 0.57, 2.05 Purity, ploidy
171	2	Upper_Right	bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd		57, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 542.6798706054688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB bd48fa5e−0152−46f0−a4fa−8cf723ff2dcd Liver−HCC Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 394 SVs in sample 10, Oscillating CN in chr (2 and 3 states) 16 CN segments 0.57, 2.05 Purity, ploidy
171	3	Lower_Left	bee9d6c8-948f-4b76-97ca-b985064249ef		7, 7		{'min_x': 31.049999237060547, 'min_y': 718.9249877929688, 'max_x': 272.1520080566406, 'max_y': 830.013916015625}	40 MB 80 MB 120 MB 160 MB bee9d6c8−948f−4b76−97ca−b985064249ef Liver−HCC Cancer type 7 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 164 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
171	4	Lower_Right	RK006		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB RK006 Liver−HCC Cancer type 12 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 46 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
172	1	Upper_Left	RK025		33, 4		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 263.072021484375, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB RK025 Liver−HCC Cancer type X Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 71 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.33, 4.17 Purity, ploidy
172	2	Upper_Right	RK036		14, 11		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB RK036 Liver−HCC Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 22 SVs in sample 14, Oscillating CN in chr (2 and 3 states) 24 CN segments NA, NA Purity, ploidy
172	3	Lower_Left	RK042		7, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB RK042 Liver−HCC Cancer type 11 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 93 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
172	4	Lower_Right	RK070		9, 8		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB RK070 Liver−HCC Cancer type 8 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 281 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
173	1	Upper_Left	RK072		7, 4		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	25 MB 50 MB 75 MB RK072 Liver−HCC Cancer type 16 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 282 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.7, 4.49 Purity, ploidy
173	2	Upper_Right	RK080		77, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB RK080 Liver−HCC Cancer type 2 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 26 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 15 CN segments 0.77, 3.85 Purity, ploidy
173	3	Lower_Left	RK080		9, 4		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB RK080 Liver−HCC Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 26 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
173	4	Lower_Right	RK087		9, 4		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB RK087 Liver−HCC Cancer type 4 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 62 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
174	1	Upper_Left	RK087		26, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB RK087 Liver−HCC Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 62 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.26, 1.9 Purity, ploidy
174	2	Upper_Right	RK125		72, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 544.6118774414062, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB 100 MB RK125 Liver−HCC Cancer type 14 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 18 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.72, 3.47 Purity, ploidy
174	3	Lower_Left	RK148		17, 1		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 271.6021423339844, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 250 MB RK148 Liver−HCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 195 SVs in sample 17, Oscillating CN in chr (2 and 3 states)
174	4	Lower_Right	RK148		9, 6		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 531.93212890625, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB RK148 Liver−HCC Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 195 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
175	1	Upper_Left	RK207		38, 3		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB RK207 Liver−HCC Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 122 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 15 CN segments 0.38, 3.72 Purity, ploidy
175	2	Upper_Right	RK216		84, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 547.3800048828125, 'max_y': 413.843994140625}	0 MB 20 MB 40 MB 60 MB RK216 Liver−HCC Cancer type 20 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 38 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.84, 3.4 Purity, ploidy
175	3	Lower_Left	RK234		7, 1		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB RK234 Liver−HCC Cancer type 12 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 51 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
175	4	Lower_Right	RK244		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB RK244 Liver−HCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 24 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
176	1	Upper_Left	RK245		47, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB RK245 Liver−HCC Cancer type 5 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 48 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.47, 2.16 Purity, ploidy
176	2	Upper_Right	RK258		17, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB RK258 Liver−HCC Cancer type 10 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 61 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.17, 3.23 Purity, ploidy
176	3	Lower_Left	RK261		7, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB RK261 Liver−HCC Cancer type 11 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 66 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
176	4	Lower_Right	RK261		11, 13		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 30 MB 60 MB 90 MB RK261 Liver−HCC Cancer type 13 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 66 SVs in sample 11, Oscillating CN in chr (2 and 3 states)
177	1	Upper_Left	RK283		25, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB RK283 Liver−HCC Cancer type 11 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 11 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.25, 2.06 Purity, ploidy
177	2	Upper_Right	RK289		15, 34		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB RK289 Liver−HCC Cancer type 8 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 34 SVs in sample 15, Oscillating CN in chr (2 and 3 states) 18 CN segments NA, NA Purity, ploidy
177	3	Lower_Left	RK304		7, 4		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB RK304 Liver−HCC Cancer type 4 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 37 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
177	4	Lower_Right	RK304		8, 8		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB RK304 Liver−HCC Cancer type 8 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 37 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
178	1	Upper_Left	RK337		38, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB RK337 Liver−HCC Cancer type 3 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 37 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.38, 2.75 Purity, ploidy
178	2	Upper_Right	RK337		38, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.652099609375, 'max_y': 413.843994140625}	0 MB 40 MB 80 MB 120 MB 160 MB RK337 Liver−HCC Cancer type 7 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 37 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.38, 2.75 Purity, ploidy
178	3	Lower_Left	RK337		8, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB RK337 Liver−HCC Cancer type 12 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 37 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
178	4	Lower_Right	21fb46f9-4bbb-441c-af19-a687e9138344		9, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 544.683837890625, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 21fb46f9−4bbb−441c−af19−a687e9138344 Lung−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 71 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
179	1	Upper_Left	31c96e35-5e2f-429c-b12a-7bc5a497a300		49, 4		{'min_x': 30.719900131225586, 'min_y': 283.9250183105469, 'max_x': 256.199951171875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 31c96e35−5e2f−429c−b12a−7bc5a497a300 Lung−AdenoCA Cancer type 6 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 276 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.49, 4.79 Purity, ploidy
179	2	Upper_Right	a8d6694c-a213-4544-ac0b-63bce16d8f4e		62, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.652099609375, 'max_y': 413.843994140625}	0 MB 40 MB 80 MB 120 MB 160 MB a8d6694c−a213−4544−ac0b−63bce16d8f4e Lung−AdenoCA Cancer type 7 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 21 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 30 CN segments 0.62, 2.3 Purity, ploidy
179	3	Lower_Left	c4d1e105-28b7-48df-abef-fbe09782fdb2		7, 2		{'min_x': 31.899999618530273, 'min_y': 718.9249877929688, 'max_x': 255.01596069335938, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB c4d1e105−28b7−48df−abef−fbe09782fdb2 Lung−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 136 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
179	4	Lower_Right	d2824e6d-3784-45c2-9b0f-52b17356b5da		7, 3		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 562.7122192382812, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB d2824e6d−3784−45c2−9b0f−52b17356b5da Lung−AdenoCA Cancer type 3 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 1 98 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
180	1	Upper_Left	d2824e6d-3784-45c2-9b0f-52b17356b5da		38, 3		{'min_x': 30.060199737548828, 'min_y': 283.9250183105469, 'max_x': 256.8599548339844, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB d2824e6d−3784−45c2−9b0f−52b17356b5da Lung−AdenoCA Cancer type 6 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 98 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 23 CN segments 0.38, 3.03 Purity, ploidy
180	2	Upper_Right	d2824e6d-3784-45c2-9b0f-52b17356b5da		38, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 546.3599853515625, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB d2824e6d−3784−45c2−9b0f−52b17356b5da Lung−AdenoCA Cancer type 9 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 98 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.38, 3.03 Purity, ploidy
180	3	Lower_Left	81b7cbc1-c037-426f-95b0-d729a30697da		9, 2		{'min_x': 30.219900131225586, 'min_y': 718.9249877929688, 'max_x': 256.6899719238281, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 81b7cbc1−c037−426f−95b0−d729a30697da Lung−SCC Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 72 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
180	4	Lower_Right	9293e197-e38a-4e19-a7d0-1b45d1ad48bd		10, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB 9293e197−e38a−4e19−a7d0−1b45d1ad48bd Lung−SCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 187 SVs in sample 10, Oscillating CN in chr (2 and 3 states)
181	1	Upper_Left	9a874b64-d0d6-416e-97bc-e9071ed0b16b		48, 2		{'min_x': 29.219900131225586, 'min_y': 283.9250183105469, 'max_x': 271.6021423339844, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 250 MB 9a874b64−d0d6−416e−97bc−e9071ed0b16b Lung−SCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 359 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 37 CN segments 0.48, 2.68 Purity, ploidy
181	2	Upper_Right	a3e1ac67-a1f2-44fb-8343-a7e8239fc24a		48, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.10205078125, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB a3e1ac67−a1f2−44fb−8343−a7e8239fc24a Lung−SCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 118 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 11 CN segments 0.48, 1.8 Purity, ploidy
181	3	Lower_Left	bd15f523-45c4-4d7c-a3cc-4fb56abb0e54		7, 1		{'min_x': 30.719900131225586, 'min_y': 718.9249877929688, 'max_x': 256.1819763183594, 'max_y': 830.013916015625}	25 MB 50 MB 75 MB bd15f523−45c4−4d7c−a3cc−4fb56abb0e54 Lung−SCC Cancer type 16 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 139 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
181	4	Lower_Right	e6b72c24-1607-43b9-8b8a-7bf83eea5895		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB e6b72c24−1607−43b9−8b8a−7bf83eea5895 Lung−SCC Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 265 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
182	1	Upper_Left	4105746		71, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 4105746 Lymph−BNHL Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 32 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 15 CN segments 0.71, 2.03 Purity, ploidy
182	2	Upper_Right	4111326		71, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 4111326 Lymph−BNHL Cancer type 2 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 1 36 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.71, 1.98 Purity, ploidy
182	3	Lower_Left	4134005		7, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 4134005 Lymph−BNHL Cancer type 2 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 19 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
182	4	Lower_Right	4135099		7, 7		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.652099609375, 'max_y': 830.013916015625}	0 MB 40 MB 80 MB 120 MB 160 MB 4135099 Lymph−BNHL Cancer type 7 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 297 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
183	1	Upper_Left	4135099		79, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 4135099 Lymph−BNHL Cancer type 11 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 297 SVs in sample 13, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.79, 1.91 Purity, ploidy
183	2	Upper_Right	4135099		79, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 20 MB 40 MB 60 MB 4135099 Lymph−BNHL Cancer type 18 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 297 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.79, 1.91 Purity, ploidy
183	3	Lower_Left	4138527		9, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 4138527 Lymph−BNHL Cancer type 11 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 187 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
183	4	Lower_Right	4163639		9, 7		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.652099609375, 'max_y': 830.013916015625}	0 MB 40 MB 80 MB 120 MB 160 MB 4163639 Lymph−BNHL Cancer type 7 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 146 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
184	1	Upper_Left	4176133		76, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 4176133 Lymph−BNHL Cancer type 2 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 59 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.76, 1.98 Purity, ploidy
184	2	Upper_Right	4196670		63, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 30 MB 60 MB 90 MB 4196670 Lymph−BNHL Cancer type 13 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 19 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.63, 2.01 Purity, ploidy
184	3	Lower_Left	177		9, 3		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 273.2117919921875, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB 177 Lymph−CLL Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 5 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
184	4	Lower_Right	SNU_WGS_06		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB SNU_WGS_06 Myeloid−AML Cancer type 1 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 5 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
185	1	Upper_Left	SNU_WGS_12		82, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB SNU_WGS_12 Myeloid−AML Cancer type 2 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 3 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 11 CN segments 0.82, 2 Purity, ploidy
185	2	Upper_Right	AOCS-060		68, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.10205078125, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB AOCS−060 Ovary−AdenoCA Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 197 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 24 CN segments 0.68, 2.95 Purity, ploidy
185	3	Lower_Left	AOCS-065		7, 9		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB AOCS−065 Ovary−AdenoCA Cancer type 9 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 255 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
185	4	Lower_Right	AOCS-086		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 522.8402099609375, 'max_y': 830.013916015625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB AOCS−086 Ovary−AdenoCA Cancer type 19 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 162 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
186	1	Upper_Left	AOCS-088		61, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	20 MB 40 MB 60 MB AOCS−088 Ovary−AdenoCA Cancer type 18 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 220 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.61, 1.92 Purity, ploidy
186	2	Upper_Right	AOCS-091		74, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB AOCS−091 Ovary−AdenoCA Cancer type 16 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 347 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.74, 3.31 Purity, ploidy
186	3	Lower_Left	AOCS-120		7, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 255.1118927001953, 'max_y': 830.013916015625}	25 MB 50 MB 75 MB 100 MB AOCS−120 Ovary−AdenoCA Cancer type 14 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 790 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
186	4	Lower_Right	AOCS-120		7, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 522.8402099609375, 'max_y': 830.013916015625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB AOCS−120 Ovary−AdenoCA Cancer type 19 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 790 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
187	1	Upper_Left	AOCS-128		37, 3		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB AOCS−128 Ovary−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 496 SVs in sample 12, Oscillating CN in chr (2 and 3 states) 15 CN segments 0.37, 3.11 Purity, ploidy
187	2	Upper_Right	AOCS-128		37, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 554.7123413085938, 'max_y': 413.843994140625}	0 MB 25 MB 50 MB 75 MB 100 MB AOCS−128 Ovary−AdenoCA Cancer type 15 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 496 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 19 CN segments 0.37, 3.11 Purity, ploidy
187	3	Lower_Left	AOCS-138				{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 263.072021484375, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB AOCS−138 Ovary−AdenoCA Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 323 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
187	4	Lower_Right	AOCS-158		7, 4		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB AOCS−158 Ovary−AdenoCA Cancer type 4 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 236 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
188	1	Upper_Left	AOCS-167		81, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB AOCS−167 Ovary−AdenoCA Cancer type 9 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 181 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.81, 1.9 Purity, ploidy
188	2	Upper_Right	AOCS-171		76, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 562.7122192382812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB AOCS−171 Ovary−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 258 SVs in sample 19, Oscillating CN in chr (2 and 3 states) 24 CN segments 0.76, 1.87 Purity, ploidy
188	3	Lower_Left	AOCS-171		9, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	25 MB 50 MB 75 MB AOCS−171 Ovary−AdenoCA Cancer type 16 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 258 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
188	4	Lower_Right	098acb76-0bf5-44e5-bcae-f919cf5fa5e5		9, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 543.8558959960938, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 11 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 718 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
189	1	Upper_Left	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18		75, 2		{'min_x': 31.38010025024414, 'min_y': 283.9250183105469, 'max_x': 255.52195739746094, 'max_y': 413.843994140625}	50 MB 100 MB 206ce0ed−36a4−47ab−ac8e−f6fca6ac5c18 Ovary−AdenoCA Cancer type 8 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 122 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 24 CN segments 0.75, 2.77 Purity, ploidy
189	2	Upper_Right	2b14123b-8fcd-402c-9399-4e7c47f20252		77, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 562.7122192382812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 2b14123b−8fcd−402c−9399−4e7c47f20252 Ovary−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 329 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 20 CN segments 0.77, 3.57 Purity, ploidy
189	3	Lower_Left	4eac2c98-86d2-4ee6-a1d3-157d013c78dc		8, 2		{'min_x': 29.719900131225586, 'min_y': 718.9249877929688, 'max_x': 257.1979675292969, 'max_y': 830.013916015625}	30 MB 60 MB 90 MB 4eac2c98−86d2−4ee6−a1d3−157d013c78dc Ovary−AdenoCA Cancer type 13 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 545 SVs in sample 8, Oscillating CN in chr (2 and 3 states)
189	4	Lower_Right	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a				{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 552.5719604492188, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 6d10d4ee−6331−4bba−93bc−a7b64cc0b22a Ovary−AdenoCA Cancer type X Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 239 SVs in sample 11, Oscillating CN in chr (2 and 3 states)
190	1	Upper_Left	a5030259-cf9c-4a58-8710-b9da8ee59320		89, 1		{'min_x': 30.719900131225586, 'min_y': 283.9250183105469, 'max_x': 256.199951171875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB a5030259−cf9c−4a58−8710−b9da8ee59320 Ovary−AdenoCA Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 303 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 24 CN segments 0.89, 1.94 Purity, ploidy
190	2	Upper_Right	c8febeef-8e7e-459e-88cb-8086692dc559		9, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 555.0601806640625, 'max_y': 413.843994140625}	0 MB 20 MB 40 MB 60 MB 80 MB c8febeef−8e7e−459e−88cb−8086692dc559 Ovary−AdenoCA Cancer type 17 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 122 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.9, 1.63 Purity, ploidy
190	3	Lower_Left	f5033d52-ec36-4e67-88d8-b6d898b81b2f		12, 12		{'min_x': 30.719900131225586, 'min_y': 718.9249877929688, 'max_x': 256.18194580078125, 'max_y': 830.013916015625}	50 MB 100 MB f5033d52−ec36−4e67−88d8−b6d898b81b2f Ovary−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 243 SVs in sample 12, Oscillating CN in chr (2 and 3 states)
190	4	Lower_Right	ff530f28-0ec0-4494-bb54-44bb055bae1c		9, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 544.8539428710938, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB ff530f28−0ec0−4494−bb54−44bb055bae1c Ovary−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 0 170 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
191	1	Upper_Left	ICGC_0006		41, 3		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 263.072021484375, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB ICGC_0006 Panc−AdenoCA Cancer type X Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 258 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 16 CN segments 0.41, 3.23 Purity, ploidy
191	2	Upper_Right	ICGC_0124		36, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 562.7122192382812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB ICGC_0124 Panc−AdenoCA Cancer type 3 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 57 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 10 CN segments 0.36, 2.99 Purity, ploidy
191	3	Lower_Left	ICGC_0140		13, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB ICGC_0140 Panc−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 163 SVs in sample 13, Oscillating CN in chr (2 and 3 states)
191	4	Lower_Right	ICGC_0201		9, 4		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB ICGC_0201 Panc−AdenoCA Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 71 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
192	1	Upper_Left	ICGC_0227		37, 3		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 273.2117919921875, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB ICGC_0227 Panc−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 115 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 17 CN segments 0.37, 3.51 Purity, ploidy
192	2	Upper_Right	ICGC_0543		53, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.10205078125, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB ICGC_0543 Panc−AdenoCA Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 161 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.53, 1.89 Purity, ploidy
192	3	Lower_Left	PCSI_0078		7, 1		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 255.1118927001953, 'max_y': 830.013916015625}	25 MB 50 MB 75 MB 100 MB PCSI_0078 Panc−AdenoCA Cancer type 14 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 101 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
192	4	Lower_Right	PCSI_0109		9, 2		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 30 MB 60 MB 90 MB PCSI_0109 Panc−AdenoCA Cancer type 13 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 72 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
193	1	Upper_Left	PCSI_0161		63, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 242.43215942382812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB PCSI_0161 Panc−AdenoCA Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 187 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 19 CN segments 0.63, 2.98 Purity, ploidy
193	2	Upper_Right	PCSI_0161		63, 2		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 552.59033203125, 'max_y': 413.843994140625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB PCSI_0161 Panc−AdenoCA Cancer type 22 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 187 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.63, 2.98 Purity, ploidy
193	3	Lower_Left	PCSI_0218		9, 2		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 200 MB PCSI_0218 Panc−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 166 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
193	4	Lower_Right	PCSI_0285		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 561.10205078125, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB PCSI_0285 Panc−AdenoCA Cancer type 1 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 446 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
194	1	Upper_Left	PCSI_0334		78, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	20 MB 40 MB 60 MB PCSI_0334 Panc−AdenoCA Cancer type 18 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 153 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 10 CN segments 0.78, 1.86 Purity, ploidy
194	2	Upper_Right	PCSI_0456		8, 3		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB PCSI_0456 Panc−AdenoCA Cancer type 12 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 99 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 8 CN segments 0.8, 3.6 Purity, ploidy
194	3	Lower_Left	PCSI_0457		9, 5		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB PCSI_0457 Panc−AdenoCA Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 27 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
194	4	Lower_Right	PCSI_0468		9, 3		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 562.7122192382812, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB PCSI_0468 Panc−AdenoCA Cancer type 3 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 105 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
195	1	Upper_Left	PCSI_0492		65, 2		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 272.1520080566406, 'max_y': 413.843994140625}	40 MB 80 MB 120 MB 160 MB PCSI_0492 Panc−AdenoCA Cancer type 7 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 73 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.65, 2.02 Purity, ploidy
195	2	Upper_Right	PCSI_0504		75, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB PCSI_0504 Panc−AdenoCA Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 81 SVs in sample 13, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.75, 1.81 Purity, ploidy
195	3	Lower_Left	PCSI_0504		9, 5		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB PCSI_0504 Panc−AdenoCA Cancer type 5 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 81 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
195	4	Lower_Right	PCSI_0528		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 547.3800048828125, 'max_y': 830.013916015625}	0 MB 20 MB 40 MB 60 MB PCSI_0528 Panc−AdenoCA Cancer type 20 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 1 76 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
196	1	Upper_Left	ITNET-0100		95, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB ITNET−0100 Panc−Endocrine Cancer type 2 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 160 SVs in sample 12, Oscillating CN in chr (2 and 3 states) 12 CN segments 0.95, 1.8 Purity, ploidy
196	2	Upper_Right	EOPC-01		53, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB EOPC−01 Prost−AdenoCA Cancer type 8 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 10 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.53, 1.85 Purity, ploidy
196	3	Lower_Left	EOPC-01		9, 1		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB EOPC−01 Prost−AdenoCA Cancer type 12 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 10 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
196	4	Lower_Right	EOPC-04		7, 5		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB EOPC−04 Prost−AdenoCA Cancer type 5 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 0 57 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
197	1	Upper_Left	EOPC-04		58, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB EOPC−04 Prost−AdenoCA Cancer type 8 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 1 57 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.58, 1.9 Purity, ploidy
197	2	Upper_Right	EOPC-09		39, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 562.7122192382812, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB 200 MB EOPC−09 Prost−AdenoCA Cancer type 3 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 7 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.39, 1.9 Purity, ploidy
197	3	Lower_Left	CPCG0046		7, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	20 MB 40 MB 60 MB CPCG0046 Prost−AdenoCA Cancer type 18 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 299 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
197	4	Lower_Right	CPCG0046		14, 19		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 522.8402099609375, 'max_y': 830.013916015625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB CPCG0046 Prost−AdenoCA Cancer type 19 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 299 SVs in sample 14, Oscillating CN in chr (2 and 3 states)
198	1	Upper_Left	CPCG0057		56, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CPCG0057 Prost−AdenoCA Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 58 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.56, 1.84 Purity, ploidy
198	2	Upper_Right	CPCG0057		56, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 561.652099609375, 'max_y': 413.843994140625}	0 MB 40 MB 80 MB 120 MB 160 MB CPCG0057 Prost−AdenoCA Cancer type 7 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 58 SVs in sample 8, Oscillating CN in chr (2 and 3 states) 14 CN segments 0.56, 1.84 Purity, ploidy
198	3	Lower_Left	CPCG0057		7, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	25 MB 50 MB 75 MB CPCG0057 Prost−AdenoCA Cancer type 16 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 58 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
198	4	Lower_Right	CPCG0057		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 555.0601806640625, 'max_y': 830.013916015625}	0 MB 20 MB 40 MB 60 MB 80 MB CPCG0057 Prost−AdenoCA Cancer type 17 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 1 58 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
199	1	Upper_Left	CPCG0094		46, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB CPCG0094 Prost−AdenoCA Cancer type 11 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 75 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 11 CN segments 0.46, 1.79 Purity, ploidy
199	2	Upper_Right	CPCG0102		24, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 30 MB 60 MB 90 MB CPCG0102 Prost−AdenoCA Cancer type 13 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 26 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 11 CN segments 0.24, 1.91 Purity, ploidy
199	3	Lower_Left	CPCG0121		7, 4		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB CPCG0121 Prost−AdenoCA Cancer type 4 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 64 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
199	4	Lower_Right	CPCG0121		7, 0		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 30 MB 60 MB 90 MB CPCG0121 Prost−AdenoCA Cancer type 13 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 64 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
200	1	Upper_Left	CPCG0213		49, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB CPCG0213 Prost−AdenoCA Cancer type 2 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 155 SVs in sample 11, Oscillating CN in chr (2 and 3 states) 25 CN segments 0.49, 1.87 Purity, ploidy
200	2	Upper_Right	CPCG0213		49, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB CPCG0213 Prost−AdenoCA Cancer type 5 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 155 SVs in sample 12, Oscillating CN in chr (2 and 3 states) 23 CN segments 0.49, 1.87 Purity, ploidy
200	3	Lower_Left	CPCG0213		7, 0		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB CPCG0213 Prost−AdenoCA Cancer type 11 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 155 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
200	4	Lower_Right	CPCG0234		7, 5		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB CPCG0234 Prost−AdenoCA Cancer type 5 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 21 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
201	1	Upper_Left	CPCG0250		26, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 242.43215942382812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CPCG0250 Prost−AdenoCA Cancer type 6 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 28 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 17 CN segments 0.26, 1.94 Purity, ploidy
201	2	Upper_Right	CPCG0250		26, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB CPCG0250 Prost−AdenoCA Cancer type 8 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 28 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.26, 1.94 Purity, ploidy
201	3	Lower_Left	CPCG0250		7, 9		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB CPCG0250 Prost−AdenoCA Cancer type 9 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 28 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
201	4	Lower_Right	CPCG0250		7, 0		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB CPCG0250 Prost−AdenoCA Cancer type 12 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 28 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
202	1	Upper_Left	CPCG0266		51, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 232.38186645507812, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB CPCG0266 Prost−AdenoCA Cancer type 4 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 121 SVs in sample 13, Oscillating CN in chr (2 and 3 states) 13 CN segments 0.51, 1.91 Purity, ploidy
202	2	Upper_Right	CPCG0266		51, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB 150 MB CPCG0266 Prost−AdenoCA Cancer type 5 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 0 121 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 19 CN segments 0.51, 1.91 Purity, ploidy
202	3	Lower_Left	CPCG0266		7, 9		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 232.38186645507812, 'max_y': 830.013916015625}	50 MB 100 MB CPCG0266 Prost−AdenoCA Cancer type 9 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 121 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
202	4	Lower_Right	CPCG0266		7, 1		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB CPCG0266 Prost−AdenoCA Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 0 121 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
203	1	Upper_Left	CPCG0339		97, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 272.1520080566406, 'max_y': 413.843994140625}	40 MB 80 MB 120 MB 160 MB CPCG0339 Prost−AdenoCA Cancer type 7 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 51 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.97, 1.93 Purity, ploidy
203	2	Upper_Right	CPCG0341		55, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 521.8820190429688, 'max_y': 413.843994140625}	0 MB 50 MB 100 MB CPCG0341 Prost−AdenoCA Cancer type 11 Position 1 Interleaved intrachr. SVs 1 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 31 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.55, 1.89 Purity, ploidy
203	3	Lower_Left	CPCG0345		7, 7		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 272.1520080566406, 'max_y': 830.013916015625}	40 MB 80 MB 120 MB 160 MB CPCG0345 Prost−AdenoCA Cancer type 7 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 57 SVs in sample 7, Oscillating CN in chr (2 and 3 states)
203	4	Lower_Right	CPCG0345		9, 0		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 521.8820190429688, 'max_y': 830.013916015625}	0 MB 25 MB 50 MB 75 MB CPCG0345 Prost−AdenoCA Cancer type 16 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 57 SVs in sample 9, Oscillating CN in chr (2 and 3 states)
204	1	Upper_Left	CPCG0371		55, 1		{'min_x': 54.53010177612305, 'min_y': 283.9250183105469, 'max_x': 271.6021423339844, 'max_y': 413.843994140625}	50 MB 100 MB 150 MB 200 MB 250 MB CPCG0371 Prost−AdenoCA Cancer type 1 Position 1 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 90 SVs in sample 7, Oscillating CN in chr (2 and 3 states) 7 CN segments 0.55, 1.87 Purity, ploidy
204	2	Upper_Right	CPCG0371		55, 1		{'min_x': 309.42999267578125, 'min_y': 283.9250183105469, 'max_x': 552.59033203125, 'max_y': 413.843994140625}	0 MB 10 MB 20 MB 30 MB 40 MB 50 MB CPCG0371 Prost−AdenoCA Cancer type 22 Position 0 Interleaved intrachr. SVs 0 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 0; SV types t2tINV: 0; TRA: 0 90 SVs in sample 9, Oscillating CN in chr (2 and 3 states) 9 CN segments 0.55, 1.87 Purity, ploidy
204	3	Lower_Left	0078_CRUK_PC_0078		11, 95		{'min_x': 54.53010177612305, 'min_y': 718.9249877929688, 'max_x': 242.43215942382812, 'max_y': 830.013916015625}	50 MB 100 MB 150 MB 0078_CRUK_PC_0078 Prost−AdenoCA Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 95 SVs in sample 11, Oscillating CN in chr (2 and 3 states)
204	4	Lower_Right	A10-0015_CRUK_PC_0015		28, 6		{'min_x': 309.42999267578125, 'min_y': 718.9249877929688, 'max_x': 531.93212890625, 'max_y': 830.013916015625}	0 MB 50 MB 100 MB 150 MB A10−0015_CRUK_PC_0015 Prost−AdenoCA Cancer type 6 Position 2 Interleaved intrachr. SVs 2 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 0 547 SVs in sample 28, Oscillating CN in chr (2 and 3 states)
